
<html lang="en"     class="pb-page"  data-request-id="8caec07f-4943-4138-8611-c5040f3123e4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00974;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate" /></meta><meta name="dc.Creator" content="Stefano  Crosignani" /></meta><meta name="dc.Creator" content="Patrick  Bingham" /></meta><meta name="dc.Creator" content="Pauline  Bottemanne" /></meta><meta name="dc.Creator" content="Hélène  Cannelle" /></meta><meta name="dc.Creator" content="Sandra  Cauwenberghs" /></meta><meta name="dc.Creator" content="Marie  Cordonnier" /></meta><meta name="dc.Creator" content="Deepak  Dalvie" /></meta><meta name="dc.Creator" content="Frederik  Deroose" /></meta><meta name="dc.Creator" content="Jun Li  Feng" /></meta><meta name="dc.Creator" content="Bruno  Gomes" /></meta><meta name="dc.Creator" content="Samantha  Greasley" /></meta><meta name="dc.Creator" content="Stephen E  Kaiser" /></meta><meta name="dc.Creator" content="Manfred  Kraus" /></meta><meta name="dc.Creator" content="Michel  Négrerie" /></meta><meta name="dc.Creator" content="Karen  Maegley" /></meta><meta name="dc.Creator" content="Nichol  Miller" /></meta><meta name="dc.Creator" content="Brion W  Murray" /></meta><meta name="dc.Creator" content="Manfred  Schneider" /></meta><meta name="dc.Creator" content="James  Soloweij" /></meta><meta name="dc.Creator" content="Albert E  Stewart" /></meta><meta name="dc.Creator" content="Joseph  Tumang" /></meta><meta name="dc.Creator" content="Vince R  Torti" /></meta><meta name="dc.Creator" content="Benoit  Van Den Eynde" /></meta><meta name="dc.Creator" content="Martin  Wythes" /></meta><meta name="dc.Description" content="Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes ..." /></meta><meta name="Description" content="Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 21, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00974" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00974" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00974" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00974" /></link>
        
    
    

<title>Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00974" /></meta><meta property="og:title" content="Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0010.jpeg" /></meta><meta property="og:description" content="Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function. As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncology. Starting from HTS hit 5, IDO-1 inhibitor 6 (EOS200271/PF-06840003) has been developed. The structure–activity relationship around 6 is described and rationalized using the X-ray crystal structure of 6 bound to human IDO-1, which shows that 6, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode. Clinical candidate 6 shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16–19 h." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00974"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00974">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00974&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00974&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00974&amp;href=/doi/10.1021/acs.jmedchem.7b00974" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9617-9629</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01046" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01064" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Crosignani">Stefano Crosignani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Bingham">Patrick Bingham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pauline++Bottemanne">Pauline Bottemanne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H%C3%A9l%C3%A8ne++Cannelle">Hélène Cannelle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Cauwenberghs">Sandra Cauwenberghs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie++Cordonnier">Marie Cordonnier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Dalvie">Deepak Dalvie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederik++Deroose">Frederik Deroose</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun+Li++Feng">Jun Li Feng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruno++Gomes">Bruno Gomes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Greasley">Samantha Greasley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+E++Kaiser">Stephen E Kaiser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manfred++Kraus">Manfred Kraus</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++N%C3%A9grerie">Michel Négrerie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Maegley">Karen Maegley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nichol++Miller">Nichol Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brion+W++Murray">Brion W Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manfred++Schneider">Manfred Schneider</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Soloweij">James Soloweij</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert+E++Stewart">Albert E Stewart</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Tumang">Joseph Tumang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vince+R++Torti">Vince R Torti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Van+Den+Eynde">Benoit Van Den Eynde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Wythes">Martin Wythes</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">iTeos Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">La Jolla Laboratories, Pfizer Global Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Ludwig Institute for Cancer Research, Université Catholique de Louvain, 74 Avenue Hippocrate, 1200 Brussels, Belgium</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Asclepia Outsourcing Solutions, Damvalleistraat 49, Destelbergen 9070, Belgium</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Ecole Polytechnique, Unité Inserm 1182 UMR 7645, Route de Saclay, Palaiseau 91128, France</span></div><div class="corresp-info"><strong>*</strong>Phone: +3271919932. Fax: +3271919959. E-mail: <a href="/cdn-cgi/l/email-protection#b4c7c0d1d2d5dadb9ad7c6dbc7ddd3dad5daddf4ddc0d1dbc7c0dcd1c6d5c4d1c1c0ddd7c79ad7dbd9"><span class="__cf_email__" data-cfemail="0c7f78696a6d6263226f7e637f656b626d62654c657869637f7864697e6d7c697978656f7f226f6361">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: 858-622-7529. E-mail: <a href="/cdn-cgi/l/email-protection#82efe3f0f6ebecacf5fbf6eae7f1c2f2e4ebf8e7f0ace1edef"><span class="__cf_email__" data-cfemail="e5888497918c8bcb929c918d8096a595838c9f8097cb868a88">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00974&amp;href=/doi/10.1021%2Facs.jmedchem.7b00974" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9617–9629</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 7, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 July 2017</li><li><span class="item_label"><b>Published</b> online</span>21 November 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00974" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00974</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9617%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStefano%2BCrosignani%252C%2BPatrick%2BBingham%252C%2BPauline%2BBottemanne%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D23%26contentID%3Dacs.jmedchem.7b00974%26title%3DDiscovery%2Bof%2Ba%2BNovel%2Band%2BSelective%2BIndoleamine%2B2%252C3-Dioxygenase%2B%2528IDO-1%2529%2BInhibitor%2B3-%25285-Fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2B%2528EOS200271%252FPF-06840003%2529%2Band%2BIts%2BCharacterization%2Bas%2Ba%2BPotential%2BClinical%2BCandidate%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9629%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00974"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4899</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">76</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00974" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Crosignani&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Bingham&quot;},{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;Bottemanne&quot;},{&quot;first_name&quot;:&quot;Hélène&quot;,&quot;last_name&quot;:&quot;Cannelle&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Cauwenberghs&quot;},{&quot;first_name&quot;:&quot;Marie&quot;,&quot;last_name&quot;:&quot;Cordonnier&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Dalvie&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;Deroose&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Li Feng&quot;},{&quot;first_name&quot;:&quot;Bruno&quot;,&quot;last_name&quot;:&quot;Gomes&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Greasley&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;E Kaiser&quot;},{&quot;first_name&quot;:&quot;Manfred&quot;,&quot;last_name&quot;:&quot;Kraus&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Négrerie&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Maegley&quot;},{&quot;first_name&quot;:&quot;Nichol&quot;,&quot;last_name&quot;:&quot;Miller&quot;},{&quot;first_name&quot;:&quot;Brion&quot;,&quot;last_name&quot;:&quot;W Murray&quot;},{&quot;first_name&quot;:&quot;Manfred&quot;,&quot;last_name&quot;:&quot;Schneider&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Soloweij&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;E Stewart&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Tumang&quot;},{&quot;first_name&quot;:&quot;Vince&quot;,&quot;last_name&quot;:&quot;R Torti&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Van Den Eynde&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Wythes&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9617-9629&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00974&quot;},&quot;abstract&quot;:&quot;Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function. As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncology. Starting from HTS hit 5, IDO-1 inhibitor 6 (EOS200271/PF-06840003) has been developed. The structure–activity relationship around 6 is described and rationalized using the X-ray crystal structure of 6 bound to human IDO-1, which shows that 6, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode. Clinical candidate 6 shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16–19 h.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00974&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00974" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00974&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00974" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00974&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00974" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00974&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00974&amp;href=/doi/10.1021/acs.jmedchem.7b00974" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00974" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00974" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00974%26sid%3Dliteratum%253Aachs%26pmid%3D29111717%26genre%3Darticle%26aulast%3DCrosignani%26date%3D2017%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%2Band%2BSelective%2BIndoleamine%2B2%252C3-Dioxygenase%2B%2528IDO-1%2529%2BInhibitor%2B3-%25285-Fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2B%2528EOS200271%252FPF-06840003%2529%2Band%2BIts%2BCharacterization%2Bas%2Ba%2BPotential%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D23%26spage%3D9617%26epage%3D9629%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/jmcmar.2017.60.issue-23/20171214/jmcmar.2017.60.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment. IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function. As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncology. Starting from HTS hit <b>5</b>, IDO-1 inhibitor <b>6</b> (EOS200271/PF-06840003) has been developed. The structure–activity relationship around <b>6</b> is described and rationalized using the X-ray crystal structure of <b>6</b> bound to human IDO-1, which shows that <b>6</b>, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode. Clinical candidate <b>6</b> shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16–19 h.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Immune checkpoint blockade, as a breakthrough in cancer therapy with anti-PDL1 (programmed death-ligand 1), anti-PD1 (programmed cell death protein 1), and anti-CTLA4 (cytotoxic T-lymphocyte-associated protein 4), has demonstrated impressive therapeutic effects in multiple clinical trials.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, only a small minority of patients respond to such therapies. Therefore, there is a need to identify other tumor immunosuppressive and resistance mechanisms. Indoleamine 2,3-dioxygenase (IDO-1) is a heme-containing dioxygenase that contributes to metabolic immune regulation by catalyzing oxidative catabolism of the essential amino-acid tryptophan to <i>N</i>-formyl kynurenine. After this first and rate-limiting step of tryptophan catabolism, <i>N</i>-formyl kynurenine is subsequently converted to kynurenine and other immunologically active metabolites via the kynurenine pathway. IDO-1 modifies immune response by producing biologically active kynurenine pathway metabolites and natural ligands for the aryl hydrocarbon receptor (AhR) and by depleting tryptophan to trigger amino-acid sensing signal transduction pathways.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Given the IDO-1 enzymatic activity-mediated suppression of T-cell responses<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and the correlation between IDO-1 expression and poor prognosis and chemoresistance in several cancer indications,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> IDO-1 is a target of interest for cancer immunotherapy. Indeed, potential IDO-1-inhibiting drugs for use in human cancers are now the focus of research and development efforts.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p last">At the time this project was started, only one IDO-1 inhibitor was in clinical trials, INCB24360.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Considering the high attractiveness of the target, as well as the limitations of this compound, which despite its good potency still requires a relatively high dose to reach full inhibition of the target and which has a relatively short half-life in human and requires BID administration, it was important to discover novel IDO-1 inhibitors, with the potential to become clinically relevant therapeutics for oncology immunotherapy.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A library of 178 000 diverse compounds was screened using a modification of the published hIDO-1 enzymatic assay (based on detection of <i>N</i>-formyl kynurenine by measuring absorbance at 320 nm), adapted for 384-well plate format (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Among the confirmed hits, the most promising for subsequent optimization was compound <b>5</b>. When tested on the <i>p</i>-dimethylamino benzaldehyde assay (based on detection of kynurenine after formation of an adduct with <i>p</i>-dimethylamino benzaldehyde, PDMAB),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> this compound showed a moderate potency on hIDO-1 in the enzymatic assay (IC<sub>50</sub> 3.0 μM) but no activity on tryptophan 2,3-dioxygenase (hTDO-2, up to 50 μM). Given its extremely low molecular weight, the compound had a good ligand efficiency (LE) of 0.47, highlighting the high efficiency of interaction of the compound with hIDO-1. Other indole-containing compounds have been reported as hIDO-1 inhibitors but all with reported <i>K</i><sub>i</sub>s of >10 μM.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21">(13-21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some inhibitors of hIDO-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Of the two enantiomers of <b>5</b>, only one showed appreciable activity on hIDO-1 in the enzymatic assay (<b>5a</b>, IC<sub>50</sub> 1.8 μM), whereas the other enantiomer (<b>5b</b>) had only marginal activity on hIDO-1 (IC<sub>50</sub> 83 μM). The active enantiomer <b>5a</b> was further profiled to assess its suitability as a starting point for further optimization.</div><div class="NLM_p">Of particular interest, the compound displayed a very attractive ADME profile (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>): a very moderate protein binding, excellent stability in human and mouse microsomes, and excellent permeability in a Caco-2 assay (with no active efflux). Additionally, no significant cytochrome P450 (CYP) inhibition was observed on five isoforms (IC<sub>50</sub>s > 50 μM on 1A2, 2C19, 2C9, 2D6, and 3A4). <i>In vivo</i>, <b>5a</b> also displayed an excellent profile in mice, with moderate clearance (15.6 mL/min/kg, 17% Q<sub>H</sub>), medium volume of distribution, and good oral bioavailability (63% and 65%, respectively, at 5 and 30 mg/kg, using a simple suspension administration).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Hit <b>5a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hIDO-1 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (h/m, F<sub>u</sub>)</td><td class="colsep0 rowsep0" align="left">43%/55%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomal Cl<sub>int</sub> (h/m; μL/min/μg)</td><td class="colsep0 rowsep0" align="left"><10/<10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 P<sub>app</sub> (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">28 (efflux ratio 0.77)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP450 IC<sub>50</sub> (1A2, 2C9, 2C19, 2D6, 3A4; μM)</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PK Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">15.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PK V<sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PK <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PK F<sub>z</sub> (5 and 30 mg/kg)</td><td class="colsep0 rowsep0" align="left">63%/65%</td></tr></tbody></table></div></div><div class="NLM_p">Overall, despite the moderate potency, <b>5a</b> was considered a good starting point for further optimization.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Generally, 3-(3-indolyl)-succinimides could be easily prepared by heating the corresponding indoles (commercially available or prepared according to published procedures) with maleimide in acetic acid, either at reflux for several hours or at higher temperatures in a microwave apparatus (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). For scaling-up, the reaction conditions for this coupling in acetic acid were found to generate a significant number of byproducts, so a milder alternative was sought. A number of Lewis acids were tested as catalysts for the reaction, and zinc chloride in acetonitrile at 85 °C was found to give excellent conversions and to give a product easy to purify by a simple recrystallization, at least for the preparation of compound <b>6</b>. Nitriles <b>9</b> and <b>17</b> were obtained from the corresponding bromides <b>8</b> and <b>16</b>, by copper-catalyzed cyanation (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indole Derivatives <b>1</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) maleimide, acetic acid, 170 °C (microwave irradiation), 2 h. (b) CuCN, NMP, 200 °C (microwave irradiation) 1.5 h.</p></p></figure><div class="NLM_p">3-(1-Naphthyl)-succinimide <b>25</b> was prepared starting from 1-naphthyl-boronic acid, by [RhOH(cod)]<sub>2</sub>-catalyzed coupling with maleimide (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Substituted 3-(1-naphthyl)-succinimides were prepared from the corresponding 1-nephthalene-amines, via the respective diazo salts and then succinic acids (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Naphthalene Derivatives <b>25</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) maleimide, [RhOH(cod)]<sub>2</sub>, Et<sub>3</sub>N, dioxane, 50 °C, 2.5 h; (b) HBF<sub>4</sub>, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C–RT, 1 h; (c) maleic anhydride, TiCl<sub>3</sub>, water/acetone; (d) urea, 180 °C, 1 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Activity</h3><div class="NLM_p">Systematic structure–activity relationship (SAR) studies were performed on both halves of the molecule (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). It soon became apparent that the succinimide could not be modified without very significant drops in activity (list of molecules with full biological data in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Removal of either or both of the carbonyl groups to give either the regioisomeric pyrrolidinones or the corresponding pyrrolidine, or ring expansion to the corresponding glutarimide (either regioisomer) all gave compounds with IC<sub>50</sub> > 30 μM. Similarly, substitution with a methyl group on either the succinimide nitrogen or on either of the two succinimide aliphatic carbon atoms (with any stereochemistry) resulted in loss of more than an order of magnitude of activity. Also, replacing the succinimide CH<sub>2</sub> group with either a nitrogen or oxygen atom resulted in compounds with IC<sub>50</sub> > 50 μM. Finally, inserting a CH<sub>2</sub> linker between the succinimide and indole groups also resulted in loss of activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Indolyl and Naphthyl Succinimides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> hIDO-1 (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CH═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">CH═CH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">CH═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">CH═CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">CH═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>></i>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Average of <i>n</i> ≥ 2 independent experiments.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">First enantiomer (by elution order in chiral HPLC).</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Second enantiomer (by elution order in chiral HPLC).</p></div></div></div><div class="NLM_p">Exploration of the indole group also quickly showed that some parts of the molecule were not free for substitution: methylation of the indole NH or of the C2 resulted in significant drop in activity, whereas substitution in positions C4 and C7 with either methyl, chlorine, or methoxy also gave compounds with IC<sub>50</sub>s > 50 μM (full list of compounds with biological data in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). However, substitution on positions C5 and C6 of the indole turned out to be more tolerated and, in some cases, beneficial. In position 5, a clear preference was identified for halogens, with increase in activity for the fluoro (<b>6</b>, IC<sub>50</sub> 0.15 μM), chloro (<b>7</b>, IC<sub>50</sub> 0.83 μM), and bromo (<b>8</b>, IC<sub>50</sub> 0.37 μM) substitutions, whereas substitution with methyl (<b>11</b>, IC<sub>50</sub> 53 μM), methoxy (<b>10</b>, IC<sub>50</sub> 53 μM), and CF<sub>3</sub> (<b>12</b>, IC<sub>50</sub> 9.7 μM) groups led to significant loss of activity. In position 6, substitution with halogen was neutral for potency (F, <b>13</b>, IC<sub>50</sub> 3.4 μM); Cl, <b>14</b>, IC<sub>50</sub> 2.1 μM) or advantageous (Br, <b>15</b>, IC<sub>50</sub> 0.42 μM), whereas other substitutions led to loss of potency, with the exception of the nitrile substituent (<b>16</b>, IC<sub>50</sub> 1.7 μM).</div><div class="NLM_p">Having identified <b>6</b> as the most potent monosubstituted compound, we tried a small number of doubly substituted compounds based on this scaffold: as expected, adding a methyl group in position 6 (<b>22</b>, IC<sub>50</sub> 46 μM) led to a significant drop in activity, but unfortunately, adding a fluorine (<b>19</b>, IC<sub>50</sub> 1.8 μM), chlorine (<b>20</b>, IC<sub>50</sub> 0.49 μM) or bromine (<b>21</b>, IC<sub>50</sub> 0.29 μM) in position 6 did not yield any improvement in potency compared to <b>6</b>.</div><div class="NLM_p">Finally, several replacements of the indole core with alternative heterocycles were attempted. Replacement with indazole, benzimidazole, all four regioisomeric azaindoles, different isoquinoline and quinoline regioisomers, different indole regioisomers, and substituted benzofurans and benzothiophenes were all found to be significantly less active (IC<sub>50</sub> > 20 μM, full list of compounds with biological data in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The only replacement that maintained a significant potency on the target was found to be the 1-napthalene compound <b>23</b> (IC<sub>50</sub> 18 μM). It was thus decided to explore if appropriate substitution with halogens might yield potent compounds. Unfortunately, the most potent compound in this subseries was <b>24</b>, which was still significantly less potent than <b>6</b> (IC<sub>50</sub> 4.6 μM), while having significantly higher cLogP, and was thus not further pursued.</div><div class="NLM_p">Compound <b>6</b> was separated into its pure enantiomers, <b>6</b> and <b>6b</b>. As observed for <b>5</b>, only one of the two enantiomers <b>6a</b> was responsible for the inhibition of IDO-1 in the enzymatic assay. The absolute configuration of the active enantiomer of <b>6</b> was determined by X-ray crystallography and found to be (R).</div><div class="NLM_p">Subsequent to the discovery of <b>6a</b>, further structural insights to its IDO-1 inhibition binding mode were sought, by X-ray and spectroscopic methods. IDO-1 has an active site heme cofactor, which enables mechanistic characterization of inhibitor binding interactions. Heme is a porphyrin ring with an iron at its center, which absorbs light in UV–vis spectrum maximally at a wavelength around 400 nm depending on the oxidation and coordination states of its iron, the Soret band.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Inhibitors that coordinate the heme iron will shift the Soret band λ<sub>max</sub>. Inhibitors that do not directly coordinate the iron will only modulate the Soret band because the heme is highly sensitive to changes in the polarity of its surroundings.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The observed Soret bands for the ferrous IDO-1 (λ<sub>max</sub> 427 nm) and ferric IDO-1 (λ<sub>max</sub> 405 nm) are in-line with values previously reported (Fe<sup>2+</sup> form, 429 nm; Fe<sup>3+</sup> form, 404 nm).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The IDO-1 inhibitors did not shift the Soret λ<sub>max</sub> for either ferric or ferrous forms of IDO-1, which is not consistent with direct binding to the heme iron (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The binding affinity of the IDO-1 inhibitors was determined by measuring the decrease in the Soret band absorbance. Compound <b>6a</b> is shown to bind weakly to both the ferric and ferrous forms of IDO-1 in the presence of oxygen with apparent binding constants of 9 and 6 μM, respectively. Under conditions where the oxygen content is depleted, <b>6a</b> binds to the ferric form of IDO-1 with an apparent binding constant of 0.16 μM. This value is in-line with the IC<sub>50</sub> value determined kinetically and suggests that the ferric form, without oxygen bound at the heme, is the form of the enzyme that the inhibitor binds to during catalysis. Further analysis of the ferric form with depleted oxygen and added tryptophan showed that the affinity (<i>K</i><sub>d</sub><sup>app</sup> 0.15 μM) is similar to the value in the absence of tryptophan (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Since tryptophan does not bind this form of the enzyme tightly, <b>6a</b> is unlikely to be competitive with tryptophan. These findings are consistent with <b>6a</b> being a tryptophan noncompetitive, nonheme binding IDO-1 inhibitor. Similar results were shown for the racemic compound <b>6</b> indicating that the behavior of the racemic mixture and the pure enantiomer are comparable.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical Affinity Analysis for Different Forms of IDO-1<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="5" align="center">IDO-1 inhibitor binding to different forms of hIDO1 (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">IDO-1 inhibitor</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub><sup>app</sup> ferrous</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub><sup>app</sup> ferric</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub><sup>app</sup> ferric (depleted O<sub>2</sub>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub><sup>app</sup> ferric (depleted O<sub>2</sub>, +Trp)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">14 (12–16)</td><td class="colsep0 rowsep0" align="left">22.3 (22.1–22.6)</td><td class="colsep0 rowsep0" align="left">0.32 (0.27–0.38)</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">6 (3–12)</td><td class="colsep0 rowsep0" align="left">7 (5–11)</td><td class="colsep0 rowsep0" align="left">0.16 (0.13–0.19)</td><td class="colsep0 rowsep0" align="left">0.15 (0.12–0.19)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Inhibition was determined by a decrease of the Soret band intensity (ferrous form λ<sub>max</sub> = 427 nm, ferric form λ<sub>max</sub> = 405 nm). Data are represented as geometric mean in μM, plus 95% confidence interval in parentheses determined from two independent experiments. K<sub>d</sub><sup>app</sup> ferrous are derived from titrating the inhibitors into the ferrous form of IDO-1. K<sub>d</sub><sup>app</sup> ferric is derived from titrating the inhibitors into the ferric form of IDO-1 without measures to remove oxygen. K<sub>d</sub><sup>app</sup> ferric (depleted O<sub>2</sub>) is derived from titrating the inhibitors into the ferric form of IDO-1 following oxygen depletion. K<sub>d</sub><sup>app</sup> ferric (depleted O<sub>2</sub>, +Trp) is derived from titrating the inhibitors into the ferric form of IDO-1 in the presence of tryptophan following oxygen depletion. K<sub>d</sub><sup>app</sup> is the apparent dissociation constant. NT = not tested.</p></div></div></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Evaluation of <b>6</b>. (A) Ferrous hIDO1. (B) Ferric hIDO1 in the presence of oxygen. (C) Ferric hIDO1 after oxygen depletion. (D) Ferric hIDO1 with tryptophan after oxygen depletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm this binding mode hypothesis, and to map the interactions between <b>6a</b> and hIDO-1, an X-ray of the <b>6a</b>-IDO-1 complex was obtained (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WHR">5WHR</a>). This structure shows that the succinimide ring of <b>6a</b> sits parallel to the heme, at a short distance from it, displacing the apical water molecule, while the indole ring lies in the lipophilic pocket. There is no direct interaction between <b>6a</b> and the iron atom, despite the close spatial proximity, which justifies the absence of an apical water molecule. Remarkably, all four heteroatoms of <b>6a</b> participate in hydrogen bonding. The indole NH interacts with side chain of Ser167, while the succinimide NH hydrogen bonds to the heme carboxylic acid, which adopts a different rotomer compared to other IDO-1 structures in the PDB. The two carbonyls interact to the main chain NH of Ala264 and Thr379. Indeed, residues 376–383 adopt a unique conformation in the <b>6a</b> bound structure by forming a loop that folds up to close off the binding pocket and positions Thr379 to interact with the ligand (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, loop residues highlighted in dark blue Cα trace). In addition to the hydrogen bond interactions, several aromatic groups (Tyr126, Phe163, Phe164) are appropriately positioned to give π–π interactions with the indole aromatic core. Additional lipophilic residues also are in close contact with the indole group (Leu234, Val130, Cys129).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 2.28 Å X-ray structure of the complex hIDO-1-<b>6a</b>. Protein is represented in light blue Cα trace with key interacting residues in orange and green stick representation. The ligand, <b>6a</b>, is drawn in magenta and the heme in cyan stick representation. (A) Key hydrogen bond interactions. (B) Connolly surface of the protein is shown in gray highlighting the closed binding pocket as a result of the unique ordering of loop A376-D383 (dark blue Cα trace). (<b>C</b>) Superposition of the crystal structure of IDO-1 bound to <b>6a</b> versus PDB IDO-1 structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK3">5EK3</a> (gray Cα trace with gray heme in stick representation, ligand removed for clarity). The unique conformation of residues 376–383, which form a loop in the <b>6a</b>-bound structure, are shown in dark blue Cα trace. Also shown is the different rotomer adopted by the heme carboxylic acid to interact with the succinimide NH of <b>6a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The very tight packing of the molecule within the IDO-1 active site clearly explains the lack of activity of most of the analogues bearing larger substituents around the indole, as well as the challenge to change any of the succinimide features. Quaternarization of the chiral carbon, which would avoid racemization, is also prevented by its closeness to the heme.</div><div class="NLM_p">To confirm activity of <b>6</b> and <b>6a</b> on the hIDO-1 enzyme, a new assay was developed, using a more sensitive high-throughput mass spectrometry assay, which monitors tryptophan and kynurenine. The new assay format allowed us to use lower concentrations of enzyme (1.5 nM) and to have better reproducibility. The IC<sub>50</sub>s of <b>6</b> and <b>6a</b> in this assay were 0.40 and 0.20 μM, respectively; whereas the other enantiomer <b>6b</b> had much weaker affinity for hIDO1 with an IC<sub>50</sub> of 38 μM. Compounds <b>6</b> and <b>6a</b> were found to be less active on the mouse enzyme (IC<sub>50</sub> 1.5 and 7.3 μM, respectively), whereas the activity on dog IDO-1 was more similar to human IDO-1 (IC<sub>50</sub> 0.59 and 0.20 μM). Compound <b>6</b> was found to have very weak activity against hTDO-2, with an IC<sub>50</sub> of 140 μM (<a class="ref internalNav" href="#tbl3a" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl3a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of <i>in Vitro</i> Pharmacology Data for <b>6</b> and <b>6a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>6a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hIDO-1 IC<sub>50</sub> (LC–MSMS method, μM)</td><td class="colsep0 rowsep0" align="center">0.41</td><td class="colsep0 rowsep0" align="center">0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mIDO-1 IC<sub>50</sub> (LC–MS/MS method, μM)</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dIDO-1 IC<sub>50</sub> (LC–MS/MS method, μM)</td><td class="colsep0 rowsep0" align="center">0.59</td><td class="colsep0 rowsep0" align="center">0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HeLa cell IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">THP1 cell IC<sub>50</sub> (INFγ/LPS, μM)</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hTDO-2 IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">whole blood IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">4.7 (total)</td><td class="colsep0 rowsep0" align="center">2.5 (total) 1.1 (unbound)</td></tr></tbody></table></div></div><div class="NLM_p">In cellular assays, <b>6</b> and <b>6a</b> were first tested in the classical hIDO-1 HeLa assay:<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> HeLa cells are well-known to produce hIDO-1 after stimulation with interferon gamma (INFγ). Incubation of the cells for 24 h after stimulation produces significant levels of kynurenine. In addition to the HeLa cell system, <b>6</b> and <b>6a</b> were also tested using a second cellular assay based on THP1 (acute monocytic leukemia) cells to test the effect on a cell line derived from a myeloid-derived cell line. In these cellular assays, <b>6</b> and <b>6a</b> showed activity both in the HeLa assay (IC<sub>50</sub> 1.8 and 1.0 μM, respectively) as well as in the LPS/INFγ-stimulated THP1 cells (IC<sub>50</sub> 1.7 and 1.1 μM).</div><div class="NLM_p">Interestingly, we also observed a significant activity of enantiomer <b>6b</b> in the HeLa assay (IC<sub>50</sub> 13 μM), with only a 13-fold difference in potency between the two enantiomers, compared to a 190-fold difference in activity in the enzymatic assay. Considering that the chiral center of <b>6</b> is an enolizable carbon, this was interpreted as a sign that significant racemization of the compound could be happening in the conditions of the cellular assay, but not of the enzymatic assay.</div><div class="NLM_p">As reported in more detail elsewhere,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> compounds <b>6</b> and <b>6a</b> were also tested in a human whole blood assay: in this assay, whole blood from healthy volunteers, in the presence of different concentrations of inhibitors, is treated with INFγ and LPS to induce IDO-1. After 24 h, the kynurenine produced can be measured by LC–MS/MS. The presence of full plasma and red blood cells makes this assay more physiologically relevant, as plasma protein binding and red blood cell distribution will affect the potency of the compound, so that only the unbound fraction of each compound can really inhibit the target. The assay was repeated on nine different donors, to account for differences due to any possible difference in immune status or metabolism of each individual donor. Despite the moderate potency in isolated cell systems, the low protein binding makes the <b>6</b> and <b>6a</b> maintain a good efficiency in the whole blood assay, with IC<sub>50</sub> of, respectively, 4.7 ± 2.4 and 2.5 ± 1.5 μM. Compound <b>6</b> was tested against hIDO2, and it is inactive up to 200 μM. The individual enantiomers were not tested due to very limited enzyme supply.</div><div class="NLM_p last">As reported in more detail elsewhere,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> compound <b>6</b> was evaluated for target selectivity, cardiovascular effects, and genotoxic potential in a series of in vitro assays. To assess the off-target binding potential, <b>6</b> was tested at a concentration of 200 μM in a CEREP Wide Ligand Profile Screen, where it showed good selectivity.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The potential for cardiovascular impact, specifically QT prolongation, was tested using the hERG assay, where <b>6</b> showed less than 50% inhibition of the hERG channel up to 300 μM.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> ADME</h3><div class="NLM_p">Although <b>6a</b> showed optimal ADME properties similar to those of <b>5a</b>, it was rapidly converted to the inactive enantiomer <b>6b</b> in buffer and plasma of preclinical species and humans. Studies of <b>6a</b> with phosphate buffer (pH 7.4) and plasma from animal species were conducted to assess the degree of interconversion of <b>6a</b> to <b>6b</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 5">Table 5</a>). While the conversion of <b>6a</b> to <b>6b</b> was minimal in phosphate buffered saline (pH of 7.4), racemization seemed to be rapid in plasma of preclinical species and humans (<a class="ref internalNav" href="#tbl4" aria-label="Table 5">Table 5</a>, <a class="ref internalNav" href="#fig4a" aria-label="Figure 4">Figure 4</a>a,b). For example, 65% of <b>6b</b> was produced in 6 h, when <b>6a</b> was incubated with plasma from humans (<a class="ref internalNav" href="#fig4a" aria-label="Figure 4">Figure 4</a>b). Rapid interconversion in the plasma relative to phosphate buffer suggested a possibility of an enzyme catalyzed process.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Racemization Experiment: Formation of <b>6a</b>/<b>6b</b> after Incubation for 48 h of <b>6a</b> in Various Biological Media</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">matrixes</th><th class="colsep0 rowsep0" align="center"><b>6a</b> remaining (%)</th><th class="colsep0 rowsep0" align="center"><b>6b</b> formed (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphate buffered saline (pH 7.4)</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse Plasma</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog Plasma</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat Plasma</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acidified plasma<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">93.5</td><td class="colsep0 rowsep0" align="left">6.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Dog plasma was acidified.</p></div></div></div><figure id="fig4a" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0004.jpeg" id="gr100" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent racemization of <b>6a</b> in (A) plasma across species and phosphate-buffered saline (PBS) and (B) human plasma. Concentrations of <b>6a</b> (empty triangles) and <b>6b</b> (filled circles) are measured using a chiral LC–MS/MS method.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig4a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, the ratio of the two enantiomers in human plasma at 48 h was not at the theoretical level of 1:1, irrespective of which enantiomer was present at <i>T</i><sub>0</sub>. This was attributed to higher free fraction of <b>6a</b> (fup 0.449) relative to <b>6b</b> (fup 0.286). When corrected for protein binding, the ratio of the free fractions of the two enantiomers after 48 h incubations were reasonably close to the theoretical 1:1 ratio.</div><div class="NLM_p">The low interconversion barrier negated the benefits of using single enantiomer for further in vivo biological testing and characterization of the pure enantiomer (<b>6a</b>). Advancing the racemate instead of the pure enantiomer was further justified since conversion of <b>6a</b> to <b>6b</b> was also observed in vivo in all species following an IV dose of <b>6a</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 6">Table 6</a>). In fact, the exposure of <b>6a</b> after oral administration of either <b>6a</b> or <b>6</b> to cynomolgus monkeys suggested only a 20% difference in the exposure of <b>6a</b> as depicted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Rapid racemization of <b>6a</b> both in vitro and in vivo also justified the advancement of the racemate <b>6</b> rather than the active enantiomer <b>6a</b> into humans.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Exposure (AUC<sub>inf</sub>) of <b>6a</b> and <b>6b</b> after Intravenous Administration (Dose, 1 mg/kg) of the Active Enantiomer <b>6a</b> in Rat, Dog, and Monkey</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>in vivo</i> AUC <b>6a</b> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">2274</td><td class="colsep0 rowsep0" align="left">696</td><td class="colsep0 rowsep0" align="left">6808</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>in vivo</i> AUC <b>6b</b> (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">153</td><td class="colsep0 rowsep0" align="left">124</td><td class="colsep0 rowsep0" align="left">3516</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo ratio AUC <b>6b</b>/AUC <b>6a</b></td><td class="colsep0 rowsep0" align="left">0.067</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.52</td></tr></tbody></table></div></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Total concentrations of <b>6a</b> (blue diamonds) and <b>6b</b> (red squares) with dosing of either <b>6</b> (panel A) or <b>6a</b> (panel B) in monkey (PO dosing at 10 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consequently, the pharmacokinetics of the active enantiomer (<b>6a</b>) was evaluated after single IV administration of the racemic mixture <b>6</b> in CD-1 mice, Wistar Han rats, and Beagle dogs followed by quantitation of the active enantiomer using a chiral LC–MS/MS assay. After a single 1 mg/kg IV dose of <b>6</b>, the mean CLp, Vss, and <i>t</i><sub>1/2</sub> of <b>6a</b> was 7.2 mL/min/kg, 0.79 L/kg, and 1.3 h, respectively, in mouse and 3.4 mL/min/kg, 0.64 L/kg, and 2.2 h, respectively, in rat. In dogs, the CL<sub>p</sub>, V<sub>ss</sub>, and <i>t</i><sub>1/2</sub> of <b>6a</b> following a 1 mg/kg IV dose of <b>6</b> was 20 mL/min/kg, 0.96 L/kg, and 0.80 h, respectively (<a class="ref internalNav" href="#tbl6" aria-label="Table 7">Table 7</a>; <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mean Pharmacokinetics of <b>6a</b> in Mouse, Rat, Dog, and Monkey Following Intravenous Administration of <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">sex/<i>n</i></th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>inf</sub> (ng·h/kg)</th><th class="colsep0 rowsep0" align="center">CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CD-1 mouse</td><td class="colsep0 rowsep0" align="left">Male/3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1160</td><td class="colsep0 rowsep0" align="left">7.21</td><td class="colsep0 rowsep0" align="left">0.787</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wistar–Han rat</td><td class="colsep0 rowsep0" align="left">Male/3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2520</td><td class="colsep0 rowsep0" align="left">3.44</td><td class="colsep0 rowsep0" align="left">0.639</td><td class="colsep0 rowsep0" align="left">2.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Beagle dog</td><td class="colsep0 rowsep0" align="left">Male/3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">423</td><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">0.957</td><td class="colsep0 rowsep0" align="left">0.802</td></tr></tbody></table></div></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma profile of <b>6a</b> following (A) an intravenous dose (1 mg/kg) and (B) an oral dose (3 mg/kg) of the racemate <b>6</b> to CD-1 mouse, Wistar–Han rat, and Beagle dog.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These results suggested that <b>6a</b> exhibited a low plasma clearance (CL<sub>p</sub>) in the mouse and rat and moderate CL<sub>p</sub> in the dog with a low volume of distribution (V<sub>ss</sub>) in these species (<a class="ref internalNav" href="#tbl6" aria-label="Table 7">Table 7</a>). Low clearance of <b>6a</b> in mouse and rat and moderate to high clearance in dog were consistent with the projected hepatic clearance values estimated from in vitro incubation of <b>6</b> with hepatocytes from the preclinical species (<a class="ref internalNav" href="#tbl7" aria-label="Table 8">Table 8</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Projection of Hepatic Clearance (CL<sub>hep</sub>) of <b>6</b> Following Incubation with Hepatocytes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">Cl<sub>int,app</sub> μL/min/10<sup>6</sup> cells</th><th class="colsep0 rowsep0" align="center">CL<sub>hep</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">in vivo CL<sub>blood</sub><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (mL/min/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">10.3</td><td class="colsep0 rowsep0" align="left">16.6</td><td class="colsep0 rowsep0" align="left">24.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">8.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">In vivo CL<sub>blood</sub> was estimated from the ratio of CL<sub>plasma</sub> of <b>6a</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 7">Table 7</a>) and blood to plasma ratio (B/P) for mouse, rat, and dog, which was 0.863, 0.929, and 0.824, respectively.</p></div></div></div><div class="NLM_p">Absorption of <b>6a</b> was assessed after oral administration of the racemate <b>6</b> to CD-1 mice, Wistar–Han rat, and Beagle dog. Compound <b>6a</b> was rapidly absorbed in all three preclinical species when the racemate <b>6</b> was dosed at 3 mg/kg as indicated by the time to reach maximum concentration (<i>T</i><sub>max</sub>) ranging from 0.25 to 1.3 h. Oral bioavailability in the mouse and rat was 59 and 94%, respectively, and 19% in dog (<a class="ref internalNav" href="#tbl8" aria-label="Table 9">Table 9</a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Mean Pharmacokinetics of <b>6a</b> in Mouse, Rat, Dog, and Monkey Following Oral Administration of <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">sex/<i>n</i></th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>inf</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CD-1 mouse</td><td class="colsep0 rowsep0" align="left">male/3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">538</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">2170</td><td class="colsep0 rowsep0" align="left">2.48</td><td class="colsep0 rowsep0" align="left">59.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wistar–Han rat</td><td class="colsep0 rowsep0" align="left">male/3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">985</td><td class="colsep0 rowsep0" align="left">1.30</td><td class="colsep0 rowsep0" align="left">6940</td><td class="colsep0 rowsep0" align="left">2.42</td><td class="colsep0 rowsep0" align="left">94.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Beagle dog</td><td class="colsep0 rowsep0" align="left">male/3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">219</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">237</td><td class="colsep0 rowsep0" align="left">0.840</td><td class="colsep0 rowsep0" align="left">18.6</td></tr></tbody></table></div></div><div class="NLM_p">The product of fraction absorbed and fraction of <b>6a</b> escaping the gut (<i>f</i><sub>a</sub> × <i>f</i><sub>g</sub>) was calculated using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a><span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/jm-2017-00974y_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>F</i>, bioavailability; <i>f</i><sub>a</sub>, the fraction absorbed from the GI tract; <i>f</i><sub>g</sub>, the fraction escaping metabolism in the intestine; CL, the blood clearance that was estimated from CL<sub>p</sub> and blood to plasma ratio in the appropriate species, and Q, the hepatic blood flow (mouse, 90 mL/min/kg; rat, 70 mL/min/kg and dog, 40 mL/min/kg), ranging from ∼0.5 to 0.99 (mean <i>f</i><sub>a</sub> × <i>f</i><sub>g</sub> was computed to be 0.70). Good absorption in vivo was consistent with the in vitro permeability assessment of <b>6</b> in Ralph–Russ canine kidney (RRCK) cells, which demonstrated high intrinsic permeability with an apical to basal (P<sub>app A-B</sub>) value of 25.5 × 10<sup>–6</sup> cm/s. Further in vitro studies in Madin–Darby canine kidney (MDCK) cells transfected with the multidrug resistance gene (MDCK-MDR) that encodes for human P-gp showed minimal evidence of efflux [(basolateral to apical/apical to basolateral (BA/AB) efflux ratio < 1.2 up to concentrations of 10 μM] indicating that <b>6</b> (or <b>6a</b>) was a very weak P-gp substrate in humans. Based on these in vivo and in vitro results, the absorption of <b>6a</b> in humans was anticipated to be good after dosing oral administration of the racemate.</div><div class="NLM_p">Compound <b>6a</b> was weakly bound to plasma proteins and was equally distributed between red blood cells and plasma. The unbound fraction (<i>f</i><sub>u</sub>) of <b>6a</b> following incubation of the racemate with plasma from preclinical species and humans ranged from 0.25 in the rat to 0.45 in humans, while the blood to plasma ratio of <b>6a</b> ranged from 0.824 to 1.1 when <b>6</b> was allowed to equilibrate between blood and plasma. Assessment of CNS exposure of <b>6a</b> in the cerebral spinal fluid (CSF) and brain of rats after oral administration of the racemate <b>6</b> indicated that <b>6a</b> was a brain penetrant with total brain to plasma ratio (<i>K</i><sub>p</sub> = 0.51) and ratio of free concentrations in the brain (B<sub>u</sub>) to free concentrations in the plasma (P<sub>u</sub>), B<sub>u</sub>/P<sub>u</sub> = 0.20. The ratio of CSF to free plasma concentrations (CSF/P<sub>u</sub> = 0.49).</div><div class="NLM_p">Investigation into clearance mechanisms indicated that the percentage of unchanged <b>6a</b> excreted in the urine and bile of rat, and the urine of dog was limited (<1%) following dosing of <b>6</b> suggesting that <b>6a</b> was primarily cleared via metabolism in preclinical species. Preliminary in vitro metabolism studies with <b>6</b> in hepatocytes from mouse, dog, and humans indicated oxidation (hydroxylation) and hydrolysis as the primary routes of metabolism. All metabolites detected in vitro in human hepatocytes were also present in the hepatocytes evaluated from the preclinical species. CYP phenotyping studies with <b>6a</b> in cryopreserved human hepatocytes following incubation with and without 1-aminobenzotriazole (ABT), a nonspecific CYP enzyme inhibitor, suggested that CYP450-dependent metabolism accounted for approximately 61% of the metabolic turnover, and non-CYP450-dependent hydrolytic metabolism accounted for 39%. Incubation with specific inhibitors of the major CYP isoforms indicated that CYP1A2 was the primary isozyme that was responsible for oxidative metabolism of <b>6a</b>.</div><div class="NLM_p last">Inhibition and induction studies with primary CYP isoforms and major efflux transporters were conducted to assess the risk of pharmacokinetic drug interactions. These studies revealed that <b>6</b> was a very weak inhibitor of CYPs with IC<sub>50</sub> values greater than 100 μM for most major CYP isozymes except 2C19 (IC<sub>50</sub> value was 78 μM). Additionally, <b>6</b> did not exhibit metabolism-dependent (time-dependent and NADPH-dependent) or time-dependent (NADPH-independent) inhibition of the major CYP enzymes investigated. Likewise, in vitro experiments to investigate the potential for <b>6</b> to inhibit P-gp or BCRP mediated transport of digoxin and pitavastatin as known P-gp and BCRP substrates in MDCK-MDR or MDCK-BCRP cells indicated an IC<sub>50</sub> of >300 and 65.4 μM, respectively, suggesting weak inhibition of these transporters as well. Similarly, <b>6</b> was a weak inducer of CYP enzymes. Treatment of human hepatocytes with <b>6</b> did not cause induction of CYP1A2, 3A4, or 2B6 messenger ribonucleic acid (mRNA) below 100 μM concentrations.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Projection of PK Parameters in Humans</h3><div class="NLM_p">Since excellent in vitro and in vivo correlations were observed between clearances scaled from hepatocyte data and in vivo clearances of the preclinical species, estimation of hepatic clearance using human hepatocytes was considered to be an appropriate method for the projection of human clearance. The intrinsic clearance of <b>6a</b> after incubation of <b>6</b> with human hepatocytes was also low (0.58 μL/min/10<sup>6</sup> cells) and resulted in projected hepatic clearance of 0.60 mL/min/kg (CL<sub>p</sub> = 0.64 mL/min/kg) (<a class="ref internalNav" href="#tbl9" aria-label="Table 10">Table 10</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Projected Pharmacokinetic Parameters of <b>6a</b> Following Oral Administration of the Racemate <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">64</td></tr></tbody></table></div></div><div class="NLM_p">As noted earlier, distribution of the <b>6a</b> after administration of <b>6</b> to preclinical species was low to moderate in all species given that Vd<sub>ss</sub> of <b>6a</b> ranged from 0.639 to 0.957 L/kg. The apparent volume of distribution in humans of a compound is generally more related to the molecular properties of the compound, and thus, this parameter is more successfully predicted by scaling the apparent Vd<sub>ss</sub> obtained from PK data in animals and unbound bound fraction in human plasma. Using this approach, the projected human Vd<sub>ss</sub> ranged from 0.90 to 1.19 L/kg resulting with a mean Vd<sub>ss</sub> of 1.03 L/kg. In summary, after oral administration of <b>6</b>, <b>6a</b> had a predicted CL<sub>p</sub> of 0.64 mL/min/kg and a Vd<sub>ss</sub> of 1.03 L/kg in humans, yielding a half-life (<i>t</i><sub>1/2</sub>) of approximately 19 h, suggesting once to twice a day dosing regimen (<a class="ref internalNav" href="#tbl9" aria-label="Table 10">Table 10</a>). The bioavailability of <b>6a</b> in humans following oral administration of <b>6</b> was projected assuming that the <i>f</i><sub>a</sub> × <i>f</i><sub>g</sub> of <b>6a</b> in the humans following oral dosing of <b>6</b> is similar to that in monkeys. Since the exposure of <b>6a</b> following oral administration of <b>6</b> was only 20% lower than that achieved when the active enantiomer (<b>6a</b>) was orally administered, the <i>f</i><sub>a</sub> × <i>f</i><sub>g</sub> of <b>6a</b> following oral administration of <b>6</b> was estimated to be 0.67. Using this estimation in <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, the bioavailability (<i>F</i>) of <b>6a</b> was estimated to be 64% (<a class="ref internalNav" href="#tbl9" aria-label="Table 10">Table 10</a>).</div><div class="NLM_p last">As reported in more detail elsewhere,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> compound <b>6</b> modulated hIDO-1 activity in nontumor-bearing mice as determined by the strong maximum reduction in plasma <span class="smallcaps smallerCapital">l</span>-kynurenine (≥54 ± 6%) observed at or above 200 mg/kg 1 h post treatment. In addition, <b>6</b> has shown significant antitumor activity in monotherapy in Pan02, B16–F10, CT26, MC38, 4T1, and Renca models (<i>p</i> < 0.05 vs vehicle-treated group) and very good synergy in combination with anti-PDL1 mAb in CT26 model (<i>p</i> < 0.05 vs monotherapy groups).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione <b>6</b> (EOS200271/PF-06840003)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> is a novel class of hIDO-1 inhibitor, not relying on coordination to the heme iron for achieving inhibition. Although it has moderate hIDO1 enzyme inhibition (IC<sub>50</sub> 0.41 μM), it is a highly efficient compound (LE 0.53, LipE 5.1), driven by its tight packing within the enzyme, as well as the high density of hydrogen bonds it forms with hIDO-1 despite its small size. While the affinity of the compound for hIDO-1 is not as high as for other hIDO-1 inhibitors, its low plasma protein binding (<i>f</i><sub>u</sub> 0.45) gives it good potency in the more physiologically relevant human whole blood assay. The PK profile of the compound is excellent, with a low/moderate clearance in most preclinical species. Human PK predictions are promising, and after oral administration of <b>6</b>, <b>6a</b> has a predicted CL<sub>p</sub> of 0.64 mL/min/kg and a Vd<sub>ss</sub> of 1.03 L/kg with a <i>t</i><sub>1/2</sub> ≈ 19 h, which should allow QD administration. The bioavailability of <b>6a</b> after an oral dose of <b>6</b> is projected to be 64%. The compound also shows good CNS penetration in rat, suggesting potential impact on brain metastases. Based on this favorable profile, <b>6</b> was selected to advance to clinical trials and a First in Patient Study in Malignant Gliomas ((NCT02764151).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The MS data were obtained using an Agilent 6110 (ESI) or a Waters Acquity SQD (ESI). The NMR data were obtained with Bruker Ultrashield  400 PLUS and Bruker Fourier 300 MHz, and TMS was used as an internal standard. Purity for all final compounds was determined by HPLC and was generally >95%. Analytical HPLC method A: XbridgeTM C8 50 mm × 4.6 mm at a flow of 2 mL/min; 8 min gradient from 0.1% TFA in H<sub>2</sub>O to 0.07% TFA in CH<sub>3</sub>CN. The microwave chemistry was performed on a single mode microwave reactor Initiator Microwave System EU from Biotage. Preparative HPLC purifications were performed with a mass directed autopurification Fractionlynx from Waters equipped with a Xbridge Prep C18 OBD column 19 × 150 mm 5 μm, unless otherwise reported. All HPLC purifications were performed with a gradient of CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>HCO<sub>3</sub> (5 mM), CH<sub>3</sub>CN/H<sub>2</sub>O/TFA (0.1%), or CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>3</sub>·H<sub>2</sub>O (0.1%).</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Protocol for the Synthesis of 3-(Indol-3-yl)pyrrolidine-2,5-diones</h3><div class="NLM_p">A mixture of indole (2.22 mmol) and maleimide (646 mg; 6.65 mmol) in AcOH (2 mL) was stirred at 170 °C for 2 h in a microwave reaction. The reaction mixture was concentrated in vacuo. The residue was neutralized with saturated aqueous NaHCO<sub>3</sub> solution to pH 7–8 and extracted with EtOAc (10 mL × 3). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by preparative HPLC to afford the product.</div><div class="NLM_p">The following compounds were prepared according to the protocol above:</div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(1<i>H</i>-Indol-3-yl)pyrrolidine-2,5-dione (<b>5</b>)</h4><div class="NLM_p last">LC–MS for C<sub>12</sub>H<sub>10</sub>FN<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 215.1; found 215.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.29 (s, 1H), 11.02 (s, 1H), 7.42 (d, <i>J</i> = 8.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.1 Hz, 1H), 7.32 (d, <i>J</i> = 2.4 Hz, 1H), 7.12–7.07 (m, 1H), 7.02–6.97 (m, 1H), 4.33 (dd, <i>J</i> = 9.5, 5.3 Hz, 1H), 3.18 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.76 (dd, <i>J</i> = 18.0, 5.3 Hz, 1H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>6</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>9</sub>FN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H] calcd. 231.1; found 231.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.30 (brs, 1H), 11.14 (s, 1H), 7.41(d, <i>J</i> = 2.5 Hz, 1H), 7.36 (dd, <i>J</i> = 9.0, 4.6 Hz, 1H), 7.20 (dd, <i>J</i> = 10.1, 2.5 Hz, 1H), 6.94 (ddd, <i>J</i> = 9.2, 9.0, 2.5 Hz, 1H), 4.33 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.79 (dd, <i>J</i> = 18.0, 5.5 Hz, 1H).</div></div><div id="sec100" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Alternative Protocol for the Synthesis of <b>6</b></h4><div class="NLM_p last">A mixture of 5-fluoroindole (5.00 g, 35.5 mmol) and maleimide (1.5 equiv, 5.17 g, 53.3 mmol) was charged in a 50 mL vessel, and then acetonitrile (15.0 mL) and zinc chloride (1.05 equiv, 5.08 g, 37.3 mmol) were added. The reaction was heated to 85 °C over 10 min and then maintained at 85 °C for 24 h. Still at 85 °C, water (30 mL) was added slowly, while maintaining the temperature above 80 °C. Yellow solids precipitated. The reaction mixture was cooled to 50 °C over 1 h followed by stirring at 50 °C for 2 h, then cooled to 10 °C over 1 h. The reaction was stirred at 10 °C for 1 h, then the solids were filtered off, and the filter cake was washed two times with 5 mL of 1:1 ACN/water to afford isolated compound (6.85 g, 29.5 mmol, 83.1% yield). For purification, the resulting isolated compound was charged into a vessel, followed by addition of tetrahydrofuran (41 mL). This mixture was heated to 66 °C to form a homogeneous solution. Heptane (27.4 mL) was added slowly at 66 °C. The mixture was cooled to 25 °C over 3 h, then filtered and washed with heptane, followed by drying in high vacuum oven overnight to afford <b>6</b> (4.93 g, 72.0% yield).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-(5-Chloro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>7</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 247.0; found 247.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.30 (br s, 1H), 11.25 (br s, 1H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.6 Hz, 1H), 7.10 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 4.36 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.80 (dd, <i>J</i> = 18.0, 5.5 Hz, 1H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-(5-Bromo-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>8</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>9</sub>BrN<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 293.0; found 293.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.29 (s, 1H), 11.26 (s, 1H), 7.64 (d, <i>J</i> = 1.8 Hz, 1H), 7.40 (d, <i>J</i> = 2.4 Hz, 1H), 7.35 (d, <i>J</i> = 8.6 Hz, 1H), 7.21 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 4.36 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.80 (dd, <i>J</i> = 18.0, 5.5 Hz, 1H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-(2,5-Dioxopyrrolidin-3-yl)-1<i>H</i>-indole-5-carbonitrile (<b>9</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. A mixture of 3-(5-bromo-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>8</b>; 500 mg; 1.71 mmol) and CuCN (231 mg; 2.58 mmol) in NMP (3 mL) was stirred at 200 °C for 1.5 h in a microwave reactor. The reaction mixture was purified by preparative HPLC to afford the product (110 mg; 27%) as a green solid. LC–MS for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 240.1; found 240.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.63 (brs, 1H), 8.04 (s, 1H), 7.57 (d, <i>J</i> = 1.8 Hz, 1H), 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.45 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 4.44 (dd, <i>J</i> = 9.5, 5.8 Hz, 1H), 3.18 (dd, <i>J</i> = 17.8, 9.5 Hz, 1H), 2.87 (dd, <i>J</i> = 17.8, 5.8 Hz, 1H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(5-Methoxy-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>10</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 245.1; found 245.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.25 (brs, 1H), 10.86 (s, 1H), 7.27 (d, <i>J</i> = 2.2 Hz 1H), 7.26 (d, <i>J</i> = 8.6 Hz, 1H), 6.91 (d, <i>J</i> = 2.2 Hz, 1H), 6.76 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 4.30 (dd, <i>J</i> = 9.6, 5.3 Hz, 1H), 3.74 (s, 3H), 3.18 (dd, <i>J</i> = 17.9, 9.6 Hz, 1H), 2.75 (dd, <i>J</i> = 17.9, 5.3 Hz, 1H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-(5-Methyl-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>11</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 229.1; found 229.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.27 (s, 1H), 10.88 (s, 1H), 7.26 (dd, <i>J</i> = 8.3, 2.0 Hz), 7.25 (d, <i>J</i> = 2.0 Hz, 1H), 7.19 (s, 1H), 6.92 (d, <i>J</i> = 8.3 Hz, 1H), 4.29 (dd, <i>J</i> = 9.5, 5.3 Hz, 1H), 3.16 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.74 (dd, <i>J</i> = 18.0, 5.3 Hz, 1H), 2.36 (s, 3H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-(5-Trifluoromethyl-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>12</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>13</sub>H<sub>9</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 281.2; found 281.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.48 (s, 1H), 11.26 (s, 1H), 7.87 (s, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.53 (s, 1H), 7.36 (d, <i>J</i> = 8.5, 1H), 4.44 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.86 (dd, <i>J</i> = 18.0, 5.5 Hz, 1H).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(6-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>13</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>9</sub>FN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 231.1; found 231.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.10 (s, 1H), 7.43 (dd, <i>J</i> = 8.7, 5.4 Hz, 1H), 7.33 (d, <i>J</i> = 2.0 Hz, 1H), 7.14 (dd, <i>J</i> = 10.1, 2.3 Hz, 1H), 6.87 (td, <i>J</i> = 9.8, 8.7, 2.3 Hz, 1H), 4.34 (dd, <i>J</i> = 9.5, 5.4 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.77 (dd, <i>J</i> = 18.0, 5.4 Hz, 1H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-(6-Chloro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>14</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 247.0; found 247.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.27 (brs, 1H), 11.17 (s, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.41 (d, <i>J</i> = 1.8 Hz, 1H), 7.38 (d, <i>J</i> = 2.4 Hz, 1H), 7.03 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 4.34 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.77 (dd, <i>J</i> = 18.0, 5.5 Hz, 1H).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(6-Bromo-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>15</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. HPLC. LC–MS for C<sub>12</sub>H<sub>9</sub>BrN<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 293.0; found 293.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.30 (brs, 1H), 11.18 (s, 1H), 7.56 (d, <i>J</i> = 1.6 Hz, 1H), 7.41 (d, <i>J</i> = 8.5 Hz, 1H), 7.37 (d, <i>J</i> = 2.4 Hz, 1H), 7.14 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 4.34 (dd, <i>J</i> = 9.5, 5.4 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.77 (dd, <i>J</i> = 18.0, 5.4 Hz, 1H).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(2,5-Dioxopyrrolidin-3-yl)-1<i>H</i>-indole-6-carbonitrile (<b>16</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 240.1; found 240.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.63 (brs, 1H), 11.32 (s, 1H), 7.88 (s, 1H), 7.68–7.62 (m, 2H), 7.35 (dd, <i>J</i> = 9.5, 5.6 Hz, 1H), 4.42 (dd, <i>J</i> = 17.8, 9.5 Hz, 1H), 3.18 (dd, <i>J</i> = 18.0, 9.9 Hz, 1H), 2.82 (dd, <i>J</i> = 17.8, 5.6 Hz, 1H).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(6-Methoxy-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>17</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. HPLC LC–MS for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 243.1; found 243.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.26 (s, 1H), 10.81 (s, 1H), 7.29 (d, <i>J</i> = 8.7 Hz, 1H), 7.16 (d, <i>J</i> = 2.2 Hz, 1H), 6.86 (d, <i>J</i> = 2.2 Hz, 1H), 6.66 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H), 4.27 (dd, <i>J</i> = 9.5, 5.2 Hz, 1H), 3.75 (s, 3H), 3.16 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.73 (dd, <i>J</i> = 18.0, 5.2 Hz, 1H).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(6-Methyl-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>18</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. HPLC LC–MS for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 227.1; found 227.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 10.85 (brs, 2H), 11.18 (s, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.20 (d, <i>J</i> = 2.3 Hz, 1H), 7.16 (s, 1H), 6.83 (d, <i>J</i> = 8.0 Hz, 1H), 4.28 (dd, <i>J</i> = 9.5, 5.3 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.5 Hz, 1H), 2.73 (dd, <i>J</i> = 18.0, 5.3 Hz, 1H), 2.38 (s, 3H).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(5,6-Difluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>19</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>8</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 251.1; found 251.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.27 (brs, 1H), 11.21 (brs, 1H), 7.45 (dd, <i>J</i> = 11.5, 8.0 Hz, 1H), 7.41 (d, <i>J</i> = 1.8 Hz, 1H), 7.37 (dd, <i>J</i> = 11.2, 7.0 Hz, 1H), 7.48–7.34 (m, 3H), 4.34 (dd, <i>J</i> = 9.3, 5.6 Hz, 1H), 3.16 (dd, <i>J</i> = 18.0, 9.3 Hz, 1H), 2.80 (dd, <i>J</i> = 18.0, 5.6 Hz, 1H).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(6-Chloro-5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>20</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>8</sub>ClFN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 265.1; found 265.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.30 (br s, 1H), 11.27 (br s, 1H), 7.54 (d, <i>J</i> = 6.4 Hz, 1H), 7.47 (s, 1H), 7.46 (d, <i>J</i> = 10.2 Hz, 1H), 4.35 (dd, <i>J</i> = 9.4, 5.8 Hz, 1H), 3.16 (dd, <i>J</i> = 18.0, 9.4 Hz, 1H), 2.81 (dd, <i>J</i> = 18.0, 5.8 Hz, 1H).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(6-Bromo-5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>21</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>12</sub>H<sub>8</sub>BrFN<sub>2</sub>O<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 309.0; found 308.9. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.31 (s, 1H), 11.27 (s, 1H), 7.66 (d, <i>J</i> = 6.0 Hz, 1H), 7.48 (d, <i>J</i> = 1.7 Hz, 1H), 7.44 (d, <i>J</i> = 9.8 Hz, 1H), 4.36 (dd, <i>J</i> = 9.2, 5.6 Hz, 1H), 3.17 (dd, <i>J</i> = 18.0, 9.2 Hz, 1H), 2.82 (dd, <i>J</i> = 18.0, 5.6 Hz, 1H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(5-Fluoro-6-methyl-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (<b>22</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>5</b>. LC–MS for C<sub>13</sub>H<sub>11</sub>FN<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 247.1; found 247.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.28 (s, 1H), 10.99 (s, 1H), 7.31 (d, <i>J</i> = 2.5 Hz, 1H), 7.22 (d, <i>J</i> = 6.4 Hz, 1H), 7.13 (d, <i>J</i> = 10.8 Hz, 1H), 4.29 (dd, <i>J</i> = 9.4, 5.4 Hz, 1H), 3.16 (dd, <i>J</i> = 18.0, 9.4 Hz, 1H), 2.76 (dd, <i>J</i> = 18.0, 5.4 Hz, 1H), 2.30 (d,, <i>J</i> = 1.6 Hz, 3H).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(Naphthalen-1-yl)pyrrolidine-2,5-dione (<b>23</b>)</h4><div class="NLM_p last">To a solution of naphthalen-1-ylboronic acid (0.27 g; 1.57 mmol) in 1,4-dioxane (9 mL) and water (1.4 mL) was added Et<sub>3</sub>N (0.10 g; 0.99 mmol), [RhOH(cod)]<sub>2</sub> (23 mg; 0.05 mmol), and maleimide (100 mg; 1.03 mmol). The dark brown mixture was heated at 50 °C for 2.5 h, cooled to room temperature, and concentrated in vacuo. The residue was diluted with water (10 mL) and extracted with dichloromethane (20 mL × 3). The combined organic layers were dried over anhydrous sodium sulfate, filtered, concentrated, and purified by preparative HPLC to afford 136 mg (59%) of the title compound as a white solid. LC–MS for C<sub>14</sub>H<sub>11</sub>NO<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 224.1; found 224.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 11.50 (s, 1H), 8.02–7.95 (m, 2H), 7.89 (d, <i>J</i> = 9.1 Hz, 1H), 7.63–7.53 (m, 2H), 7.53–7.46 (m, 1H), 7.41 (d, <i>J</i> = 7.1 Hz, 1H), 4.96 (dd, <i>J</i> = 9.6, 5.7 Hz, 1H), 3.32 (dd, <i>J</i> = 18.0, 9.6 Hz, 1H), 2.71 (dd, <i>J</i> = 18.0, 5.7 Hz, 1H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(7-Fluoronaphthalen-1-yl)pyrrolidine-2,5-dione (<b>24</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>25</b>. LC–MS for C<sub>14</sub>H<sub>10</sub>FNO<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 242.1; found 242.0. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ [ppm]: 7.99 (dd, <i>J</i> = 9.0, 5.9 Hz, 1H), 7.88 (dd, <i>J</i> = 6.8, 2.0 Hz, 1H), 7.70 (d, <i>J</i> = 11.1, 2.0 Hz, 2H), 7.50–7.42 (m, 1H), 7.41–7.32 (m, 1H), 4.88 (dd, <i>J</i> = 9.5, 5.1 Hz, 1H), 3.43 (dd, <i>J</i> = 18.2, 9.5 Hz, 1H), 2.72 (dd, <i>J</i> = 18.2, 5.1 Hz, 1H).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(6-Fluoronaphthalen-1-yl)pyrrolidine-2,5-dione (<b>25</b>)</h4><div id="sec4_22_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Step 1: 6-Fluoronaphthalene-1-diazonium Tetrafluoroborate</h5><div class="NLM_p last">To a solution of 6-fluoronaphthalen-1-amine (500 mg; 3.10 mmol) and HBF<sub>4</sub> (40%; 2 mL; 12.6 mmol) in water (2 mL) at 0 °C was added a cold solution of NaNO<sub>2</sub> (214 mg; 3.10 mmol) in water (0.5 mL) dropwise. The reaction was stirred at room temperature for 1 h. The precipitate was collected by filtration, washed with ethanol (5 mL), diethyl ether (5 mL), and dried under vacuum to afford 0.40 g (50%) of the title compound as a pale solid, which was used directly in the next step without further purification.</div></div><div id="sec4_22_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Step 2: 2-(6-Fluoronaphthalen-1-yl)succinic Acid</h5><div class="NLM_p last">Maleic anhydride (150 mg; 1.54 mmol) was added to an aqueous NaOH solution (4 M; 0.70 mL; 2.8 mmol). The resulting solution was added at 0–5 °C to an aqueous TiCl<sub>3</sub> solution (15%; 3.2 g; 3.11 mmol), followed by acetone (2 mL). The cooling bath was removed, and 6-fluoronaphthalene-1-diazonium tetrafluoroborate (Step 1:400 mg; 1.54 mmol) was added slowly over 0.7 h. The suspension was stirred at room temperature for 1.5 h, concentrated to remove acetone, and extracted with diethyl ether (10 mL × 3). The aqueous layer was acidified to pH ≈ 1 with hydrochloric acid (1 M) and extracted with ethyl acetate (10 mL × 3). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated to afford 190 mg (47%) of the title compound as a brown solid, which was used directly in the next step without further purification. LC–MS for C<sub>14</sub>H<sub>11</sub>FO<sub>4</sub> + NH<sub>4</sub><sup>+</sup> [M + NH<sub>4</sub>]<sup>+</sup> calcd. 280.1; found 280.0.</div></div><div id="sec4_22_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step 3</h5><div class="NLM_p last">A mixture of 2-(6-fluoronaphthalen-1-yl)succinic acid (190 mg; 0.72 mmol) and urea (170 mg; 2.83 mmol) was stirred at 180 °C for 1 h. The reaction mixture was purified by silica gel chromatography (petroleum ether/ehtyl acetate = 1/1) to give a yellow solid, which was further purified by preparative HPLC to afford 63 mg (36%) of the title compound as a white solid. LC–MS for C<sub>14</sub>H<sub>10</sub>FNO<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 244.1; found 243.9. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 8.08 (dd, <i>J</i> = 9.3, 5.6 Hz, 1H), 7.87 (d, <i>J</i> = 8.2 Hz, 1H), 7.76 (dd, <i>J</i> = 10.2, 2.7 Hz, 1H), 7.56–7.46 (m, 2H), 7.38 (d, <i>J</i> = 6.6 Hz, 1H), 4.95 (dd, <i>J</i> = 9.4, 5.6 Hz, 1H), 3.30 (dd, <i>J</i> = 18.0, 9.4 Hz, 1H), 2.71 (dd, <i>J</i> = 18.0, 5.6 Hz, 1H).</div></div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(7-Chloronaphthalen-1-yl)pyrrolidine-2,5-dione (<b>26</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>25</b>. LC–MS for C<sub>14</sub>H<sub>10</sub>ClNO<sub>2</sub> + H<sup>+</sup> [M + H]<sup>+</sup> calcd. 260.0; found 260.0. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ [ppm]: 8.08 (s, 1H), 7.95 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 1H), 7.59–7.53 (m, 3H), 4.94 (dd, <i>J</i> = 9.6, 5.4 Hz, 1H), 3.44 (dd, <i>J</i> = 18.3, 9.6 Hz, 1H), 2.75(dd, <i>J</i> = 18.3, 5.4 Hz, 1H).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(6-Chloronaphthalen-1-yl)pyrrolidine-2,5-dione (<b>27</b>)</h4><div class="NLM_p last">Prepared according to the procedure described for compound <b>25</b>. LC–MS for C<sub>14</sub>H<sub>10</sub>ClNO<sub>2</sub> – H<sup>–</sup> [M – H]<sup>−</sup> calcd. 258.0; found 257.9. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ [ppm]: 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.96 (d, <i>J</i> = 1.8 Hz, 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 1H), 7.57–7.49 (m, 2H), 7.42 (d, <i>J</i> = 7.3 Hz, 1H), 4.96 (dd, <i>J</i> = 9.8, 5.3 Hz, 1H), 3.44 (dd, <i>J</i> = 18.3, 9.8 Hz, 1H), 2.77 (dd, <i>J</i> = 18.2, 5.3 Hz, 1H).</div></div></div><div id="sec4_24_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Assay for hIDO-1 Enzymatic Activity Determination: PDMAB Assay</h3><div class="NLM_p last">To measure enzymatic activity of human hIDO-1, the reaction mixture contained (final concentrations) potassium phosphate buffer (50 mM, pH 6.5), ascorbic acid (10 mM), methylene blue (5 μM), and human recombinant hIDO-1 enzyme (final concentration 5 μg/mL) without or with the test compounds at 10 different concentrations (total volume 112.5 μL). The reaction was initiated by the addition of 37.5 μL of <span class="smallcaps smallerCapital">l</span>-Trp (final concentration 100 μM) at room temperature. The reaction was conducted at room temperature during 15 min and stopped by the addition of 30 μL of 30% (w/v) trichloroacetic acid. To convert <i>N</i>-formylkynurenine into kynurenine, the reaction mixture was incubated at 65 °C for 30 min. Then 120 μL of 2.5% (w/v) 4-(dimethylamino)-benzaldehyde in acetic acid were added, and the mixture incubated for 5 min at room temperature. Kynurenine concentrations were determined by measuring the absorbance at 480 nm. A standard curve was made with pure kynurenine. The hIDO-1 activity was measured as described above using ten serial concentrations of the compounds to be tested.</div></div><div id="sec4_24_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Assay for hIDO-1, hIDO-2, and hTDO-2 Enzymatic Activity Determination: LC–MS Assay</h3><div class="NLM_p">The inhibition of human, dog, and mouse IDO-1, human IDO2, and human TDO was measured by quantitating tryptophan and kynurenine by mass spectrometry (MS). hIDO-1 catalyzes the conversion of tryptophan to <i>N</i>-formyl kynurenine. This assay measures the generation of kynurenine by MS, which forms quantitatively following nonenzymatic transformation of <i>N</i>-formyl kynurenine. Enzyme (final concentration 1.5 nM hIDO-1, 20 nM TDO, and 250 nM hIDO2) was incubated with various concentrations of the inhibitor, in duplicate, at room temperature in assay buffer (Mg<sup>2+</sup>, Ca<sup>2+</sup>-free phosphate buffered saline (PBS), 20 mM ascorbic acid, 10 μM methylene blue, 800 nM catalase, 15 μM tryptophan) in a final volume of 100 μL. After 22 min, 15 μL of 25% HCl was added to each well. The HCl stops the enzyme reaction and also converts the <i>N</i>-formyl kynurenine to kynurenine. Complete conversion occurs in less than 15 min at room temperature. Sealed plates were then transferred to a RapidFire 365 high-throughput solid phase extraction (SPE) chromatography system coupled to a 6495 triple quadrupole mass spectrometer (Agilent Technologies, Santa Clara, CA). Detection of tryptophan and kynurenine was accomplished following injection of assay reaction (injection loop volume is 10 μL) onto an Agilent Graphite Type D cartridge in 0.01% trifluoroacetic acid (TFA) plus 0.09% formic acid and eluted using 80% acetonitrile, 0.09% formic acid, and 0.01% TFA. The finalized RapidFire settings were as follows: aspiration time, 600 ms or until the loop is full per the sip sensor; load time, 5000 ms; elution time, 5000 ms; re-equilibration time, 500 ms at a flow rate of 1.5 mL/min.</div><div class="NLM_p">Following RapidFire SPE, samples were eluted into an Agilent 6495 triple quadrupole mass spectrometer with an Agilent Jet Stream source with ion funnel technology, set in positive ion mode. A multiple reaction monitoring (MRM) protocol was optimized employing Q1 <i>m</i>/<i>z</i> ratios of 205 and 209 for tryptophan and kynurenine, respectively. The second quadrupole (Q2) was used as a collision chamber employing house nitrogen as the collision gas. The third quadrupole (Q3) was set to select the product ions of tryptophan (<i>m</i>/<i>z</i> = 188) and kynurenine (<i>m</i>/<i>z</i> = 146). Fragmentor voltage was 380 V, collision energy (CE) was 10 V, and cell accelerator voltage was 10 V. AUC for tryptophan and kynurenine was quantitated using RapidFire Integrator software version 4.0.13141.13143 (Agilent). For conversion of AUC to picomoles of analyte, standard curves were generated over a range of concentrations from 1 nM up to 1 μM.</div><div class="NLM_p last">IC<sub>50</sub> values were determined from an 11-point dose response curve by plotting the AUC for kynurenine as a function of inhibitor concentration and fitting the data to the standard four parameter (log[inhibitor] vs response) equation for enzyme inhibition, using a Pfizer proprietary software package. Each compound was tested a minimum of three times against each species of purified IDO-1 enzyme except for the dog enzyme where there were two replicates. Similarly, there were two replicates for hIDO2 and hTDO. Values displayed are the geometric means of all determinations.</div></div><div id="sec4_24_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> HeLa Cellular hIDO-1 Assay</h3><div class="NLM_p last">To test the hIDO-1 activity in a cellular context, two hIDO1 inducible cell models were used. HeLa cervical carcinoma cells were used as a representative human cancer cell line. HeLa cells were harvested from cell culture flasks using 0.25% trypsin/EDTA (Gibco-Life Technologies) and neutralized with EMEM growth medium. Following resuspension in fresh growth media, cells were seeded at 20,000 cells per well in 200 μL growth media in a 96-well plate and allowed to adhere at 37 °C at 5% CO<sub>2</sub> overnight. The following day, growth media was aspirated and replaced with 200 μL of reduced (2%) serum media containing 100 ng/mL recombinant human interferon gamma (rhIFNγ) and incubated at 37 °C with 5% CO<sub>2</sub> for 48 h to induce IDO-1 expression. On day four, compounds were diluted to 10 mM in DMSO and 11-point three-fold dilutions were prepared. rhIFNγ-containing media was removed, and following dilution into EMEM, compounds were added to cells at 50 μM top concentration and allowed to incubate 16–24 h at 37 °C with 5% CO<sub>2</sub>. On day five of the assay, 100 μL of cell supernatant was transferred to a v-bottom 96-well plate. Thirty microliters of 30% trichloroacetic acid (TCA) was added to each well to precipitate proteins, and plates were centrifuged at 3000 rpm for 10 min. One hundred microliters was transferred to a fresh flat-bottom 96-well plate, and 100 μL/well of 2% 4-(dimethylamino)benzaldehyde (pDMAB) in acetic acid was added to derivatize <i>N</i>-formyl kynurenine to kynurenine for quantitative colorimetric readout. Assay plates were read at A492 on Envision plate reader (PerkinElmer). IC<sub>50</sub> values were calculated using Activity Base software and nonlinear regression of percent inhibition versus Log<sub>10</sub> concentration of hIDO-1 inhibitor compound.</div></div><div id="sec4_24_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> THP-1 Cellular hIDO-1 Assay</h3><div class="NLM_p last">To complement the HeLa cellular assay, an additional assay tested the activity of hIDO1 in the human peripheral blood-derived monocytic THP-1 cell line. THP-1 cells were resuspended into Iscove’s modified Dulbecco’s media (IMDM) containing 4% FBS, plus 100 ng/mL lipopolysaccharide (LPS) and 50 ng/mL rhIFNγ to stimulate hIDO1 expression, then seeded at 100,000 cells per well at 100 μL in a 96-well plate. hIDO-1 inhibitor compounds were diluted to 10 mM using DMSO, and 11-point three-fold dilutions were prepared and diluted into IMDM medium and added to cells at 50 μM top concentration and allowed to incubate 16–24 h at 37 °C with 5% CO<sub>2</sub>. Following TCA protein precipitation, plates were processed, read, and data analyzed as described above in the <a class="ref internalNav" href="#sec4_24_4" aria-label="HeLa Cellular hIDO-1 Assay">HeLa Cellular hIDO-1 Assay</a> section.</div></div><div id="sec4_24_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Human Whole Blood Assay</h3><div class="NLM_p">Fresh human whole blood was collected in sodium heparin (20 mL) and gently mixed. All sample and agonist addition steps were followed with a mixing step. LPS (Sigma #L-4391) was added to the whole blood to a final concentration of 25 μg/mL. IFNγ (R&D, 285-IF-100) was added next to a final concentration of 100 ng/mL. The stimulated whole blood was transferred immediately to a 96-well U-bottom plate, 200 μL per well. Compound <b>6</b> was prepared in DMSO from (0.01–100 μM) and aliquotted to individual wells. The final DMSO concentration was 0.5%. <b>6</b> spiked whole blood was incubated at 37 °C overnight. The next day samples were mixed.</div><div class="NLM_p">A 20 μL aliquot of plasma was precipitated with 80 μL acetonitrile, vortexed vigorously and centrifuged at 3220 x <i>g</i> for 15 min at 10 °C. An aliquot of the supernatant organic solution was diluted in water prior and spiked with stable labeled isotopes of kynurenine and tryptophan as internal standards prior to analysis.</div><div class="NLM_p">Kynurenine inhibition was determined by dividing the drug treated internal standard adjusted kynurenine counts by the positive control internal standard adjusted value. The no drug treated sample containing DMSO was used as the positive control.</div><div class="NLM_p last">In order to quantify <b>6a</b>, a calibration standard curve was prepared in untreated (i.e., no drug) whole blood.</div></div><div id="sec4_24_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Inhibitor Binding Studies</h3><div class="NLM_p last">Equilibrium binding studies were performed against different ferric and ferrous forms of human hIDO-1, and binding affinity was determined. Titrations of ferric and ferrous forms of human IDO-1(LJEC-1862A1) with inhibitors were performed with either an open cuvette (ferric + O<sub>2</sub>) or in an argon environment (ferric, depleted O<sub>2</sub> and ferrous) in a closed cuvette with a silicon septum. Typical binding conditions were 50 mM MOPS buffer (pH 7.0), 4.5 μM human IDO-1 (with 100-fold excess dithionite ferrous form only), and 100 μM tryptophan (when used) at RT. Microliter volumes of titrant were added with a gastight syringe. Analysis of the titration results for <i>K</i><sub>d</sub><sup>app</sup> values was carried out using GraphPad Prism 6.0.</div></div><div id="sec4_24_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Protein Purification</h3><div class="NLM_p last">The full length and truncated (12–403 aa) cDNA for human IDO-1 were cloned into pET24(+) based vector with an N-terminal cleavable His tag. Protein was overexpressed in bacterial cells (BL21(DE3)) with IPTG and purified using Ni affinity column in lysis buffer containing 25 mM Tris Cl, pH 7.4, 300 mM NaCl, 5% glycerol, and 1 mM TCEP plus protease inhibitor cocktails. The nontagged protein was obtained by TEV treatment of nickel purified protein overnight at 4 °C. To obtain pure and hemin fully loaded protein, 10× molar ratio of hemin dissolved in 25 mM NaOH was added slowly to protein and incubated at 4 °C overnight followed by anion exchange column with a starting buffer containing 25 mM Tris Cl, pH 8.0, 25 mM NaCl, 5% glycerol, and 1 mM TCEP. The flow through from anion exchange column was concentrated and further purified by size exclusion chromatography in a buffer containing 25 mM Tris Cl, pH 8, 150 mM NaCl, 5% glycerol, and 1 mM TCEP. The full length protein (LJEC-1862A1) was concentrated to 2.6 mg/mL for biochemical assays, and the truncated protein (LJEC-1863) was concentrated to 24 mg/mL for crystallization.</div></div><div id="sec4_24_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Crystallization, Structure Determination, and Refinement</h3><div class="NLM_p">IDO-1–<b>6a</b> complex was prepared by mixing hIDO-1 (LJEC-1863) at 24 mg/mL with 100 mM <b>6a</b> in DMSO for a final molar ratio of 4:1 (<b>6a</b>/hIDO-1). The mixture was incubated for 1 h on ice, then centrifuged at 16 100<i>g</i> at 4 °C for 10 min to remove any insoluble material. Using a mosquito liquid handler (TTP Labtech), the complex was screened in sitting drop 200 nL + 200 nL of drops. Good quality crystals grew in Hampton Research Peg/Ion screen condition #4 (20% PEG3350, 0.2 M lithium chloride) at 13 °C. Crystals were cryopreserved by a 2 min soak in cryo-solution composed of 14% PEG3350, 140 mM ammonium formate, 21% glucose, and 1 mM <b>6a</b> before flash cooling in liquid nitrogen.</div><div class="NLM_p">Diffraction data were collected at 98 K at the IMCA-CAT beamline 17-ID at the Advanced Photon Source using a Dectris Pilatus 6M Pixel Array. Data were processed using autoPROC and programs from the CCP4 suite, and the structure was determined by molecular replacement using MOLREP using the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T">2D0T</a> PDB hIDO-1 structure as the search model. Refinement was carried out using autoBUSTER, with cycles of rebuilding in COOT. The statistics of the data processing and structure refinement are listed in <a class="ref internalNav" href="#notes-1" aria-label="Supplementary Table S1">Supplementary Table S1</a>. Further details of structure refinement are given in the PDB header.</div><div class="NLM_p last">All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00974">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00974" class="ext-link">10.1021/acs.jmedchem.7b00974</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full list of compounds not showing significant activity on hIDO-1 and statistics for the crystallographic analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_001.pdf">jm7b00974_si_001.pdf (177.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_002.csv">jm7b00974_si_002.csv (1.51 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Compound <b>6a</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WHR">5WHR</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00974" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Crosignani</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1360677675727d7c3d70617c607a747d727d7a537a67767c60677b766172637666677a70603d707c7e"><span class="__cf_email__" data-cfemail="077473626166696829647568746e606966696e476e73626874736f627566776272736e64742964686a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Wythes</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#701d110204191e5e070904181503300016190a15025e131f1d"><span class="__cf_email__" data-cfemail="8de0ecfff9e4e3a3faf4f9e5e8fecdfdebe4f7e8ffa3eee2e0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Bingham</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline Bottemanne</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hélène Cannelle</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Cauwenberghs</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie Cordonnier</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Dalvie</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik Deroose</span> - <span class="hlFld-Affiliation affiliation">Asclepia
Outsourcing Solutions, Damvalleistraat 49, Destelbergen 9070, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Li Feng</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruno Gomes</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Greasley</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen E Kaiser</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manfred Kraus</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Négrerie</span> - <span class="hlFld-Affiliation affiliation">Ecole
Polytechnique, Unité Inserm 1182
UMR 7645, Route de Saclay, Palaiseau 91128, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Maegley</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nichol Miller</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brion W Murray</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manfred Schneider</span> - <span class="hlFld-Affiliation affiliation">iTeos
Therapeutics, Rue des Frères Wright 29, 6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Soloweij</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert E Stewart</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Tumang</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vince R Torti</span> - <span class="hlFld-Affiliation affiliation">La
Jolla Laboratories, Pfizer Global Research
and Development, 10770 Science Center Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Van Den Eynde</span> - <span class="hlFld-Affiliation affiliation">Ludwig
Institute for Cancer Research, Université
Catholique de Louvain, 74 Avenue Hippocrate, 1200 Brussels, Belgium</span></div></li></ul></li><li></li><li><span class="author-information-subsection-header">Funding</span><p>iTeos is supported by the Walloon Region of Belgium and the FEDER (European Fund for Economic and Regional Development).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Patrick Bingham, Deepak Dalvie, Jun Li Feng, Samantha Greasley, Stephen E. Kaiser, Manfred Kraus, Karen Maegley, Nichol Miller, Brion W. Murray, James Soloweij, Al Stewart, Joseph Tumang, Vince Torti, and Martin Wythes are current employees or former employees and/or have ownership interest (including patents) in Pfizer. Stefano Crosignani, Pauline Bottemanne, Hlne Cannelle, Sandra Cauwenberghs, Marie Cordonnier, Frederik Deroose, Bruno Gomes, Manfred Schneider, and Benoit Van Den Eynde are current or former employees and/or consultants and may have a business and/or financial interest in iTeos.<br /></br></div></li></ul></div><div class="ack" id="ACK-d85e4827-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Jenny Chaplin, Martin Edwards, Stephanie Scales, Theodore Johnson, and Jay Srirangam for helpful discussions during the course of this work.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">ABT</td><td class="NLM_def"><p class="first last">aminobenzotriazole</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption–distribution–metabolism–excretion</p></td></tr><tr><td class="NLM_term">AhR</td><td class="NLM_def"><p class="first last">aryl hydrocarbon receptor</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">bis in die (twice a day)</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">F<sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">F<sub>z</sub></td><td class="NLM_def"><p class="first last">absolute oral bioavailability</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen bond acceptor</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go-Related Gene</p></td></tr><tr><td class="NLM_term">IDO-1</td><td class="NLM_def"><p class="first last">indoleamine-2,3-dioxygenase 1</p></td></tr><tr><td class="NLM_term">IDO-2</td><td class="NLM_def"><p class="first last">indoleamine-2,3-dioxygenase 2</p></td></tr><tr><td class="NLM_term">INFγ</td><td class="NLM_def"><p class="first last">interferon gamma</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methylpyrrolidinone</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">per os (by oral administration)</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells</p></td></tr><tr><td class="NLM_term">P<sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PDMAB</td><td class="NLM_def"><p class="first last"><i>para</i>-dimethylaminobenzaldehyde</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">Q<sub>H</sub></td><td class="NLM_def"><p class="first last">liver blood flow</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph–Russ canine kidney cells</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TDO-2</td><td class="NLM_def"><p class="first last">tryptophan-2,3-dioxygenase 2</p></td></tr><tr><td class="NLM_term">Vd<sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">WBA</td><td class="NLM_def"><p class="first last">whole-blood assay</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mahoney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. J.</span><span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span><span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-584&author=K.+M.+Mahoneyauthor=P.+D.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0lgQXqjxOYQj5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DK.%2BM.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D584%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Munn, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, A. L.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3 dioxygenase and metabolic control of immune responses</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.it.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.it.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23103127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFymtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=137-143&author=D.+H.+Munnauthor=A.+L.+Mellor&title=Indoleamine+2%2C3+dioxygenase+and+metabolic+control+of+immune+responses&doi=10.1016%2Fj.it.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3 dioxygenase and metabolic control of immune responses</span></div><div class="casAuthors">Munn, David H.; Mellor, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-143</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sustained access to nutrients is a fundamental biol. need, esp. for proliferating cells, and controlling nutrient supply is an ancient strategy to regulate cellular responses to stimuli.  By catabolizing the essential amino acid TRP, cells expressing the enzyme indoleamine 2,3 dioxygenase (IDO) can mediate potent local effects on innate and adaptive immune responses to inflammatory insults.  Here, we discuss recent progress in elucidating how IDO activity promotes local metabolic changes that impact cellular and systemic responses to inflammatory and immunol. signals.  These recent developments identify potential new targets for therapy in a range of clin. settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfMMPvAs6AMrVg90H21EOLACvtfcHk0lgQXqjxOYQj5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFymtrnO&md5=f46000a6437e343ac1879088d36013bd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DMellor%26aufirst%3DA.%2BL.%26atitle%3DIndoleamine%25202%252C3%2520dioxygenase%2520and%2520metabolic%2520control%2520of%2520immune%2520responses%26jtitle%3DTrends%2520Immunol.%26date%3D2013%26volume%3D34%26spage%3D137%26epage%3D143%26doi%3D10.1016%2Fj.it.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">van Baren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B. J.</span><span> </span><span class="NLM_article-title">Tryptophan-degrading enzymes in tumoral immune resistance</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.3389%2Ffimmu.2015.00034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=25657648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kjs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-9&author=N.+van+Barenauthor=B.+J.+Van+den+Eynde&title=Tryptophan-degrading+enzymes+in+tumoral+immune+resistance&doi=10.3389%2Ffimmu.2015.00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan-degrading enzymes in tumoral immune resistance</span></div><div class="casAuthors">van Baren, Nicolas; Van den Eynde, Benoit J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Tryptophan is required for T lymphocyte effector functions.  Its degrdn. is one of the mechanisms selected by tumors to resist immune destruction.Two enzymes, tryptophan- 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1, control tryptophan degrdn. through the kynurenine pathway.  A third protein, indoleamine 2,3-dioxygenase 2, was identified more recently.  All three enzymes were reported to be expressed in tumors, and are candidate targets for pharmacol. inhibition aimed at restoring effective anti-tumoral immunity.  In this review, we compare these three enzymes in terms of structure, activity, regulation, and expression in healthy and cancerous tissues, in order to appreciate their relevance to tumoral immune resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3ajq2AGu0rVg90H21EOLACvtfcHk0lhJvT8bUYBF7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kjs7rJ&md5=5317c395bec31f1f31eed71aea45e12a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00034%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBaren%26aufirst%3DN.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DTryptophan-degrading%2520enzymes%2520in%2520tumoral%2520immune%2520resistance%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D9%26doi%3D10.3389%2Ffimmu.2015.00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Uyttenhove, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théate, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Eynde, B. J.</span><span> </span><span class="NLM_article-title">Evidence for a tumoral immune resistance mechanism based on typrotophan degradation by indoleamine-2,3-dioxygenase</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span><span class="refDoi"> DOI: 10.1038/nm934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1038%2Fnm934" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1269-1274&author=C.+Uyttenhoveauthor=L.+Pilotteauthor=I.+Th%C3%A9ateauthor=V.+Stroobantauthor=D.+Colauauthor=N.+Parmentierauthor=T.+Boonauthor=B.+J.+Van+Den+Eynde&title=Evidence+for+a+tumoral+immune+resistance+mechanism+based+on+typrotophan+degradation+by+indoleamine-2%2C3-dioxygenase&doi=10.1038%2Fnm934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm934%26sid%3Dliteratum%253Aachs%26aulast%3DUyttenhove%26aufirst%3DC.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ate%26aufirst%3DI.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DParmentier%26aufirst%3DN.%26aulast%3DBoon%26aufirst%3DT.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520tumoral%2520immune%2520resistance%2520mechanism%2520based%2520on%2520typrotophan%2520degradation%2520by%2520indoleamine-2%252C3-dioxygenase%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D10%26spage%3D1269%26epage%3D1274%26doi%3D10.1038%2Fnm934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikaido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaihara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isonishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">6030</span><span class="NLM_x">–</span> <span class="NLM_lpage">6039</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-04-2671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=16115948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6030-6039&author=A.+Okamotoauthor=T.+Nikaidoauthor=K.+Ochiaiauthor=S.+Takakuraauthor=M.+Saitoauthor=Y.+Aokiauthor=N.+Ishiiauthor=N.+Yanaiharaauthor=K.+Yamadaauthor=O.+Takikawaauthor=R.+Kawaguchiauthor=S.+Isonishiauthor=T.+Tanakaauthor=M.+Urashima&title=Indoleamine+2%2C3-dioxygenase+serves+as+a+marker+of+poor+prognosis+in+gene+expression+profiles+of+serous+ovarian+cancer+cells&doi=10.1158%2F1078-0432.CCR-04-2671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells</span></div><div class="casAuthors">Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu; Yamada, Kyosuke; Takikawa, Osamu; Kawaguchi, Rie; Isonishi, Seiji; Tanaka, Tadao; Urashima, Mitsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6030-6039</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We aimed to find key mols. assocd. with chemoresistance in ovarian cancer using gene expression profiling as a screening tool.  Exptl. Design: Using two newly established paclitaxel-resistant ovarian cancer cell lines from an original paclitaxel-sensitive cell line and four supersensitive and four refractory surgical ovarian cancer specimens from paclitaxel-based chemotherapy, mols. assocd. with chemoresistance were screened with gene expression profiling arrays contg. 39,000 genes.  We further analyzed 44 genes that showed significantly different expressions between paclitaxel-sensitive samples and paclitaxel-resistant samples with permutation tests, which were common in cell lines and patients' tumors.  Results: Eight of these genes showed reproducible results with real-time reverse transcription-PCR, of which indoleamine 2,3-dioxygenase gene expression was the most prominent and consistent.  Moreover, by immunohistochem. anal. using a total of 24 serous-type ovarian cancer surgical specimens (stage III, n = 21; stage IV, n = 7), excluding samples used for GeneChip anal., the Kaplan-Meier survival curve showed a clear relationship between indoleamine 2,3-dioxygenase staining patterns and overall survival (log-rank test, P = 0.0001).  All patients classified as neg. survived without relapse.  The 50% survival of patients classified as sporadic, focal, and diffuse was 41, 17, and 11 mo, resp.  Conclusion: The indoleamine 2,3-dioxygenase screened with the GeneChip was pos. assocd. with paclitaxel resistance and with impaired survival in patients with serous-type ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKy6bi9608B7Vg90H21EOLACvtfcHk0lhJvT8bUYBF7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D&md5=b8b8784e723cd5c337cec2c4e159d865</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2671%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DYanaihara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKawaguchi%26aufirst%3DR.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520serves%2520as%2520a%2520marker%2520of%2520poor%2520prognosis%2520in%2520gene%2520expression%2520profiles%2520of%2520serous%2520ovarian%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6030%26epage%3D6039%26doi%3D10.1158%2F1078-0432.CCR-04-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brandacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perathoner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladurner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneeberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obrist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner-Felmayer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margreiter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konigsrainer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amberger, A.</span><span> </span><span class="NLM_article-title">PrognosticValue of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-1966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-05-1966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=16489067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1144-1151&author=G.+Brandacherauthor=A.+Perathonerauthor=R.+Ladurnerauthor=S.+Schneebergerauthor=P.+Obristauthor=C.+Winklerauthor=E.+R.+Wernerauthor=G.+Werner-Felmayerauthor=H.+G.+Weissauthor=G.+Gobelauthor=R.+Margreiterauthor=A.+Konigsrainerauthor=D.+Fuchsauthor=A.+Amberger&title=PrognosticValue+of+Indoleamine+2%2C3-Dioxygenase+Expression+in+Colorectal+Cancer%3A+Effect+on+Tumor-Infiltrating+T+Cells&doi=10.1158%2F1078-0432.CCR-05-1966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span></div><div class="casAuthors">Brandacher, Gerald; Perathoner, Alexander; Ladurner, Ruth; Schneeberger, Stefan; Obrist, Peter; Winkler, Christiana; Werner, Ernst R.; Werner-Felmayer, Gabriele; Weiss, Helmut G.; Goebel, Georg; Margreiter, Raimund; Koenigsrainer, Alfred; Fuchs, Dietmar; Amberger, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1144-1151</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pathol. interactions between tumor and host immune cells within the tumor microenvironment create an immunosuppressive network that promotes tumor growth and protects the tumor from immune attack.  In this study, we examd. the contribution of the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) on this phenomenon.  Exptl. Design: Expression of IDO was analyzed in colorectal cancer cell lines by reverse transcription-PCR and functional enzyme activity was assessed by high-pressure liq. chromatog.  Semiquant. immunohistochem. was used to evaluate IDO expression in the tissue samples of 143 patients with colorectal carcinoma, and was then correlated with the no. of tumor-infiltrating T cells and clin. variables.  RESULTS: In vitro IDO expression and functional enzyme activity in colorectal cancer cells was found to be strictly dependent on IFN-γ stimulation.  Immunohistochem. scores revealed IDO-high expression in 56 of 143 (39.2%) tumor specimens, whereas 87 of 143 (60.8%) cases showed low IDO expression levels.  IDO-high expression was assocd. with a significant redn. of CD3+ infiltrating T cells (46.02 ± 7.25) as compared with tissue samples expressing low IDO (19.42 ± 2.50; P = 0.0003).  Furthermore, IDO-high immunoreactivity significantly correlated with the frequency of liver metastases (P = 0.003).  Kaplan-Meier anal. showed the crossing of survival curves at 45 mo.  By multivariate Cox's anal., IDO-high expression emerged as an independent prognostic variable (<45 mo, P = 0.006; >45 mo, P = 0.04).  CONCLUSION: IDO-high expression by colorectal tumor cells enables certain cancer subsets to initially avoid immune attack and defeat the invasion of T cells via local tryptophan depletion and the prodn. of proapoptotic tryptophan catabolites.  Thus, IDO significantly contributes to disease progression and overall survival in patients with colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuBdys9PLf7Vg90H21EOLACvtfcHk0lhJvT8bUYBF7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D&md5=623837bb245e71dd4fe137e790ddbfe9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1966%26sid%3Dliteratum%253Aachs%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DPerathoner%26aufirst%3DA.%26aulast%3DLadurner%26aufirst%3DR.%26aulast%3DSchneeberger%26aufirst%3DS.%26aulast%3DObrist%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DWerner%26aufirst%3DE.%2BR.%26aulast%3DWerner-Felmayer%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DH.%2BG.%26aulast%3DGobel%26aufirst%3DG.%26aulast%3DMargreiter%26aufirst%3DR.%26aulast%3DKonigsrainer%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DAmberger%26aufirst%3DA.%26atitle%3DPrognosticValue%2520of%2520Indoleamine%25202%252C3-Dioxygenase%2520Expression%2520in%2520Colorectal%2520Cancer%253A%2520Effect%2520on%2520Tumor-Infiltrating%2520T%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1144%26epage%3D1151%26doi%3D10.1158%2F1078-0432.CCR-05-1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Holmgaard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munn, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, J. P.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1084/jem.20130066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1084%2Fjem.20130066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23752227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=1389-402&author=R.+B.+Holmgaardauthor=D.+Zamarinauthor=D.+H.+Munnauthor=J.+D.+Wolchokauthor=J.+P.+Allison&title=Indoleamine+2%2C3-dioxygenase+is+a+critical+resistance+mechanism+in+antitumor+T+cell+immunotherapy+targeting+CTLA-4&doi=10.1084%2Fjem.20130066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4</span></div><div class="casAuthors">Holmgaard, Rikke B.; Zamarin, Dmitriy; Munn, David H.; Wolchok, Jedd D.; Allison, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1389-1402</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The cytotoxic T lymphocyte antigen-4 (CTLA-4)-blocking antibody ipilimumab results in durable responses in metastatic melanoma, though therapeutic benefit has been limited to a fraction of patients.  This calls for identification of resistance mechanisms and development of combinatorial strategies.  Here, we examine the inhibitory role of indoleamine 2,3-dioxygenase (IDO) on the antitumor efficacy of CTLA-4 blockade.  In IDO knockout mice treated with anti-CTLA-4 antibody, we demonstrate a striking delay in B16 melanoma tumor growth and increased overall survival when compared with wild-type mice.  This was also obsd. with antibodies targeting PD-1-PD-L1 and GITR.  To highlight the therapeutic relevance of these findings, we show that CTLA-4 blockade strongly synergizes with IDO inhibitors to mediate rejection of both IDO-expressing and nonexpressing poorly immunogenic tumors, emphasizing the importance of the inhibitory role of both tumor- and host-derived IDO.  This effect was T cell dependent, leading to enhanced infiltration of tumor-specific effector T cells and a marked increase in the effector-to-regulatory T cell ratios in the tumors.  Overall, these data demonstrate the immunosuppressive role of IDO in the context of immunotherapies targeting immune checkpoints and provide a strong incentive to clin. explore combination therapies using IDO inhibitors irresp. of IDO expression by the tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn2vZr-icci7Vg90H21EOLACvtfcHk0ljb3a3LTTCyyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGiurnP&md5=ed5a4e2074d7f0448eb503d7e11c2e91</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130066%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgaard%26aufirst%3DR.%2BB.%26aulast%3DZamarin%26aufirst%3DD.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520a%2520critical%2520resistance%2520mechanism%2520in%2520antitumor%2520T%2520cell%2520immunotherapy%2520targeting%2520CTLA-4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D1389%26epage%3D402%26doi%3D10.1084%2Fjem.20130066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Platten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Knebel Doeberitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oezen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, K.</span><span> </span><span class="NLM_article-title">Cancer immunotherapy by targeting IDO-1/TDO and their downstream effectors</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="refDoi"> DOI: 10.3389/fimmu.2014.00673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.3389%2Ffimmu.2014.00673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=25628622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=673&author=M.+Plattenauthor=N.+von+Knebel+Doeberitzauthor=I.+Oezenauthor=W.+Wickauthor=K.+Ochs&title=Cancer+immunotherapy+by+targeting+IDO-1%2FTDO+and+their+downstream+effectors&doi=10.3389%2Ffimmu.2014.00673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2014.00673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2014.00673%26sid%3Dliteratum%253Aachs%26aulast%3DPlatten%26aufirst%3DM.%26aulast%3Dvon%2BKnebel%2BDoeberitz%26aufirst%3DN.%26aulast%3DOezen%26aufirst%3DI.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DOchs%26aufirst%3DK.%26atitle%3DCancer%2520immunotherapy%2520by%2520targeting%2520IDO-1%252FTDO%2520and%2520their%2520downstream%2520effectors%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D5%26spage%3D673%26doi%3D10.3389%2Ffimmu.2014.00673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Röhrig, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majjigapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoete, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michielin, O.</span><span> </span><span class="NLM_article-title">Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9421</span><span class="NLM_x">–</span> <span class="NLM_lpage">9437</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlChsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9421-9437&author=U.+F.+R%C3%B6hrigauthor=S.+R.+Majjigapuauthor=P.+Vogelauthor=V.+Zoeteauthor=O.+Michielin&title=Challenges+in+the+discovery+of+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors</span></div><div class="casAuthors">Rohrig, Ute F.; Majjigapu, Somi Reddy; Vogel, Pierre; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9421-9437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) as an attractive target for anticancer therapy in 2003, the search for inhibitors has been intensely pursued both in academia and in pharmaceutical companies.  Many novel IDO1 inhibitor scaffolds have been described, and a few potent compds. have entered clin. trials.  However, a significant no. of the reported compds. contain problematic functional groups, suggesting that enzyme inhibition could be the result of undesirable side reactions instead of selective binding to IDO1.  Here, we describe issues in the employed exptl. protocols, review and classify reported IDO1 inhibitors, and suggest different approaches for confirming viable inhibitor scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR3nr-l4vgNLVg90H21EOLACvtfcHk0liRGMNuDANRAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlChsrw%253D&md5=1b44178d33badc00215915c28d027b5d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00326%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DChallenges%2520in%2520the%2520discovery%2520of%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9421%26epage%3D9437%26doi%3D10.1021%2Facs.jmedchem.5b00326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Beatty, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dwyer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajewski, T. F.</span><span> </span><span class="NLM_article-title">First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 Epacadostat (INCB024360) in patients with advanced solid malignancies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3269</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-16-2272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=28053021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3269-3276&author=G.+L.+Beattyauthor=P.+J.+O%E2%80%99Dwyerauthor=J.+Clarkauthor=J.+G.+Shiauthor=K.+J.+Bowmanauthor=P.+A.+Scherleauthor=R.+C.+Newtonauthor=R.+Schaubauthor=J.+Maleskiauthor=L.+Leopoldauthor=T.+F.+Gajewski&title=First-in-human+phase+I+study+of+the+oral+inhibitor+of+indoleamine+2%2C3-dioxygenase-1+Epacadostat+%28INCB024360%29+in+patients+with+advanced+solid+malignancies&doi=10.1158%2F1078-0432.CCR-16-2272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies</span></div><div class="casAuthors">Beatty, Gregory L.; O'Dwyer, Peter J.; Clark, Jason; Shi, Jack G.; Bowman, Kevin J.; Scherle, Peggy A.; Newton, Robert C.; Schaub, Richard; Maleski, Janet; Leopold, Lance; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3269-3276</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase-1 (IDO1) catalyzes the degrdn. of tryptophan to N-formyl-kynurenine.  Overexpressed in many solid malignancies, IDO1 can promote tumor escape from host immunosurveillance.  This first-in-human phase I study investigated the max. tolerated dose, safety, pharmacokinetics, pharmacodynamics, and antitumor activity of epacadostat (INCB024360), a potent and selective inhibitor of IDO1.  Fifty-two patients with advanced solid malignancies were treated with epacadostat [50 mg once daily or 50, 100, 300, 400, 500, 600, or 700 mg twice daily (BID)] in a dose-escalation 3 + 3 design and evaluated in 28-day cycles.  Treatment was continued until disease progression or unacceptable toxicity.  One dose-limiting toxicity (DLT) occurred at the dose of 300 mg BID (grade 3, radiation pneumonitis); another DLT occurred at 400 mg BID (grade 3, fatigue).  The most common adverse events in >20% of patients overall were fatigue, nausea, decreased appetite, vomiting, constipation, abdominal pain, diarrhea, dyspnea, back pain, and cough.  Treatment produced significant dose-dependent redns. in plasma kynurenine levels and in the plasma kynurenine/tryptophan ratio at all doses and in all patients.  Near maximal changes were obsd. at doses of ≥100 mg BID with >80% to 90% inhibition of IDO1 achieved throughout the dosing period.  Although no objective responses were detected, stable disease lasting ≥16 wk was obsd. in 7 of 52 patients.  Epacadostat was generally well tolerated, effectively normalized kynurenine levels, and produced maximal inhibition of IDO1 activity at doses of ≥100 mg BID.  Studies investigating epacadostat in combination with other immunomodulatory drugs are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdL__p3Q7B7Vg90H21EOLACvtfcHk0liRGMNuDANRAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfP&md5=dee4464e680b476ebe0dbad7f5ec8d46</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2272%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DG.%2BL.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%2BG.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DSchaub%26aufirst%3DR.%26aulast%3DMaleski%26aufirst%3DJ.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DFirst-in-human%2520phase%2520I%2520study%2520of%2520the%2520oral%2520inhibitor%2520of%2520indoleamine%25202%252C3-dioxygenase-1%2520Epacadostat%2520%2528INCB024360%2529%2520in%2520patients%2520with%2520advanced%2520solid%2520malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3269%26epage%3D3276%26doi%3D10.1158%2F1078-0432.CCR-16-2272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leffet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansbury, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span> </span><span class="NLM_article-title">Discovery of potent competitive inhibitors of Indoleamine 2,3-Dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7364</span><span class="NLM_x">–</span> <span class="NLM_lpage">7367</span><span class="refDoi"> DOI: 10.1021/jm900518f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900518f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7364-7367&author=E.+W.+Yueauthor=B.+Doutyauthor=B.+Waylandauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=C.+Liuauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=B.+Metcalfauthor=P.+A.+Scherleauthor=A.+P.+Combs&title=Discovery+of+potent+competitive+inhibitors+of+Indoleamine+2%2C3-Dioxygenase+with+in+vivo+pharmacodynamic+activity+and+efficacy+in+a+mouse+melanoma+model&doi=10.1021%2Fjm900518f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model</span></div><div class="casAuthors">Yue, Eddy W.; Douty, Brent; Wayland, Brian; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Liu, Changnian; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Metcalf, Brian; Scherle, Peggy A.; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7364-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydroxyamidine chemotype has been discovered as a key pharmacophore in novel inhibitors of indoleamine 2,3-dioxygenase (IDO).  Optimization led to the identification of (I), which is a potent (HeLa IC50 = 19 nM) competitive inhibitor of IDO.  Testing of I in mice demonstrated pharmacodynamic inhibition of IDO, as measured by decreased kynurenine levels (>50%) in plasma and dose dependent efficacy in mice bearing GM-CSF-secreting B16 melanoma tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsq88hx0J77Vg90H21EOLACvtfcHk0liRGMNuDANRAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D&md5=328d92bffb88a86da030c31eff707dc6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm900518f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900518f%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520competitive%2520inhibitors%2520of%2520Indoleamine%25202%252C3-Dioxygenase%2520with%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520efficacy%2520in%2520a%2520mouse%2520melanoma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7364%26epage%3D7367%26doi%3D10.1021%2Fjm900518f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLonde, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuHadaway, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malachowski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. J.</span><span> </span><span class="NLM_article-title">Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4977</span><span class="refDoi"> DOI: 10.1021/jm800512z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800512z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4968-4977&author=S.+Kumarauthor=D.+Jallerauthor=B.+Patelauthor=J.+M.+LaLondeauthor=J.+B.+DuHadawayauthor=W.+P.+Malachowskiauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Structure+based+development+of+phenylimidazole-derived+inhibitors+of+indoleamine+2%2C3-dioxygenase&doi=10.1021%2Fjm800512z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase</span></div><div class="casAuthors">Kumar, Sanjeev; Jaller, Daniel; Patel, Bhumika; LaLonde, Judith M.; DuHadaway, James B.; Malachowski, William P.; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4968-4977</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  With the goal of developing more potent IDO inhibitors, a systematic study of 4-phenylimidazole (4-PI) derivs. was undertaken.  Computational docking expts. guided design and synthesis efforts with analogs of 4-PI.  In particular, three interactions of 4-PI analogs with IDO were studied: the active site entrance, the interior of the active site, and the heme iron binding.  The three most potent inhibitors I (R = 4-HOC6H4, 3-HSC6H4, 4-HSC6H4) appear to exploit interactions with C129 and S167 in the interior of the active site.  All three inhibitors are approx. 10-fold more potent than 4-PI.  The study represents the first example of enzyme inhibitor development with the recently reported crystal structure of IDO and offers important lessons in the search for more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTIIEf7DjmLVg90H21EOLACvtfcHk0lgsjmzi3dsqZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D&md5=6e232cb983d0ba2396bea16060a5b7a1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800512z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800512z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DStructure%2520based%2520development%2520of%2520phenylimidazole-derived%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4968%26epage%3D4977%26doi%3D10.1021%2Fjm800512z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cady, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sono, M.</span><span> </span><span class="NLM_article-title">1-Methyl-DL-tryptophan, beta-(3- benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/0003-9861(91)90142-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2F0003-9861%2891%2990142-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1991&pages=326-333&author=S.+G.+Cadyauthor=M.+Sono&title=1-Methyl-DL-tryptophan%2C+beta-%283-+benzofuranyl%29-DL-alanine+%28the+oxygen+analog+of+tryptophan%29%2C+and+beta-%5B3-benzo%28b%29thienyl%5D-DL-alanine+%28the+sulfur+analog+of+tryptophan%29+are+competitive+inhibitors+for+indoleamine+2%2C3-dioxygenase&doi=10.1016%2F0003-9861%2891%2990142-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2891%2990142-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252891%252990142-6%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BG.%26aulast%3DSono%26aufirst%3DM.%26atitle%3D1-Methyl-DL-tryptophan%252C%2520beta-%25283-%2520benzofuranyl%2529-DL-alanine%2520%2528the%2520oxygen%2520analog%2520of%2520tryptophan%2529%252C%2520and%2520beta-%255B3-benzo%2528b%2529thienyl%255D-DL-alanine%2520%2528the%2520sulfur%2520analog%2520of%2520tryptophan%2529%2520are%2520competitive%2520inhibitors%2520for%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1991%26volume%3D291%26spage%3D326%26epage%3D333%26doi%3D10.1016%2F0003-9861%2891%2990142-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Peterson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migawa, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaker, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arend, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of functionalized tryptophan derivatives and related compounds as competitive inhibitors of indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFCqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=531-544&author=A.+C.+Petersonauthor=M.+T.+Migawaauthor=M.+J.+Martinauthor=L.+K.+Hamakerauthor=K.+M.+Czerwinskiauthor=W.+Zhangauthor=R.+A.+Arendauthor=P.+L.+Fisetteauthor=Y.+Okaziauthor=J.+A.+Willauthor=R.+R.+Brownauthor=J.+M.+Cook&title=Evaluation+of+functionalized+tryptophan+derivatives+and+related+compounds+as+competitive+inhibitors+of+indoleamine+2%2C3-dioxygenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">evaluation of functionalized tryptophan derivatives and related compounds as competitive inhibitors of indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Peterson, Andrew C.; Migawa, Michael T.; Martin, Michael J.; Hamaker, Linda K.; Czerwinski, Kevin M.; Zhang, Weijiang; Arend, Richard A.; Fisette, Philip L.; Ozaki, Yoshisuke; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">531-44</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    </div><div class="casAbstract">The stereochem. requirements of the active site of human monocyte/macrophage indoleamine 2,3-dioxygenase (IDO) were probed by assays of both antipodes of 1-methyltryptophan.  The L-isomer of 1-methyltryptophan (62.9% inhibition, Ki=34 μM) was significantly more active than its antipode (11.6% inhibition).  These results indicate stereoselectivity of binding at the tryptophan binding site of IDO.  The 1-ethyltryptophan antipodes, however, were not potent inhibitors of this enzyme.  In addn., both D- and L-dihydrotryptophan diastereomers were inactive.  In contrast, both DL-oxindolylalanine and 5-methoxytryptamine were relatively potent effectors, activating IDO at 43.3% and 43.9% activation, resp.  Quinolinic acid, kynurenic acid, L-kynurenine, 3-hydroxykynurenine, xanthurenic acid and picolinic acid were all inactive.  However, L-5-hydroxytryptophan showed modest inhibition (14% inhibition).  The D-and L-isomers of quinoline-3-alanine, resp., were inactive as were tryptazan and DL-7-azatryptophan.  These results suggest that the tryptophan binding site of IDO is composed of a largely lipophilic cleft, except in the region where the amino acid function binds.  The nonindolic compd., 3-amino-2-naphthoic acid, was the most potent inhibitor in this investigation (75.2% inhibition) and demonstrates that the indole nitrogen moiety is not necessary for activity at this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrSynMTA04LVg90H21EOLACvtfcHk0lhsFsU7CFlv2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFCqsbc%253D&md5=228fb816606e3519fe96bb54aa7ca158</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DA.%2BC.%26aulast%3DMigawa%26aufirst%3DM.%2BT.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DHamaker%26aufirst%3DL.%2BK.%26aulast%3DCzerwinski%26aufirst%3DK.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArend%26aufirst%3DR.%2BA.%26aulast%3DFisette%26aufirst%3DP.%2BL.%26aulast%3DOkazi%26aufirst%3DY.%26aulast%3DWill%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DR.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520functionalized%2520tryptophan%2520derivatives%2520and%2520related%2520compounds%2520as%2520competitive%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D1994%26volume%3D3%26spage%3D531%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, M. P.</span><span> </span><span class="NLM_article-title">4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferongamma-stimulated monocytes (THP-1 cells)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1042/bj2910011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1042%2Fbj2910011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1993&pages=11-14&author=K.+Saitoauthor=C.+Y.+Chenauthor=M.+Masanaauthor=J.+S.+Crowleyauthor=S.+P.+Markeyauthor=M.+P.+Heyes&title=4-Chloro-3-hydroxyanthranilate%2C+6-chlorotryptophan+and+norharmane+attenuate+quinolinic+acid+formation+by+interferongamma-stimulated+monocytes+%28THP-1+cells%29&doi=10.1042%2Fbj2910011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj2910011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2910011%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DMasana%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DJ.%2BS.%26aulast%3DMarkey%26aufirst%3DS.%2BP.%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26atitle%3D4-Chloro-3-hydroxyanthranilate%252C%25206-chlorotryptophan%2520and%2520norharmane%2520attenuate%2520quinolinic%2520acid%2520formation%2520by%2520interferongamma-stimulated%2520monocytes%2520%2528THP-1%2520cells%2529%26jtitle%3DBiochem.%2520J.%26date%3D1993%26volume%3D291%26spage%3D11%26epage%3D14%26doi%3D10.1042%2Fbj2910011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gaspari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malachowski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuHadaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, A. M.</span><span> </span><span class="NLM_article-title">Structure-activity study of brassinin derivatives as indoleamine 2,3- dioxygenase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1021/jm0508888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=684-692&author=P.+Gaspariauthor=T.+Banerjeeauthor=W.+P.+Malachowskiauthor=A.+J.+Mullerauthor=G.+C.+Prendergastauthor=J.+DuHadawayauthor=S.+Bennettauthor=A.+M.+Donovan&title=Structure-activity+study+of+brassinin+derivatives+as+indoleamine+2%2C3-+dioxygenase+inhibitors&doi=10.1021%2Fjm0508888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0508888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508888%26sid%3Dliteratum%253Aachs%26aulast%3DGaspari%26aufirst%3DP.%26aulast%3DBanerjee%26aufirst%3DT.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDuHadaway%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DA.%2BM.%26atitle%3DStructure-activity%2520study%2520of%2520brassinin%2520derivatives%2520as%2520indoleamine%25202%252C3-%2520dioxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D684%26epage%3D692%26doi%3D10.1021%2Fjm0508888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikkyu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8661</span><span class="NLM_x">–</span> <span class="NLM_lpage">8669</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2008.07.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8661-8669&author=H.+Nakashimaauthor=Y.+Utoauthor=E.+Nakataauthor=H.+Nagasawaauthor=K.+Ikkyuauthor=N.+Hiraokaauthor=K.+Nakashimaauthor=Y.+Sasakiauthor=H.+Sugimotoauthor=Y.+Shiroauthor=T.+Hashimotoauthor=Y.+Okamotoauthor=Y.+Asakawaauthor=H.+Hori&title=Synthesis+and+biological+activity+of+1-methyl-tryptophan-tirapazamine+hybrids+as+hypoxia-targeting+indoleamine+2%2C3-dioxygenase+inhibitors&doi=10.1016%2Fj.bmc.2008.07.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.087%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DUto%26aufirst%3DY.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DNagasawa%26aufirst%3DH.%26aulast%3DIkkyu%26aufirst%3DK.%26aulast%3DHiraoka%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DShiro%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25201-methyl-tryptophan-tirapazamine%2520hybrids%2520as%2520hypoxia-targeting%2520indoleamine%25202%252C3-dioxygenase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8661%26epage%3D8669%26doi%3D10.1016%2Fj.bmc.2008.07.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dolusič, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapunaric, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredérick, R.</span><span> </span><span class="NLM_article-title">Discovery and preliminary SARs of keto- indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3058</span><span class="NLM_x">–</span> <span class="NLM_lpage">3065</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.02.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.ejmech.2011.02.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3058-3065&author=E.+Dolusi%C4%8Dauthor=P.+Larrieuauthor=S.+Blancauthor=F.+Sapunaricauthor=J.+Pouyezauthor=L.+Moineauxauthor=D.+Coletteauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=T.+Ferainauthor=G.+Fraserauthor=M.+Galleniauthor=J.-M.+Frereauthor=B.+Masereelauthor=B.+Van+den+Eyndeauthor=J.+Woutersauthor=R.+Fred%C3%A9rick&title=Discovery+and+preliminary+SARs+of+keto-+indoles+as+novel+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.ejmech.2011.02.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.049%26sid%3Dliteratum%253Aachs%26aulast%3DDolusi%25C4%258D%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DS.%26aulast%3DSapunaric%26aufirst%3DF.%26aulast%3DPouyez%26aufirst%3DJ.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DColette%26aufirst%3DD.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DFerain%26aufirst%3DT.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.-M.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFred%25C3%25A9rick%26aufirst%3DR.%26atitle%3DDiscovery%2520and%2520preliminary%2520SARs%2520of%2520keto-%2520indoles%2520as%2520novel%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3058%26epage%3D3065%26doi%3D10.1016%2Fj.ejmech.2011.02.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dolusič, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapunaric, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredérick, R.</span><span> </span><span class="NLM_article-title">Indol-2-yl ethanones as noveĺ indoleamine 2,3-dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2010.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1550-1561&author=E.+Dolusi%C4%8Dauthor=P.+Larrieuauthor=S.+Blancauthor=F.+Sapunaricauthor=B.+Norbergauthor=L.+Moineauxauthor=D.+Coletteauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=T.+Ferainauthor=G.+Fraserauthor=M.+Galleniauthor=M.+Galeniauthor=J.-M.+Frereauthor=B.+Masereelauthor=B.+Van+den+Eyndeauthor=J.+Woutersauthor=R.+Fred%C3%A9rick&title=Indol-2-yl+ethanones+as+nove%C4%BA+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.bmc.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DDolusi%25C4%258D%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DS.%26aulast%3DSapunaric%26aufirst%3DF.%26aulast%3DNorberg%26aufirst%3DB.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DColette%26aufirst%3DD.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DFerain%26aufirst%3DT.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DGaleni%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.-M.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFred%25C3%25A9rick%26aufirst%3DR.%26atitle%3DIndol-2-yl%2520ethanones%2520as%2520nove%25C4%25BA%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1550%26epage%3D1561%26doi%3D10.1016%2Fj.bmc.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, Y.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3- dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2012.12.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1159-1165&author=M.+Tanakaauthor=X.+Liauthor=H.+Hikawaauthor=T.+Suzukiauthor=K.+Tsutsumiauthor=M.+Satoauthor=O.+Takikawaauthor=H.+Suzukiauthor=Y.+Yokoyama&title=Synthesis+and+biological+evaluation+of+novel+tryptoline+derivatives+as+indoleamine+2%2C3-+dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.bmc.2012.12.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHikawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsutsumi%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520tryptoline%2520derivatives%2520as%2520indoleamine%25202%252C3-%2520dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1159%26epage%3D1165%26doi%3D10.1016%2Fj.bmc.2012.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cavalheiro Tourino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belle, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dörr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campa, A.</span><span> </span><span class="NLM_article-title">Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells</span> <span class="citation_source-journal">Cell Biochem. Funct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1002/cbf.2980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1002%2Fcbf.2980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23754498" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=361-364&author=M.+Cavalheiro+Tourinoauthor=E.+M.+de+Oliveiraauthor=L.+P.+Belleauthor=F.+H.+Knebelauthor=R.+C.+Albuquerqueauthor=F.+A.+D%C3%B6rrauthor=S.+S.+Okadaauthor=S.+Miglioriniauthor=I.+S.+Soaresauthor=A.+Campa&title=Tryptamine+and+dimethyltryptamine+inhibit+indoleamine+2%2C3+dioxygenase+and+increase+the+tumor-reactive+effect+of+peripheral+blood+mononuclear+cells&doi=10.1002%2Fcbf.2980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcbf.2980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.2980%26sid%3Dliteratum%253Aachs%26aulast%3DCavalheiro%2BTourino%26aufirst%3DM.%26aulast%3Dde%2BOliveira%26aufirst%3DE.%2BM.%26aulast%3DBelle%26aufirst%3DL.%2BP.%26aulast%3DKnebel%26aufirst%3DF.%2BH.%26aulast%3DAlbuquerque%26aufirst%3DR.%2BC.%26aulast%3DD%25C3%25B6rr%26aufirst%3DF.%2BA.%26aulast%3DOkada%26aufirst%3DS.%2BS.%26aulast%3DMigliorini%26aufirst%3DS.%26aulast%3DSoares%26aufirst%3DI.%2BS.%26aulast%3DCampa%26aufirst%3DA.%26atitle%3DTryptamine%2520and%2520dimethyltryptamine%2520inhibit%2520indoleamine%25202%252C3%2520dioxygenase%2520and%2520increase%2520the%2520tumor-reactive%2520effect%2520of%2520peripheral%2520blood%2520mononuclear%2520cells%26jtitle%3DCell%2520Biochem.%2520Funct.%26date%3D2013%26volume%3D31%26spage%3D361%26epage%3D364%26doi%3D10.1002%2Fcbf.2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Soret, J.-L.</span><span> </span><span class="NLM_article-title">Analyse Spectrale – Sur le spectre d’absorption du sang dans la partie violette et ultra-violette</span> <span class="citation_source-journal">C. R. Hebd. Séances Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1883</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1883&pages=1269-70&author=J.-L.+Soret&title=Analyse+Spectrale+%E2%80%93+Sur+le+spectre+d%E2%80%99absorption+du+sang+dans+la+partie+violette+et+ultra-violette"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoret%26aufirst%3DJ.-L.%26atitle%3DAnalyse%2520Spectrale%2520%25E2%2580%2593%2520Sur%2520le%2520spectre%2520d%25E2%2580%2599absorption%2520du%2520sang%2520dans%2520la%2520partie%2520violette%2520et%2520ultra-violette%26jtitle%3DC.%2520R.%2520Hebd.%2520S%25C3%25A9ances%2520Acad.%2520Sci.%26date%3D1883%26volume%3D97%26spage%3D1269%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cady, S. G.</span><span> </span><span class="NLM_article-title">Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">5392</span><span class="NLM_x">–</span> <span class="NLM_lpage">5399</span><span class="refDoi"> DOI: 10.1021/bi00439a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00439a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADyaL1MXktF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=5392-5399&author=M.+Sonoauthor=S.+G.+Cady&title=Enzyme+kinetic+and+spectroscopic+studies+of+inhibitor+and+effector+interactions+with+indoleamine+2%2C3-dioxygenase.+1.+Norharman+and+4-phenylimidazole+binding+to+the+enzyme+as+inhibitors+and+heme+ligands&doi=10.1021%2Fbi00439a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands</span></div><div class="casAuthors">Sono, Masanori; Cady, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5392-9</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The effects of norharman, one of the few known inhibitors of the heme protein indoleamine 2,3-dioxygenase, and of 4-phenylimidazole (4-PheImid), a heme ligand, on the catalytic (Vmax, Km) and spectroscopic properties (optical absorption, CD, and MCD) of rabbit small intestine dioxygenase were investigated.  Assays were performed with the substrate L- or D-tryptophan (Trp) and an ascorbic acid-methylene blue cofactor system at 25°.  Both norharman and 4-PheImid exhibit noncompetitive inhibition with respect to L-Trp and D-Trp.  The binding of norharman to the enzyme results in the formation of a low-spin complex in both the ferric and ferrous enzyme with comparable dissocn. consts. (Kd = ∼10 μM at pH 7.0) that are ∼10-fold smaller than the obsd. Ki.  L-Trp exerts no effect for the ferric enzyme and slight neg. cooperative effects for the ferrous enzyme on norharman binding.  Close spectral similarities are obsd. between the adducts of the enzyme with norharman and 4-PheImid in the resp. oxidn. states.  This, together with competition expts. using CN-, demonstrates that norharman binds directly to the heme Fe of the enzyme as a N donor ligand.  Thus, norharman competes with O2 for the heme Fe of the ferrous (active) enzyme, resulting in the obsd. inhibition.  L-Trp and 4-PheImid appear to compete for the heme-binding site in the ferric enzyme and display slight neg. cooperativity on binding to the ferrous enzyme.  The obsd. Ki for 4-PheImid is comparable with the Kd (∼10 μM at pH 7.0) of its adduct with the ferric enzyme, but is ∼40-fold smaller than the Kd for the corresponding ferrous complex.  Apparently, the inhibition of the dioxygenase activity by 4-PheImid is due to its binding to the heme Fe of the ferric enzyme, preventing the reductive activation of the dioxygenase by the ascorbic acid-methylene blue cofactor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFgFeeIW5--LVg90H21EOLACvtfcHk0lhNGPB_Hdtkyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktF2qtLg%253D&md5=87f3a4be44f5626760b567185013050a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00439a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00439a012%26sid%3Dliteratum%253Aachs%26aulast%3DSono%26aufirst%3DM.%26aulast%3DCady%26aufirst%3DS.%2BG.%26atitle%3DEnzyme%2520kinetic%2520and%2520spectroscopic%2520studies%2520of%2520inhibitor%2520and%2520effector%2520interactions%2520with%2520indoleamine%25202%252C3-dioxygenase.%25201.%2520Norharman%2520and%25204-phenylimidazole%2520binding%2520to%2520the%2520enzyme%2520as%2520inhibitors%2520and%2520heme%2520ligands%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D5392%26epage%3D5399%26doi%3D10.1021%2Fbi00439a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, S. R.</span><span> </span><span class="NLM_article-title">Biochem. Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5028</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1021/bi1005078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1005078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=5028-34&author=C.+Luauthor=Y.+Linauthor=S.+R.+Yeh&title=Biochem.+Spectroscopic+studies+of+ligand+and+substrate+binding+to+human+indoleamine+2%2C3-dioxygenase&doi=10.1021%2Fbi1005078"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi1005078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005078%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DS.%2BR.%26atitle%3DBiochem.%2520Spectroscopic%2520studies%2520of%2520ligand%2520and%2520substrate%2520binding%2520to%2520human%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D5028%26epage%3D34%26doi%3D10.1021%2Fbi1005078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gomes, B.; Driessens, G.; Bartlett, D.; Cauwenberghs, S.; Crosignani, S.; Dalvie, D.; Denies, S.; Fantin, V. R.; Guo, J.; Letellier, M.-C.; Li, W.; Maegley, K.; Marillier, R.; Miller, N.; Pirson, R.; Rabolli, V.; Ray, C.; Streiner, N.; Torti, V. R.; Tsaparikos, K.; van den Eynde, B.; Wythes, M.; Zheng, X.; Tumang, J.; Kraus, M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gomes%2C+B.%3B+Driessens%2C+G.%3B+Bartlett%2C+D.%3B+Cauwenberghs%2C+S.%3B+Crosignani%2C+S.%3B+Dalvie%2C+D.%3B+Denies%2C+S.%3B+Fantin%2C+V.+R.%3B+Guo%2C+J.%3B+Letellier%2C+M.-C.%3B+Li%2C+W.%3B+Maegley%2C+K.%3B+Marillier%2C+R.%3B+Miller%2C+N.%3B+Pirson%2C+R.%3B+Rabolli%2C+V.%3B+Ray%2C+C.%3B+Streiner%2C+N.%3B+Torti%2C+V.+R.%3B+Tsaparikos%2C+K.%3B+van+den+Eynde%2C+B.%3B+Wythes%2C+M.%3B+Zheng%2C+X.%3B+Tumang%2C+J.%3B+Kraus%2C+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DB." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Crosignani, S.; Cauwenberghs, S.; Driessens, G.; Deroose, F.</span> Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as indoleamine 2,3-dioxygenase-1 inhibitors. PCT Patent WO 2015173764, Nov 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crosignani%2C+S.%3B+Cauwenberghs%2C+S.%3B+Driessens%2C+G.%3B+Deroose%2C+F.+Pyrrolidine-2%2C5-dione+derivatives%2C+pharmaceutical+compositions+and+methods+for+use+as+indoleamine+2%2C3-dioxygenase-1+inhibitors.+PCT+Patent+WO+2015173764%2C+Nov+19%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 76 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matthew M. Hamilton, Faika Mseeh, Timothy J. McAfoos, Paul G. Leonard, Naphtali J. Reyna, Angela L. Harris, Alan Xu, Michelle Han, Michael J. Soth, Barbara Czako, Jay P. Theroff, Pijus K. Mandal, Jason P. Burke, Brett Virgin-Downey, Alessia Petrocchi, Dana Pfaffinger, Norma E. Rogers, Connor A. Parker, Simon S. Yu, Yongying Jiang, Stephan Krapp, Alfred Lammens, Graham Trevitt, Martin R. Tremblay, Keith Mikule, Keith Wilcoxen, Jason B. Cross, Philip Jones, Joseph R. Marszalek, <span class="NLM_string-name hlFld-ContribAuthor">Richard T. Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00679%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIACS-9779%252Band%252BIACS-70465%252Bas%252BPotent%252BInhibitors%252BTargeting%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252B%252528IDO1%252529%252BApoenzyme%26aulast%3DHamilton%26aufirst%3DMatthew%2BM.%26date%3D2021%26date%3D2021%26date%3D13042021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiang-Li Ning, Yu-Zhi Li, Cui Huo, Ji Deng, Cheng Gao, Kai-Rong Zhu, Miao Wang, Yu-Xiang Wu, Jun-Lin Yu, Ya-Li Ren, Zong-Yuan Luo, Gen Li, Yang Chen, Si-Yao Wang, Cheng Peng, Ling-Ling Yang, Zhou-Yu Wang, Yong Wu, Shan Qian, <span class="NLM_string-name hlFld-ContribAuthor">Guo-Bo Li</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8303-8332. <a href="https://doi.org/10.1021/acs.jmedchem.1c00303" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DX-ray%252BStructure-Guided%252BDiscovery%252Bof%252Ba%252BPotent%25252C%252BOrally%252BBioavailable%25252C%252BDual%252BHuman%252BIndoleamine%25252FTryptophan%252B2%25252C3-Dioxygenase%252B%252528hIDO%25252FhTDO%252529%252BInhibitor%252BThat%252BShows%252BActivity%252Bin%252Ba%252BMouse%252BModel%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DNing%26aufirst%3DXiang-Li%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8303%26epage%3D8332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett Andrew Hopkins, Wensheng Yu, Hongjun Zhang, Sulagna Sanyal, Qinglin Pu, Hua Zhou, Kun Liu, Jongwon Lim, Xavier Fradera, Charles A. Lesburg, Alfred Lammens, Theodore A. Martinot, Ryan D. Cohen, Amy C. Doty, Heidi Ferguson, Elliott B. Nickbarg, Mangeng Cheng, Peter Spacciapoli, Prasanthi Geda, Xuelei Song, Nadya Smotrov, Pravien Abeywickrema, Christine Andrews, Chad Chamberlin, Omar Mabrouk, Patrick Curran, Matthew Richards, Peter Saradjian, J. Richard Miller, Ian Knemeyer, Karin M. Otte, Stella Vincent, Nunzio Sciammetta, Alexander Pasternak, David Jonathan Bennett, <span class="NLM_string-name hlFld-ContribAuthor">Yongxin Han</span>. </span><span class="cited-content_cbyCitation_article-title">Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 389-396. <a href="https://doi.org/10.1021/acsmedchemlett.0c00525" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00525%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarbamate%252Band%252BN-Pyrimidine%252BMitigate%252BAmide%252BHydrolysis%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BTetrahydroquinoline%252BIDO1%252BInhibitors%26aulast%3DLi%26aufirst%3DDerun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D23022021%26date%3D26022021%26volume%3D12%26issue%3D3%26spage%3D389%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Miyuki Kumazawa, Manabu Tejima, Miwa Fukuda, Shota Takeda, Kenji Suzuki, Yukiko Mizumoto, Kakeru Sato, Minoru Waki, Hiroyuki Miyachi, Akira Asai, Osamu Takikawa, Tomoko Hashimoto, Osamu Ohno, <span class="NLM_string-name hlFld-ContribAuthor">Kenji Matsuno</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Carbono(di)thioates as Indoleamine 2,3-Dioxygenase 1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 211-216. <a href="https://doi.org/10.1021/acsmedchemlett.0c00527" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00527%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BCarbono%252528di%252529thioates%252Bas%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252BInhibitors%26aulast%3DKumazawa%26aufirst%3DMiyuki%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02102020%26date%3D08012021%26date%3D15012021%26volume%3D12%26issue%3D2%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily C. Cherney, Liping Zhang, Susheel Nara, Xiao Zhu, Johnni Gullo-Brown, Derrick Maley, Tai-An Lin, John T. Hunt, Christine Huang, Zheng Yang, Celia Darienzo, Lorell Discenza, Asoka Ranasinghe, Mary Grubb, Theresa Ziemba, Sarah C. Traeger, Xin Li, Kathy Johnston, Lisa Kopcho, Mark Fereshteh, Kimberly Foster, Kevin Stefanski, Joseph Fargnoli, Jesse Swanson, Jennifer Brown, Diane Delpy, Steven P. Seitz, Robert Borzilleri, Gregory Vite, <span class="NLM_string-name hlFld-ContribAuthor">Aaron Balog</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 288-294. <a href="https://doi.org/10.1021/acsmedchemlett.0c00668" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00668%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BPreclinical%252BEvaluation%252Bof%252BBMS-986242%25252C%252Ba%252BPotent%25252C%252BSelective%252BInhibitor%252Bof%252BIndoleamine-2%25252C3-dioxygenase%252B1%26aulast%3DCherney%26aufirst%3DEmily%2BC.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20122020%26date%3D22012021%26date%3D28012021%26volume%3D12%26issue%3D2%26spage%3D288%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Khoa N. Pham, Ariel Lewis-Ballester, <span class="NLM_string-name hlFld-ContribAuthor">Syun-Ru Yeh</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational Plasticity in Human Heme-Based Dioxygenases. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (4)
                                     , 1836-1845. <a href="https://doi.org/10.1021/jacs.0c09970" title="DOI URL">https://doi.org/10.1021/jacs.0c09970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c09970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c09970%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DConformational%252BPlasticity%252Bin%252BHuman%252BHeme-Based%252BDioxygenases%26aulast%3DPham%26aufirst%3DKhoa%2BN.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D17092020%26date%3D29122020%26volume%3D143%26issue%3D4%26spage%3D1836%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Feng, Dongdong Liao, Dongyu Liu, An Ping, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15115-15139. <a href="https://doi.org/10.1021/acs.jmedchem.0c00925" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00925%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252BInhibitors%252Bfor%252BCancer%252BTherapy%252Band%252BBeyond%25253A%252BA%252BRecent%252BPerspective%26aulast%3DFeng%26aufirst%3DXi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31052020%26date%3D20112020%26volume%3D63%26issue%3D24%26spage%3D15115%26epage%3D15139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Olga N. Petrova, Isabelle Lamarre, Fabienne Fasani, Catherine Grillon, <span class="NLM_string-name hlFld-ContribAuthor">Michel Negrerie</span>. </span><span class="cited-content_cbyCitation_article-title">Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (12)
                                     , 3642-3651. <a href="https://doi.org/10.1021/acs.jnatprod.0c00854" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00854%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSoluble%252BGuanylate%252BCyclase%252BInhibitors%252BDiscovered%252Bamong%252BNatural%252BCompounds%26aulast%3DPetrova%26aufirst%3DOlga%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31072020%26date%3D08122020%26volume%3D83%26issue%3D12%26spage%3D3642%26epage%3D3651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wieslaw M. Kazmierski, Bing Xia, John Miller, Martha De la Rosa, David Favre, Richard M. Dunham, Yoshiaki Washio, Zhengrong Zhu, Feng Wang, Makda Mebrahtu, Hongfeng Deng, Jonathan Basilla, Liping Wang, Ghotas Evindar, Lijun Fan, Alison Olszewski, Ninad Prabhu, Christopher Davie, Jeffrey A. Messer, <span class="NLM_string-name hlFld-ContribAuthor">Vicente Samano</span>. </span><span class="cited-content_cbyCitation_article-title">DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3552-3562. <a href="https://doi.org/10.1021/acs.jmedchem.9b01799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDNA-Encoded%252BLibrary%252BTechnology-Based%252BDiscovery%25252C%252BLead%252BOptimization%25252C%252Band%252BProdrug%252BStrategy%252Btoward%252BStructurally%252BUnique%252BIndoleamine%252B2%25252C3-Dioxygenase-1%252B%252528IDO1%252529%252BInhibitors%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27112019%26date%3D19032020%26date%3D19022020%26volume%3D63%26issue%3D7%26spage%3D3552%26epage%3D3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brendan T. Parr, Richard Pastor, Benjamin D. Sellers, Zhonghua Pei, Firoz A. Jaipuri, Georgette M. Castanedo, Lewis Gazzard, Sanjeev Kumar, Xiaokai Li, Wen Liu, Rohan Mendonca, Roheeth K. Pavana, Hima Potturi, Cheng Shao, Venkata Velvadapu, Jesse P. Waldo, Guosheng Wu, Po-wai Yuen, Zuhui Zhang, Yamin Zhang, Seth F. Harris, Angela J. Oh, Antonio DiPasquale, Kevin Dement, Hank La, Leanne Goon, Amy Gustafson, Erica C. VanderPorten, Mario R. Mautino, <span class="NLM_string-name hlFld-ContribAuthor">Yichin Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 541-549. <a href="https://doi.org/10.1021/acsmedchemlett.0c00004" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImplementation%252Bof%252Bthe%252BCYP%252BIndex%252Bfor%252Bthe%252BDesign%252Bof%252BSelective%252BTryptophan-2%25252C3-dioxygenase%252BInhibitors%26aulast%3DParr%26aufirst%3DBrendan%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03012020%26date%3D04032020%26date%3D06032020%26date%3D04032020%26volume%3D11%26issue%3D4%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, <span class="NLM_string-name hlFld-ContribAuthor">Silvia Fallarini</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3047-3065. <a href="https://doi.org/10.1021/acs.jmedchem.9b01809" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01809%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%252BBenzimidazole%252BDerivatives%252Bas%252BIndoleamine%252B2%25252C3-Dioxygenase-1%252B%252528IDO1%252529%252BInhibitors%25253A%252BFrom%252BStructure-Based%252BVirtual%252BScreening%252Bto%252Bin%252BVivo%252BPharmacodynamic%252BActivity%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31102019%26date%3D17032020%26date%3D09032020%26volume%3D63%26issue%3D6%26spage%3D3047%26epage%3D3065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rizhen Huang, Xiaoteng Jing, Xiaochao Huang, Yingming Pan, Yilin Fang, Guibin Liang, Zhixin Liao, Hengshan Wang, Zhenfeng Chen, <span class="NLM_string-name hlFld-ContribAuthor">Ye Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1544-1563. <a href="https://doi.org/10.1021/acs.jmedchem.9b01386" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01386%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252BNaphthoquinone%252BAromatic%252BAmide-Oxime%252BDerivatives%252BExert%252BCombined%252BImmunotherapeutic%252Band%252BAntitumor%252BEffects%252Bthrough%252BSimultaneous%252BTargeting%252Bof%252BIndoleamine-2%25252C3-dioxygenase%252Band%252BSignal%252BTransducer%252Band%252BActivator%252Bof%252BTranscription%252B3%26aulast%3DHuang%26aufirst%3DRizhen%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D22082019%26date%3D17022020%26date%3D30012020%26volume%3D63%26issue%3D4%26spage%3D1544%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, Ramajayam Kuppusamy, An-Siou Li, Chi-Han Chen, Yu-Shiou Fan, Sing-Yi Wang, Mine-Hsine Wu, Ching-Cheng Hsueh, Jia-Yu Chang, Lung-Chun Lee, Chuan Shih, Kak-Shan Shia, Teng-Kuang Yeh, Ming-Shiu Hung, Ching-Chuan Kuo, Jen-Shin Song, Su-Ying Wu, <span class="NLM_string-name hlFld-ContribAuthor">Shau-Hua Ueng</span>. </span><span class="cited-content_cbyCitation_article-title">Unique Sulfur–Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1642-1659. <a href="https://doi.org/10.1021/acs.jmedchem.9b01549" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01549%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnique%252BSulfur%2525E2%252580%252593Aromatic%252BInteractions%252BContribute%252Bto%252Bthe%252BBinding%252Bof%252BPotent%252BImidazothiazole%252BIndoleamine%252B2%25252C3-Dioxygenase%252BInhibitors%26aulast%3DPeng%26aufirst%3DYi-Hui%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17092019%26date%3D10022020%26date%3D21012020%26volume%3D63%26issue%3D4%26spage%3D1642%26epage%3D1659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Khoa N. Pham, Ariel Lewis-Ballester, <span class="NLM_string-name hlFld-ContribAuthor">Syun-Ru Yeh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (47)
                                     , 18771-18779. <a href="https://doi.org/10.1021/jacs.9b08871" title="DOI URL">https://doi.org/10.1021/jacs.9b08871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08871%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DStructural%252BBasis%252Bof%252BInhibitor%252BSelectivity%252Bin%252BHuman%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252Band%252BTryptophan%252BDioxygenase%26aulast%3DPham%26aufirst%3DKhoa%2BN.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16082019%26date%3D14112019%26date%3D04112019%26volume%3D141%26issue%3D47%26spage%3D18771%26epage%3D18779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dan Yang, Shengnan Zhang, Xin Fang, Leilei Guo, Nan Hu, Zhanling Guo, Xishuai Li, Shuangshuang Yang, Jin Chao He, Chunxiang Kuang, <span class="NLM_string-name hlFld-ContribAuthor">Qing Yang</span>. </span><span class="cited-content_cbyCitation_article-title">N-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9161-9174. <a href="https://doi.org/10.1021/acs.jmedchem.9b01079" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01079%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Benzyl%25252FAryl%252BSubstituted%252BTryptanthrin%252Bas%252BDual%252BInhibitors%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252Band%252BTryptophan%252B2%25252C3-Dioxygenase%26aulast%3DYang%26aufirst%3DDan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04072019%26date%3D03102019%26volume%3D62%26issue%3D20%26spage%3D9161%26epage%3D9174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanjeev Kumar, Jesse P. Waldo, Firoz A. Jaipuri, Agnieszka Marcinowicz, Clarissa Van Allen, James Adams, Tanay Kesharwani, Xiaoxia Zhang, Richard Metz, Angela J. Oh, Seth F. Harris, <span class="NLM_string-name hlFld-ContribAuthor">Mario R. Mautino</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6705-6733. <a href="https://doi.org/10.1021/acs.jmedchem.9b00662" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00662%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252B%2525281R%25252C4r%252529-4-%252528%252528R%252529-2-%252528%252528S%252529-6-Fluoro-5H-imidazo%25255B5%25252C1-a%25255Disoindol-5-yl%252529-1-hydroxyethyl%252529cyclohexan-1-ol%252B%252528Navoximod%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%26aulast%3DKumar%26aufirst%3DSanjeev%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D02072019%26date%3D18062019%26volume%3D62%26issue%3D14%26spage%3D6705%26epage%3D6733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wangyang Tu, Fanglong Yang, Guoji Xu, Jiangtao Chi, Zhiwei Liu, Wei Peng, Bing Hu, Lei Zhang, Hong Wan, Nan Yu, Fangfang Jin, Qiyue Hu, Lianshan Zhang, Feng He, <span class="NLM_string-name hlFld-ContribAuthor">Weikang Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 949-953. <a href="https://doi.org/10.1021/acsmedchemlett.9b00114" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00114%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BImidazoisoindole%252BDerivatives%252Bas%252BHighly%252BPotent%252Band%252BOrally%252BActive%252BIndoleamine-2%25252C3-dioxygenase%252BInhibitors%26aulast%3DTu%26aufirst%3DWangyang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17032019%26date%3D03062019%26date%3D05062019%26date%3D03062019%26volume%3D10%26issue%3D6%26spage%3D949%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Khoa N. Pham, <span class="NLM_string-name hlFld-ContribAuthor">Syun-Ru Yeh</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3-Dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (44)
                                     , 14538-14541. <a href="https://doi.org/10.1021/jacs.8b07994" title="DOI URL">https://doi.org/10.1021/jacs.8b07994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b07994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b07994%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DMapping%252Bthe%252BBinding%252BTrajectory%252Bof%252Ba%252BSuicide%252BInhibitor%252Bin%252BHuman%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%26aulast%3DPham%26aufirst%3DKhoa%2BN.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27072018%26date%3D24102018%26date%3D23102018%26volume%3D140%26issue%3D44%26spage%3D14538%26epage%3D14541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael G.  Brant</span>, <span class="hlFld-ContribAuthor ">Jake  Goodwin-Tindall</span>, <span class="hlFld-ContribAuthor ">Kurt R.  Stover</span>, <span class="hlFld-ContribAuthor ">Paul M.  Stafford</span>, <span class="hlFld-ContribAuthor ">Fan  Wu</span>, <span class="hlFld-ContribAuthor ">Autumn R.  Meek</span>, <span class="hlFld-ContribAuthor ">Paolo  Schiavini</span>, <span class="hlFld-ContribAuthor ">Stephanie  Wohnig</span>, and <span class="hlFld-ContribAuthor ">Donald F.  Weaver</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 131-136. <a href="https://doi.org/10.1021/acsmedchemlett.7b00488" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00488%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BPotent%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252B%252528IDO1%252529%252BInhibitors%252BBased%252Bon%252Ba%252BPhenylimidazole%252BScaffold%26aulast%3DBrant%26aufirst%3DMichael%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D27112017%26date%3D11012018%26date%3D22012018%26date%3D08022018%26date%3D11012018%26volume%3D9%26issue%3D2%26spage%3D131%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Ya-Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Yihui  Song</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01080-8" title="DOI URL">https://doi.org/10.1186/s13045-021-01080-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01080-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DIndoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%252Bin%252Bclinical%252Btrials%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DTang%26aufirst%3DKai%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Chen</span>, <span class="hlFld-ContribAuthor ">Wencheng  Ding</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Hongyan  Hou</span>, <span class="hlFld-ContribAuthor ">Yong  Bai</span>, <span class="hlFld-ContribAuthor ">Yuwen  Zhou</span>, <span class="hlFld-ContribAuthor ">Kezhen  Li</span>, <span class="hlFld-ContribAuthor ">Shunian  Xiang</span>, <span class="hlFld-ContribAuthor ">Panhong  Liu</span>, <span class="hlFld-ContribAuthor ">Jia  Ju</span>, <span class="hlFld-ContribAuthor ">Ensong  Guo</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>, <span class="hlFld-ContribAuthor ">Junpeng  Fan</span>, <span class="hlFld-ContribAuthor ">Liang  He</span>, <span class="hlFld-ContribAuthor ">Ziyong  Sun</span>, <span class="hlFld-ContribAuthor ">Ling  Feng</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Tangchun  Wu</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Jin  Cheng</span>, <span class="hlFld-ContribAuthor ">Hui  Xing</span>, <span class="hlFld-ContribAuthor ">Yifan  Meng</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Li</span>, <span class="hlFld-ContribAuthor ">Yuanliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongbo  Luo</span>, <span class="hlFld-ContribAuthor ">Gang  Xie</span>, <span class="hlFld-ContribAuthor ">Xianmei  Lan</span>, <span class="hlFld-ContribAuthor ">Ye  Tao</span>, <span class="hlFld-ContribAuthor ">Jiafeng  Li</span>, <span class="hlFld-ContribAuthor ">Hao  Yuan</span>, <span class="hlFld-ContribAuthor ">Kang  Huang</span>, <span class="hlFld-ContribAuthor ">Wan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Qian</span>, <span class="hlFld-ContribAuthor ">Zhichao  Li</span>, <span class="hlFld-ContribAuthor ">Mingxi  Huang</span>, <span class="hlFld-ContribAuthor ">Peiwen  Ding</span>, <span class="hlFld-ContribAuthor ">Haoyu  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaying  Qiu</span>, <span class="hlFld-ContribAuthor ">Feiyue  Wang</span>, <span class="hlFld-ContribAuthor ">Shiyou  Wang</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiangning  Ding</span>, <span class="hlFld-ContribAuthor ">Chaochao  Chai</span>, <span class="hlFld-ContribAuthor ">Langchao  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Wang</span>, <span class="hlFld-ContribAuthor ">Lihua  Luo</span>, <span class="hlFld-ContribAuthor ">Yuzhe  Sun</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Zhuang</span>, <span class="hlFld-ContribAuthor ">Tao  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Shaoqiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Linnan  Zhu</span>, <span class="hlFld-ContribAuthor ">Ashley  Chang</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Yiquan  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Ma</span>, <span class="hlFld-ContribAuthor ">Fang  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Ren</span>, <span class="hlFld-ContribAuthor ">Xun  Xu</span>, <span class="hlFld-ContribAuthor ">Siqi  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Huanming  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Chaoyang  Sun</span>, <span class="hlFld-ContribAuthor ">Ding  Ma</span>, <span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The trans-omics landscape of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-24482-1" title="DOI URL">https://doi.org/10.1038/s41467-021-24482-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-24482-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-24482-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Btrans-omics%252Blandscape%252Bof%252BCOVID-19%26aulast%3DWu%26aufirst%3DPeng%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junmin  Dong</span>, <span class="hlFld-ContribAuthor ">Xuan  Pan</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhanzhu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113631. <a href="https://doi.org/10.1016/j.ejmech.2021.113631" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113631%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bexiguamine%252BA%252Banalogues%252Bas%252BIDO1%252Binhibitors%26aulast%3DDong%26aufirst%3DJunmin%26date%3D2021%26volume%3D223%26spage%3D113631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaymaa Emam  Kassab</span>, <span class="hlFld-ContribAuthor ">Samar  Mowafy</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>242 </em><a href="https://doi.org/10.1002/cmdc.202100253" title="DOI URL">https://doi.org/10.1002/cmdc.202100253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BBasis%252Bof%252BSelective%252BHuman%252BIndoleamine%2525E2%252580%2525902%25252C3%2525E2%252580%252590dioxygenase%252B1%252B%252528hIDO1%252529%252BInhibition%26aulast%3DKassab%26aufirst%3DShaymaa%2BEmam%26date%3D2021%26date%3D2021%26volume%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Mor</span>, <span class="hlFld-ContribAuthor ">Anna  Tankiewicz-Kwedlo</span>, <span class="hlFld-ContribAuthor ">Dariusz  Pawlak</span>. </span><span class="cited-content_cbyCitation_article-title">Kynurenines as a Novel Target for the Treatment of Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 606. <a href="https://doi.org/10.3390/ph14070606" title="DOI URL">https://doi.org/10.3390/ph14070606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070606%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DKynurenines%252Bas%252Ba%252BNovel%252BTarget%252Bfor%252Bthe%252BTreatment%252Bof%252BMalignancies%26aulast%3DMor%26aufirst%3DAdrian%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhananjay S.  Nipate</span>, <span class="hlFld-ContribAuthor ">Vikki N.  Shinde</span>, <span class="hlFld-ContribAuthor ">Krishnan  Rangan</span>, <span class="hlFld-ContribAuthor ">Anil  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Switchable regioselective hydroalkylation of 2-arylindoles with maleimides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (22)
                                     , 4910-4921. <a href="https://doi.org/10.1039/D1OB00690H" title="DOI URL">https://doi.org/10.1039/D1OB00690H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00690H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00690H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSwitchable%252Bregioselective%252Bhydroalkylation%252Bof%252B2-arylindoles%252Bwith%252Bmaleimides%26aulast%3DNipate%26aufirst%3DDhananjay%2BS.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D22%26spage%3D4910%26epage%3D4921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Capochiani de Iudicibus</span>, <span class="hlFld-ContribAuthor ">Petr  Tomek</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Sofian M.  Tijono</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Lai-Ming  Ching</span>. </span><span class="cited-content_cbyCitation_article-title">Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116160. <a href="https://doi.org/10.1016/j.bmc.2021.116160" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116160%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DParallel%252Bdiscovery%252Bof%252Bselective%252Band%252Bdual%252Binhibitors%252Bof%252Btryptophan%252Bdioxygenases%252BIDO1%252Band%252BTDO2%252Bwith%252Ba%252Bnewly-modified%252Benzymatic%252Bassay%26aulast%3DCapochiani%2Bde%2BIudicibus%26aufirst%3DRossella%26date%3D2021%26volume%3D39%26spage%3D116160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seanghai  Hor</span>, <span class="hlFld-ContribAuthor ">Kin-ichi  Oyama</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Koga</span>, <span class="hlFld-ContribAuthor ">Masaki  Tsukamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted acid-catalyzed 1,4-addition of 1,3,5-trimethoxybenzene to maleimides and acrylates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>74 </em>, 153100. <a href="https://doi.org/10.1016/j.tetlet.2021.153100" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153100%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DBr%2525C3%2525B8nsted%252Bacid-catalyzed%252B1%25252C4-addition%252Bof%252B1%25252C3%25252C5-trimethoxybenzene%252Bto%252Bmaleimides%252Band%252Bacrylates%26aulast%3DHor%26aufirst%3DSeanghai%26date%3D2021%26volume%3D74%26spage%3D153100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zheng</span>, <span class="hlFld-ContribAuthor ">Paul M.  Stafford</span>, <span class="hlFld-ContribAuthor ">Kurt R.  Stover</span>, <span class="hlFld-ContribAuthor ">Darapaneni Chandra  Mohan</span>, <span class="hlFld-ContribAuthor ">Mayuri  Gupta</span>, <span class="hlFld-ContribAuthor ">Eric C.  Keske</span>, <span class="hlFld-ContribAuthor ">Paolo  Schiavini</span>, <span class="hlFld-ContribAuthor ">Laura  Villar</span>, <span class="hlFld-ContribAuthor ">Fan  Wu</span>, <span class="hlFld-ContribAuthor ">Alexander  Kreft</span>, <span class="hlFld-ContribAuthor ">Kiersten  Thomas</span>, <span class="hlFld-ContribAuthor ">Elana  Raaphorst</span>, <span class="hlFld-ContribAuthor ">Jagadeesh P.  Pasangulapati</span>, <span class="hlFld-ContribAuthor ">Siva R.  Alla</span>, <span class="hlFld-ContribAuthor ">Simmi  Sharma</span>, <span class="hlFld-ContribAuthor ">Ramana R.  Mittapalli</span>, <span class="hlFld-ContribAuthor ">Irina  Sagamanova</span>, <span class="hlFld-ContribAuthor ">Shea L.  Johnson</span>, <span class="hlFld-ContribAuthor ">Mark A.  Reed</span>, <span class="hlFld-ContribAuthor ">Donald F.  Weaver</span>. </span><span class="cited-content_cbyCitation_article-title">A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1002/cmdc.202100107" title="DOI URL">https://doi.org/10.1002/cmdc.202100107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100107%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BSeries%252Bof%252B2%2525E2%252580%252590%252528%2525281%2525E2%252580%252590Phenyl%2525E2%252580%2525901H%2525E2%252580%252590imidazol%2525E2%252580%2525905%2525E2%252580%252590yl%252529methyl%252529%2525E2%252580%2525901H%2525E2%252580%252590indoles%252Bas%252BIndoleamine%252B2%25252C3%2525E2%252580%252590Dioxygenase%252B1%252B%252528IDO1%252529%252BInhibitors%26aulast%3DZheng%26aufirst%3DYong%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Dolšak</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>221 </em>, 107746. <a href="https://doi.org/10.1016/j.pharmthera.2020.107746" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107746%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DIndoleamine%252Band%252Btryptophan%252B2%25252C3-dioxygenases%252Bas%252Bimportant%252Bfuture%252Btherapeutic%252Btargets%26aulast%3DDol%25C5%25A1ak%26aufirst%3DAna%26date%3D2021%26volume%3D221%26spage%3D107746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulun  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Tan</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The ups, downs and new trends of IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104815. <a href="https://doi.org/10.1016/j.bioorg.2021.104815" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104815%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bups%25252C%252Bdowns%252Band%252Bnew%252Btrends%252Bof%252BIDO1%252Binhibitors%26aulast%3DChen%26aufirst%3DShulun%26date%3D2021%26volume%3D110%26spage%3D104815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Cruz-Bermúdez</span>, <span class="hlFld-ContribAuthor ">Raquel  Laza-Briviesca</span>, <span class="hlFld-ContribAuthor ">Marta  Casarrubios</span>, <span class="hlFld-ContribAuthor ">Belén  Sierra-Rodero</span>, <span class="hlFld-ContribAuthor ">Mariano  Provencio</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (4)
                                     , 361. <a href="https://doi.org/10.3390/biomedicines9040361" title="DOI URL">https://doi.org/10.3390/biomedicines9040361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9040361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9040361%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DThe%252BRole%252Bof%252BMetabolism%252Bin%252BTumor%252BImmune%252BEvasion%25253A%252BNovel%252BApproaches%252Bto%252BImprove%252BImmunotherapy%26aulast%3DCruz-Berm%25C3%25BAdez%26aufirst%3DAlberto%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D4%26spage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iqbal N.  Shaikh</span>, <span class="hlFld-ContribAuthor ">Abdul  Rahim</span>, <span class="hlFld-ContribAuthor ">Shaikh  Faazil</span>, <span class="hlFld-ContribAuthor ">Syed Farooq  Adil</span>, <span class="hlFld-ContribAuthor ">Mohamed E.  Assal</span>, <span class="hlFld-ContribAuthor ">Mohammad Rafe  Hatshan</span>. </span><span class="cited-content_cbyCitation_article-title">BF3-OEt2 Catalyzed C3-Alkylation of Indole: Synthesis of Indolylsuccinimidesand Their Cytotoxicity Studies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2202. <a href="https://doi.org/10.3390/molecules26082202" title="DOI URL">https://doi.org/10.3390/molecules26082202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082202%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBF3-OEt2%252BCatalyzed%252BC3-Alkylation%252Bof%252BIndole%25253A%252BSynthesis%252Bof%252BIndolylsuccinimidesand%252BTheir%252BCytotoxicity%252BStudies%26aulast%3DShaikh%26aufirst%3DIqbal%2BN.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zefeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Jiangxin  Yue</span>, <span class="hlFld-ContribAuthor ">Xiaotong  Ji</span>, <span class="hlFld-ContribAuthor ">Meng  Nian</span>, <span class="hlFld-ContribAuthor ">Kaiwen  Kang</span>, <span class="hlFld-ContribAuthor ">Haifa  Qiao</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress in biological activities of succinimide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104557. <a href="https://doi.org/10.1016/j.bioorg.2020.104557" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104557%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bin%252Bbiological%252Bactivities%252Bof%252Bsuccinimide%252Bderivatives%26aulast%3DZhao%26aufirst%3DZefeng%26date%3D2021%26volume%3D108%26spage%3D104557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Singh</span>, <span class="hlFld-ContribAuthor ">Deepak B.  Salunke</span>. </span><span class="cited-content_cbyCitation_article-title">Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113071. <a href="https://doi.org/10.1016/j.ejmech.2020.113071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiverse%252Bchemical%252Bspace%252Bof%252Bindoleamine-2%25252C3-dioxygenase%252B1%252B%252528Ido1%252529%252Binhibitors%26aulast%3DSingh%26aufirst%3DRahul%26date%3D2021%26volume%3D211%26spage%3D113071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ebrahimi</span>. </span><span class="cited-content_cbyCitation_article-title">Nanotechnology for Diagnosis, Imaging, and Treatment of Head and Neck Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 63-120. <a href="https://doi.org/10.1007/978-3-030-69859-1_4" title="DOI URL">https://doi.org/10.1007/978-3-030-69859-1_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-69859-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-69859-1_4%26sid%3Dliteratum%253Aachs%26atitle%3DNanotechnology%252Bfor%252BDiagnosis%25252C%252BImaging%25252C%252Band%252BTreatment%252Bof%252BHead%252Band%252BNeck%252BCancer%26aulast%3DEbrahimi%26aufirst%3DMehdi%26date%3D2021%26date%3D2021%26spage%3D63%26epage%3D120%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEarly%252BDetection%252Band%252BTreatment%252Bof%252BHead%252B%252526%252BNeck%252BCancers%26aulast%3DEl%2BAssal%26aufirst%3DRami%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgane  Modoux</span>, <span class="hlFld-ContribAuthor ">Nathalie  Rolhion</span>, <span class="hlFld-ContribAuthor ">Sridhar  Mani</span>, <span class="hlFld-ContribAuthor ">Harry  Sokol</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptophan Metabolism as a Pharmacological Target. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (1)
                                     , 60-73. <a href="https://doi.org/10.1016/j.tips.2020.11.006" title="DOI URL">https://doi.org/10.1016/j.tips.2020.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTryptophan%252BMetabolism%252Bas%252Ba%252BPharmacological%252BTarget%26aulast%3DModoux%26aufirst%3DMorgane%26date%3D2021%26volume%3D42%26issue%3D1%26spage%3D60%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Tereza  Dvorakova</span>, <span class="hlFld-ContribAuthor ">Florence  Schramme</span>, <span class="hlFld-ContribAuthor ">Vincent  Stroobant</span>, <span class="hlFld-ContribAuthor ">Benoit J.  Van den Eynde</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.601759" title="DOI URL">https://doi.org/10.3389/fimmu.2020.601759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.601759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.601759%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DTryptophan%252B2%25252C3-Dioxygenase%252BExpression%252BIdentified%252Bin%252BMurine%252BDecidual%252BStromal%252BCells%252BIs%252BNot%252BEssential%252Bfor%252BFeto-Maternal%252BTolerance%26aulast%3DHoffmann%26aufirst%3DDelia%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulei  Pan</span>, <span class="hlFld-ContribAuthor ">Yangli  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yanlin  Wang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Luyi  Huang</span>, <span class="hlFld-ContribAuthor ">Jinshan  Nan</span>, <span class="hlFld-ContribAuthor ">Linli  Li</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112703. <a href="https://doi.org/10.1016/j.ejmech.2020.112703" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112703%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252B1-aryl-1H-naphtho%25255B2%25252C3-d%25255D%25255B1%25252C2%25252C3%25255Dtriazole-4%25252C9-dione%252Bderivatives%252Bas%252Bpotent%252Bdual%252Binhibitors%252Bof%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Band%252Btrytophan%252B2%25252C3-dioxygenase%252B%252528TDO%252529%26aulast%3DPan%26aufirst%3DShulei%26date%3D2020%26volume%3D207%26spage%3D112703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John F.  Tierney</span>, <span class="hlFld-ContribAuthor ">Alyx  Vogle</span>, <span class="hlFld-ContribAuthor ">Brendan  Finnerty</span>, <span class="hlFld-ContribAuthor ">Rasa  Zarnegar</span>, <span class="hlFld-ContribAuthor ">Ritu  Ghai</span>, <span class="hlFld-ContribAuthor ">Paolo  Gattuso</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Fahey</span>, <span class="hlFld-ContribAuthor ">Xavier M.  Keutgen</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Surgical Research</span><span> <strong>2020,</strong> <em>256 </em>, 90-95. <a href="https://doi.org/10.1016/j.jss.2020.06.016" title="DOI URL">https://doi.org/10.1016/j.jss.2020.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jss.2020.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jss.2020.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Surgical%2520Research%26atitle%3DIndoleamine%252B2%25252C3-Dioxygenase-1%252BExpression%252Bin%252BAdrenocortical%252BCarcinoma%26aulast%3DTierney%26aufirst%3DJohn%2BF.%26date%3D2020%26volume%3D256%26spage%3D90%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manon  Mirgaux</span>, <span class="hlFld-ContribAuthor ">Laurence  Leherte</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of the presence of the heme cofactor on the JK-loop structure in indoleamine 2,3-dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2020,</strong> <em>76 </em>
                                    (12)
                                     , 1211-1221. <a href="https://doi.org/10.1107/S2059798320013510" title="DOI URL">https://doi.org/10.1107/S2059798320013510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798320013510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798320013510%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DInfluence%252Bof%252Bthe%252Bpresence%252Bof%252Bthe%252Bheme%252Bcofactor%252Bon%252Bthe%252BJK-loop%252Bstructure%252Bin%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%26aulast%3DMirgaux%26aufirst%3DManon%26date%3D2020%26date%3D2020%26volume%3D76%26issue%3D12%26spage%3D1211%26epage%3D1221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Reardon</span>, <span class="hlFld-ContribAuthor ">Annick  Desjardins</span>, <span class="hlFld-ContribAuthor ">Olivier  Rixe</span>, <span class="hlFld-ContribAuthor ">Timothy  Cloughesy</span>, <span class="hlFld-ContribAuthor ">Shilpa  Alekar</span>, <span class="hlFld-ContribAuthor ">Jason H.  Williams</span>, <span class="hlFld-ContribAuthor ">Ray  Li</span>, <span class="hlFld-ContribAuthor ">Carrie Turich  Taylor</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Lassman</span>. </span><span class="cited-content_cbyCitation_article-title">A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2020,</strong> <em>38 </em>
                                    (6)
                                     , 1784-1795. <a href="https://doi.org/10.1007/s10637-020-00950-1" title="DOI URL">https://doi.org/10.1007/s10637-020-00950-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-020-00950-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-020-00950-1%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DA%252Bphase%252B1%252Bstudy%252Bof%252BPF-06840003%25252C%252Ban%252Boral%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitor%252Bin%252Bpatients%252Bwith%252Brecurrent%252Bmalignant%252Bglioma%26aulast%3DReardon%26aufirst%3DDavid%2BA.%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D6%26spage%3D1784%26epage%3D1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery and development of selective heme-displacing IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 1223-1232. <a href="https://doi.org/10.1080/17460441.2020.1781811" title="DOI URL">https://doi.org/10.1080/17460441.2020.1781811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1781811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1781811%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bselective%252Bheme-displacing%252BIDO1%252Binhibitors%26aulast%3DSun%26aufirst%3DLijun%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D1223%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long-fei  Mao</span>, <span class="hlFld-ContribAuthor ">Yu-wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhao</span>, <span class="hlFld-ContribAuthor ">Gui-qing  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-jun  Yao</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.579024" title="DOI URL">https://doi.org/10.3389/fphar.2020.579024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.579024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.579024%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DDiscovery%252Bof%252BIcotinib-1%25252C2%25252C3-Triazole%252BDerivatives%252Bas%252BIDO1%252BInhibitors%26aulast%3DMao%26aufirst%3DLong-fei%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhifeng  Xia</span>, <span class="hlFld-ContribAuthor ">Yanyang  Nan</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Guangyu  Lin</span>, <span class="hlFld-ContribAuthor ">Kedan  Gu</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Weili  Zhao</span>, <span class="hlFld-ContribAuthor ">Dianwen  Ju</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (13)
                                     , 1592-1603. <a href="https://doi.org/10.2174/1871520620666200604121225" title="DOI URL">https://doi.org/10.2174/1871520620666200604121225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520620666200604121225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520620666200604121225%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B1%25252C2%25252C5-Oxadiazol-3-%252BCarboximidamide%252BDerivatives%252Bas%252BIndoleamine%252B2%25252C%252B3-Dioxygenase%252B1%252B%252528IDO1%252529%252BInhibitors%26aulast%3DXia%26aufirst%3DZhifeng%26date%3D2020%26volume%3D20%26issue%3D13%26spage%3D1592%26epage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Zhang</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potential indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors by an FBG-based 3D QSAR pharmacophore model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107628. <a href="https://doi.org/10.1016/j.jmgm.2020.107628" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DIdentification%252Bof%252Bpotential%252Bindoleamine%252B2%25252C%252B3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%252Bby%252Ban%252BFBG-based%252B3D%252BQSAR%252Bpharmacophore%252Bmodel%26aulast%3DZhang%26aufirst%3DLu%26date%3D2020%26volume%3D99%26spage%3D107628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Mammoli</span>, <span class="hlFld-ContribAuthor ">Alice  Coletti</span>, <span class="hlFld-ContribAuthor ">Marco  Ballarotto</span>, <span class="hlFld-ContribAuthor ">Alessandra  Riccio</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Ursula  Grohmann</span>, <span class="hlFld-ContribAuthor ">Emidio  Camaioni</span>, <span class="hlFld-ContribAuthor ">Antonio  Macchiarulo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 891-899. <a href="https://doi.org/10.1002/cmdc.202000116" title="DOI URL">https://doi.org/10.1002/cmdc.202000116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000116%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNew%252BInsights%252Bfrom%252BCrystallographic%252BData%25253A%252BDiversity%252Bof%252BStructural%252BMotifs%252Band%252BMolecular%252BRecognition%252BProperties%252Bbetween%252BGroups%252Bof%252BIDO1%252BStructures%26aulast%3DMammoli%26aufirst%3DAndrea%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D891%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Yanyang  Nan</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Xia</span>, <span class="hlFld-ContribAuthor ">Kedan  Gu</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Dong</span>, <span class="hlFld-ContribAuthor ">Dianwen  Ju</span>, <span class="hlFld-ContribAuthor ">Weili  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 127038. <a href="https://doi.org/10.1016/j.bmcl.2020.127038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bhydroxyamidine%252Bderivatives%252Bas%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252Binhibitors%252Bwith%252Bin%252Bvivo%252Banti-tumor%252Befficacy%26aulast%3DLiu%26aufirst%3DChang%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D127038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shixian  Hua</span>, <span class="hlFld-ContribAuthor ">Feihong  Chen</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112041. <a href="https://doi.org/10.1016/j.ejmech.2020.112041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-functional%252Bconjugates%252Bimproving%252Bcancer%252Bimmunochemotherapy%252Bby%252Binhibiting%252Btubulin%252Bpolymerization%252Band%252Bindoleamine-2%25252C3-dioxygenase%26aulast%3DHua%26aufirst%3DShixian%26date%3D2020%26volume%3D189%26spage%3D112041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohan  Song</span>, <span class="hlFld-ContribAuthor ">Pu  Sun</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-hua  Meng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112059. <a href="https://doi.org/10.1016/j.ejmech.2020.112059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C2%25252C5-oxadiazole-3-carboximidamide%252Bderivatives%252Bas%252Bnovel%252Bindoleamine-2%25252C3-dioxygenase%252B1%252Binhibitors%26aulast%3DSong%26aufirst%3DXiaohan%26date%3D2020%26volume%3D189%26spage%3D112059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-min  Kong</span>, <span class="hlFld-ContribAuthor ">Jia-wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing-zhi  Liu</span>, <span class="hlFld-ContribAuthor ">Guang-rong  Meng</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126901. <a href="https://doi.org/10.1016/j.bmcl.2019.126901" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126901%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-%252528pyridin-3-yl%252529-1H-indole-4%25252C7-diones%252Bas%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%26aulast%3DKong%26aufirst%3DKai-min%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guonan  Cui</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Bailing  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 111985. <a href="https://doi.org/10.1016/j.ejmech.2019.111985" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111985%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bindole-2-carboxylic%252Bacid%252Bderivatives%252Bas%252BIDO1%25252FTDO%252Bdual%252Binhibitors%26aulast%3DCui%26aufirst%3DGuonan%26date%3D2020%26volume%3D188%26spage%3D111985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiane A.  Opitz</span>, <span class="hlFld-ContribAuthor ">Luis F.  Somarribas Patterson</span>, <span class="hlFld-ContribAuthor ">Soumya R.  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Dyah L.  Dewi</span>, <span class="hlFld-ContribAuthor ">Ahmed  Sadik</span>, <span class="hlFld-ContribAuthor ">Michael  Platten</span>, <span class="hlFld-ContribAuthor ">Saskia  Trump</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic potential of targeting tryptophan catabolism in cancer. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>122 </em>
                                    (1)
                                     , 30-44. <a href="https://doi.org/10.1038/s41416-019-0664-6" title="DOI URL">https://doi.org/10.1038/s41416-019-0664-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-019-0664-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-019-0664-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DThe%252Btherapeutic%252Bpotential%252Bof%252Btargeting%252Btryptophan%252Bcatabolism%252Bin%252Bcancer%26aulast%3DOpitz%26aufirst%3DChristiane%2BA.%26date%3D2020%26date%3D2019%26volume%3D122%26issue%3D1%26spage%3D30%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Klar</span>, <span class="hlFld-ContribAuthor ">Sven  Michel</span>, <span class="hlFld-ContribAuthor ">Monika  Schell</span>, <span class="hlFld-ContribAuthor ">Lisa  Hinterwimmer</span>, <span class="hlFld-ContribAuthor ">Alfred  Zippelius</span>, <span class="hlFld-ContribAuthor ">Frank  Jaschinski</span>. </span><span class="cited-content_cbyCitation_article-title">A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression. </span><span class="cited-content_cbyCitation_journal-name">Cancer Immunology, Immunotherapy</span><span> <strong>2020,</strong> <em>69 </em>
                                    (1)
                                     , 57-67. <a href="https://doi.org/10.1007/s00262-019-02438-1" title="DOI URL">https://doi.org/10.1007/s00262-019-02438-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00262-019-02438-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00262-019-02438-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Immunology%252C%2520Immunotherapy%26atitle%3DA%252Bhighly%252Befficient%252Bmodality%252Bto%252Bblock%252Bthe%252Bdegradation%252Bof%252Btryptophan%252Bfor%252Bcancer%252Bimmunotherapy%25253A%252Blocked%252Bnucleic%252Bacid-modified%252Bantisense%252Boligonucleotides%252Bto%252Binhibit%252Bhuman%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%25252Ftryptophan%252B2%25252C3-dioxygenase%252Bexpression%26aulast%3DKlar%26aufirst%3DRichard%26date%3D2020%26date%3D2019%26volume%3D69%26issue%3D1%26spage%3D57%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Xueting  Liu</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103356. <a href="https://doi.org/10.1016/j.bioorg.2019.103356" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103356%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbicyclic%252Bcarboxylic%252Bacid%252Bderivatives%252Bas%252BIDO1%252Binhibitors%26aulast%3DCai%26aufirst%3DShi%26date%3D2020%26volume%3D94%26spage%3D103356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianming  Du</span>, <span class="hlFld-ContribAuthor ">Xi  Feng</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wang</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinliang  Qu</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111629. <a href="https://doi.org/10.1016/j.ejmech.2019.111629" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111629%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bphosphonamidate%252BIDO1%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DDu%26aufirst%3DQianming%26date%3D2019%26volume%3D182%26spage%3D111629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhizheng  Bai</span>, <span class="hlFld-ContribAuthor ">Huidan  Huang</span>, <span class="hlFld-ContribAuthor ">Jianqiu  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yimei  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel imidazoles as IDO1 inhibitors through microwave‐assisted one‐pot multicomponent reactions. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (11)
                                     , 1900165. <a href="https://doi.org/10.1002/ardp.201900165" title="DOI URL">https://doi.org/10.1002/ardp.201900165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900165%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIdentification%252Bof%252Bnovel%252Bimidazoles%252Bas%252BIDO1%252Binhibitors%252Bthrough%252Bmicrowave%2525E2%252580%252590assisted%252Bone%2525E2%252580%252590pot%252Bmulticomponent%252Breactions%26aulast%3DBai%26aufirst%3DZhizheng%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D11%26spage%3D1900165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Xiu  Wang</span>, <span class="hlFld-ContribAuthor ">Si-Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Qing-Qing  Dong</span>, <span class="hlFld-ContribAuthor ">Xiao-Xiang  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Ya-Qun  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 1740-1754. <a href="https://doi.org/10.1039/C9MD00208A" title="DOI URL">https://doi.org/10.1039/C9MD00208A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00208A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00208A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%26aulast%3DWang%26aufirst%3DXiu-Xiu%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D10%26spage%3D1740%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulun  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Liu</span>, <span class="hlFld-ContribAuthor ">Pu  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Chunyong  Ding</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 38-55. <a href="https://doi.org/10.1016/j.ejmech.2019.06.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantitumor%252Bstudy%252Bof%252Ba%252Bseries%252Bof%252BN-Cyclic%252Bsulfamoylaminoethyl%252Bsubstituted%252B1%25252C2%25252C5-oxadiazol-3-amines%252Bas%252Bnew%252Bindoleamine%252B2%25252C%252B3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%26aulast%3DChen%26aufirst%3DShulun%26date%3D2019%26volume%3D179%26spage%3D38%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Vijai Kumar Reddy  Tangadanchu</span>, <span class="hlFld-ContribAuthor ">Narsaiah  Battini</span>, <span class="hlFld-ContribAuthor ">Rammohan R. Yadav  Bheemanaboina</span>, <span class="hlFld-ContribAuthor ">Zhong-Lin  Zang</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Indole-nitroimidazole conjugates as efficient manipulators to decrease the genes expression of methicillin-resistant Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 723-735. <a href="https://doi.org/10.1016/j.ejmech.2019.06.093" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndole-nitroimidazole%252Bconjugates%252Bas%252Befficient%252Bmanipulators%252Bto%252Bdecrease%252Bthe%252Bgenes%252Bexpression%252Bof%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%26aulast%3DLi%26aufirst%3DZhen-Zhen%26date%3D2019%26volume%3D179%26spage%3D723%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuyang  Ding</span>, <span class="hlFld-ContribAuthor ">Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Xue</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Muzammal  Hussain</span>, <span class="hlFld-ContribAuthor ">Yanhui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Jiancun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 102870. <a href="https://doi.org/10.1016/j.bioorg.2019.03.044" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.03.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.03.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DRational%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bubiquinone%252Bderivatives%252Bas%252BIDO1%252Binhibitors%26aulast%3DDing%26aufirst%3DYuyang%26date%3D2019%26volume%3D89%26spage%3D102870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Wen</span>, <span class="hlFld-ContribAuthor ">Yuke  Liu</span>, <span class="hlFld-ContribAuthor ">Shufang  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Huaqing  Cui</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (11)
                                     , 2124. <a href="https://doi.org/10.3390/molecules24112124" title="DOI URL">https://doi.org/10.3390/molecules24112124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24112124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24112124%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%252BInhibitors%252Band%252BEvaluation%252Bof%252BTheir%252BUse%252Bas%252BAnti-Tumor%252BAgents%26aulast%3DWen%26aufirst%3DHui%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D11%26spage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanskar  Jain</span>, <span class="hlFld-ContribAuthor ">Bhagwati  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Shovanlal  Gayen</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of good and bad structural fingerprints for inhibition of indoleamine-2,3-dioxygenase enzyme in cancer immunotherapy using Monte Carlo optimization and Bayesian classification QSAR modeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>14 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2019.1615000" title="DOI URL">https://doi.org/10.1080/07391102.2019.1615000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1615000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1615000%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DExploration%252Bof%252Bgood%252Band%252Bbad%252Bstructural%252Bfingerprints%252Bfor%252Binhibition%252Bof%252Bindoleamine-2%25252C3-dioxygenase%252Benzyme%252Bin%252Bcancer%252Bimmunotherapy%252Busing%252BMonte%252BCarlo%252Boptimization%252Band%252BBayesian%252Bclassification%252BQSAR%252Bmodeling%26aulast%3DJain%26aufirst%3DSanskar%26date%3D2019%26date%3D2019%26volume%3D14%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita C.  Acúrcio</span>, <span class="hlFld-ContribAuthor ">Anna  Scomparin</span>, <span class="hlFld-ContribAuthor ">Ronit  Satchi‐Fainaro</span>, <span class="hlFld-ContribAuthor ">Helena F.  Florindo</span>, <span class="hlFld-ContribAuthor ">Rita C.  Guedes</span>. </span><span class="cited-content_cbyCitation_article-title">Computer‐aided drug design in new druggable targets for the next generation of immune‐oncology therapies. </span><span class="cited-content_cbyCitation_journal-name">Wiley Interdisciplinary Reviews: Computational Molecular Science</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , e1397. <a href="https://doi.org/10.1002/wcms.1397" title="DOI URL">https://doi.org/10.1002/wcms.1397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1397%26sid%3Dliteratum%253Aachs%26jtitle%3DWiley%2520Interdisciplinary%2520Reviews%253A%2520Computational%2520Molecular%2520Science%26atitle%3DComputer%2525E2%252580%252590aided%252Bdrug%252Bdesign%252Bin%252Bnew%252Bdruggable%252Btargets%252Bfor%252Bthe%252Bnext%252Bgeneration%252Bof%252Bimmune%2525E2%252580%252590oncology%252Btherapies%26aulast%3DAc%25C3%25BArcio%26aufirst%3DRita%2BC.%26date%3D2019%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3De1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Platten</span>, <span class="hlFld-ContribAuthor ">Ellen A. A.  Nollen</span>, <span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Christiane A.  Opitz</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (5)
                                     , 379-401. <a href="https://doi.org/10.1038/s41573-019-0016-5" title="DOI URL">https://doi.org/10.1038/s41573-019-0016-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0016-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTryptophan%252Bmetabolism%252Bas%252Ba%252Bcommon%252Btherapeutic%252Btarget%252Bin%252Bcancer%25252C%252Bneurodegeneration%252Band%252Bbeyond%26aulast%3DPlatten%26aufirst%3DMichael%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D5%26spage%3D379%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojun  Yang</span>, <span class="hlFld-ContribAuthor ">Shi  Cai</span>, <span class="hlFld-ContribAuthor ">Xueting  Liu</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1605-1618. <a href="https://doi.org/10.1016/j.bmc.2019.03.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C5-dimethylfuran-3-carboxylic%252Bacid%252Bderivatives%252Bas%252Bpotential%252BIDO1%252Binhibitors%26aulast%3DYang%26aufirst%3DXiaojun%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1605%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W.  Labadie</span>, <span class="hlFld-ContribAuthor ">Riyue  Bao</span>, <span class="hlFld-ContribAuthor ">Jason J.  Luke</span>. </span><span class="cited-content_cbyCitation_article-title">Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2019,</strong> <em>25 </em>
                                    (5)
                                     , 1462-1471. <a href="https://doi.org/10.1158/1078-0432.CCR-18-2882" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-18-2882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-18-2882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-18-2882%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DReimagining%252BIDO%252BPathway%252BInhibition%252Bin%252BCancer%252BImmunotherapy%252Bvia%252BDownstream%252BFocus%252Bon%252Bthe%252BTryptophan%2525E2%252580%252593Kynurenine%2525E2%252580%252593Aryl%252BHydrocarbon%252BAxis%26aulast%3DLabadie%26aufirst%3DBrian%2BW.%26date%3D2019%26date%3D2018%26volume%3D25%26issue%3D5%26spage%3D1462%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bang  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Mao</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Na  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">HFIP-promoted Michael reactions: direct
              para
              -selective C–H activation of anilines with maleimides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (8)
                                     , 2242-2246. <a href="https://doi.org/10.1039/C8OB03073A" title="DOI URL">https://doi.org/10.1039/C8OB03073A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB03073A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB03073A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHFIP-promoted%252BMichael%252Breactions%25253A%252Bdirect%252Bpara%252B-selective%252BC%2525E2%252580%252593H%252Bactivation%252Bof%252Banilines%252Bwith%252Bmaleimides%26aulast%3DLi%26aufirst%3DBang%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D8%26spage%3D2242%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Yinghe  Ma</span>, <span class="hlFld-ContribAuthor ">Hongting  Liu</span>, <span class="hlFld-ContribAuthor ">Quanjin  Rong</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yameng  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Cheng</span>, <span class="hlFld-ContribAuthor ">Ruijia  Ge</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 250-263. <a href="https://doi.org/10.1080/14756366.2018.1480614" title="DOI URL">https://doi.org/10.1080/14756366.2018.1480614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1480614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1480614%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcyanopyridine%252Bscaffold%252Bas%252Bnovel%252Bindoleamine-2%25252C3-dioxygenase%252B1%252B%252528IDO1%252529%252Binhibitors%252Bthrough%252Bvirtual%252Bscreening%252Band%252Bpreliminary%252Bhit%252Boptimisation%26aulast%3DXu%26aufirst%3DXi%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D250%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  Gomes</span>, <span class="hlFld-ContribAuthor ">Gregory  Driessens</span>, <span class="hlFld-ContribAuthor ">Derek  Bartlett</span>, <span class="hlFld-ContribAuthor ">Danying  Cai</span>, <span class="hlFld-ContribAuthor ">Sandra  Cauwenberghs</span>, <span class="hlFld-ContribAuthor ">Stefano  Crosignani</span>, <span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Sofie  Denies</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Dillon</span>, <span class="hlFld-ContribAuthor ">Valeria R.  Fantin</span>, <span class="hlFld-ContribAuthor ">Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Marie-Claire  Letellier</span>, <span class="hlFld-ContribAuthor ">Wenlin  Li</span>, <span class="hlFld-ContribAuthor ">Karen  Maegley</span>, <span class="hlFld-ContribAuthor ">Reece  Marillier</span>, <span class="hlFld-ContribAuthor ">Nichol  Miller</span>, <span class="hlFld-ContribAuthor ">Romain  Pirson</span>, <span class="hlFld-ContribAuthor ">Virginie  Rabolli</span>, <span class="hlFld-ContribAuthor ">Chad  Ray</span>, <span class="hlFld-ContribAuthor ">Nicole  Streiner</span>, <span class="hlFld-ContribAuthor ">Vince R.  Torti</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Tsaparikos</span>, <span class="hlFld-ContribAuthor ">Benoit J.  Van den Eynde</span>, <span class="hlFld-ContribAuthor ">Martin  Wythes</span>, <span class="hlFld-ContribAuthor ">Li-Chin  Yao</span>, <span class="hlFld-ContribAuthor ">Xianxian  Zheng</span>, <span class="hlFld-ContribAuthor ">Joseph  Tumang</span>, <span class="hlFld-ContribAuthor ">Manfred  Kraus</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (12)
                                     , 2530-2542. <a href="https://doi.org/10.1158/1535-7163.MCT-17-1104" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-1104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-1104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-1104%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DCharacterization%252Bof%252Bthe%252BSelective%252BIndoleamine%252B2%25252C3-Dioxygenase-1%252B%252528IDO1%252529%252BCatalytic%252BInhibitor%252BEOS200271%25252FPF-06840003%252BSupports%252BIDO1%252Bas%252Ba%252BCritical%252BResistance%252BMechanism%252Bto%252BPD-%252528L%2525291%252BBlockade%252BTherapy%26aulast%3DGomes%26aufirst%3DBruno%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D12%26spage%3D2530%26epage%3D2542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shukun  Luo</span>, <span class="hlFld-ContribAuthor ">Ke  Xu</span>, <span class="hlFld-ContribAuthor ">Shaoyun  Xiang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyun  Chen</span>, <span class="hlFld-ContribAuthor ">Chuangxin  Guo</span>, <span class="hlFld-ContribAuthor ">Youzhi  Tong</span>, <span class="hlFld-ContribAuthor ">Liang  Tong</span>. </span><span class="cited-content_cbyCitation_article-title">High-resolution structures of inhibitor complexes of human indoleamine 2,3-dioxygenase 1 in a new crystal form. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2018,</strong> <em>74 </em>
                                    (11)
                                     , 717-724. <a href="https://doi.org/10.1107/S2053230X18012955" title="DOI URL">https://doi.org/10.1107/S2053230X18012955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X18012955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X18012955%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DHigh-resolution%252Bstructures%252Bof%252Binhibitor%252Bcomplexes%252Bof%252Bhuman%252Bindoleamine%252B2%25252C3-dioxygenase%252B1%252Bin%252Ba%252Bnew%252Bcrystal%252Bform%26aulast%3DLuo%26aufirst%3DShukun%26date%3D2018%26date%3D2018%26volume%3D74%26issue%3D11%26spage%3D717%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binbin  Cheng</span>, <span class="hlFld-ContribAuthor ">Wei-En  Yuan</span>, <span class="hlFld-ContribAuthor ">Jing  Su</span>, <span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in small molecule based cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 582-598. <a href="https://doi.org/10.1016/j.ejmech.2018.08.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bsmall%252Bmolecule%252Bbased%252Bcancer%252Bimmunotherapy%26aulast%3DCheng%26aufirst%3DBinbin%26date%3D2018%26volume%3D157%26spage%3D582%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae Eun  Cheong</span>, <span class="hlFld-ContribAuthor ">Anil  Ekkati</span>, <span class="hlFld-ContribAuthor ">Lijun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of IDO1 inhibitors for cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 317-330. <a href="https://doi.org/10.1080/13543776.2018.1441290" title="DOI URL">https://doi.org/10.1080/13543776.2018.1441290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1441290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1441290%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252BIDO1%252Binhibitors%252Bfor%252Bcancer%26aulast%3DCheong%26aufirst%3DJae%2BEun%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D4%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micah T.  Nelp</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Kates</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Aaron  Balog</span>, <span class="hlFld-ContribAuthor ">Derrick  Maley</span>, <span class="hlFld-ContribAuthor ">Xiao  Zhu</span>, <span class="hlFld-ContribAuthor ">Lynn  Abell</span>, <span class="hlFld-ContribAuthor ">Alban  Allentoff</span>, <span class="hlFld-ContribAuthor ">Robert  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Hal A.  Lewis</span>, <span class="hlFld-ContribAuthor ">Zeyu  Lin</span>, <span class="hlFld-ContribAuthor ">Steven P.  Seitz</span>, <span class="hlFld-ContribAuthor ">Chunhong  Yan</span>, <span class="hlFld-ContribAuthor ">John T.  Groves</span>. </span><span class="cited-content_cbyCitation_article-title">Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (13)
                                     , 3249-3254. <a href="https://doi.org/10.1073/pnas.1719190115" title="DOI URL">https://doi.org/10.1073/pnas.1719190115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1719190115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1719190115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DImmune-modulating%252Benzyme%252Bindoleamine%252B2%25252C3-dioxygenase%252Bis%252Beffectively%252Binhibited%252Bby%252Btargeting%252Bits%252Bapo-form%26aulast%3DNelp%26aufirst%3DMicah%2BT.%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D13%26spage%3D3249%26epage%3D3254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some inhibitors of hIDO-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indole Derivatives <b>1</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) maleimide, acetic acid, 170 °C (microwave irradiation), 2 h. (b) CuCN, NMP, 200 °C (microwave irradiation) 1.5 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Naphthalene Derivatives <b>25</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) maleimide, [RhOH(cod)]<sub>2</sub>, Et<sub>3</sub>N, dioxane, 50 °C, 2.5 h; (b) HBF<sub>4</sub>, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C–RT, 1 h; (c) maleic anhydride, TiCl<sub>3</sub>, water/acetone; (d) urea, 180 °C, 1 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Evaluation of <b>6</b>. (A) Ferrous hIDO1. (B) Ferric hIDO1 in the presence of oxygen. (C) Ferric hIDO1 after oxygen depletion. (D) Ferric hIDO1 with tryptophan after oxygen depletion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 2.28 Å X-ray structure of the complex hIDO-1-<b>6a</b>. Protein is represented in light blue Cα trace with key interacting residues in orange and green stick representation. The ligand, <b>6a</b>, is drawn in magenta and the heme in cyan stick representation. (A) Key hydrogen bond interactions. (B) Connolly surface of the protein is shown in gray highlighting the closed binding pocket as a result of the unique ordering of loop A376-D383 (dark blue Cα trace). (<b>C</b>) Superposition of the crystal structure of IDO-1 bound to <b>6a</b> versus PDB IDO-1 structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK3">5EK3</a> (gray Cα trace with gray heme in stick representation, ligand removed for clarity). The unique conformation of residues 376–383, which form a loop in the <b>6a</b>-bound structure, are shown in dark blue Cα trace. Also shown is the different rotomer adopted by the heme carboxylic acid to interact with the succinimide NH of <b>6a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4a" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0004.jpeg" id="rightTab-gr100" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent racemization of <b>6a</b> in (A) plasma across species and phosphate-buffered saline (PBS) and (B) human plasma. Concentrations of <b>6a</b> (empty triangles) and <b>6b</b> (filled circles) are measured using a chiral LC–MS/MS method.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig4a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Total concentrations of <b>6a</b> (blue diamonds) and <b>6b</b> (red squares) with dosing of either <b>6</b> (panel A) or <b>6a</b> (panel B) in monkey (PO dosing at 10 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/medium/jm-2017-00974y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma profile of <b>6a</b> following (A) an intravenous dose (1 mg/kg) and (B) an oral dose (3 mg/kg) of the racemate <b>6</b> to CD-1 mouse, Wistar–Han rat, and Beagle dog.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00974/20171215/images/large/jm-2017-00974y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00974&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mahoney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. J.</span><span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span><span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-584&author=K.+M.+Mahoneyauthor=P.+D.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0lgW4JJhAXaFDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DK.%2BM.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D584%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Munn, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, A. L.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3 dioxygenase and metabolic control of immune responses</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.it.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.it.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23103127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFymtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=137-143&author=D.+H.+Munnauthor=A.+L.+Mellor&title=Indoleamine+2%2C3+dioxygenase+and+metabolic+control+of+immune+responses&doi=10.1016%2Fj.it.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3 dioxygenase and metabolic control of immune responses</span></div><div class="casAuthors">Munn, David H.; Mellor, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-143</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sustained access to nutrients is a fundamental biol. need, esp. for proliferating cells, and controlling nutrient supply is an ancient strategy to regulate cellular responses to stimuli.  By catabolizing the essential amino acid TRP, cells expressing the enzyme indoleamine 2,3 dioxygenase (IDO) can mediate potent local effects on innate and adaptive immune responses to inflammatory insults.  Here, we discuss recent progress in elucidating how IDO activity promotes local metabolic changes that impact cellular and systemic responses to inflammatory and immunol. signals.  These recent developments identify potential new targets for therapy in a range of clin. settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfMMPvAs6AMrVg90H21EOLACvtfcHk0lg3owtNpSY90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFymtrnO&md5=f46000a6437e343ac1879088d36013bd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DMellor%26aufirst%3DA.%2BL.%26atitle%3DIndoleamine%25202%252C3%2520dioxygenase%2520and%2520metabolic%2520control%2520of%2520immune%2520responses%26jtitle%3DTrends%2520Immunol.%26date%3D2013%26volume%3D34%26spage%3D137%26epage%3D143%26doi%3D10.1016%2Fj.it.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">van Baren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B. J.</span><span> </span><span class="NLM_article-title">Tryptophan-degrading enzymes in tumoral immune resistance</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.3389%2Ffimmu.2015.00034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=25657648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kjs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-9&author=N.+van+Barenauthor=B.+J.+Van+den+Eynde&title=Tryptophan-degrading+enzymes+in+tumoral+immune+resistance&doi=10.3389%2Ffimmu.2015.00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan-degrading enzymes in tumoral immune resistance</span></div><div class="casAuthors">van Baren, Nicolas; Van den Eynde, Benoit J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Tryptophan is required for T lymphocyte effector functions.  Its degrdn. is one of the mechanisms selected by tumors to resist immune destruction.Two enzymes, tryptophan- 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1, control tryptophan degrdn. through the kynurenine pathway.  A third protein, indoleamine 2,3-dioxygenase 2, was identified more recently.  All three enzymes were reported to be expressed in tumors, and are candidate targets for pharmacol. inhibition aimed at restoring effective anti-tumoral immunity.  In this review, we compare these three enzymes in terms of structure, activity, regulation, and expression in healthy and cancerous tissues, in order to appreciate their relevance to tumoral immune resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3ajq2AGu0rVg90H21EOLACvtfcHk0lg3owtNpSY90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kjs7rJ&md5=5317c395bec31f1f31eed71aea45e12a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00034%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBaren%26aufirst%3DN.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DTryptophan-degrading%2520enzymes%2520in%2520tumoral%2520immune%2520resistance%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D9%26doi%3D10.3389%2Ffimmu.2015.00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Uyttenhove, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Théate, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Eynde, B. J.</span><span> </span><span class="NLM_article-title">Evidence for a tumoral immune resistance mechanism based on typrotophan degradation by indoleamine-2,3-dioxygenase</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span><span class="refDoi"> DOI: 10.1038/nm934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1038%2Fnm934" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1269-1274&author=C.+Uyttenhoveauthor=L.+Pilotteauthor=I.+Th%C3%A9ateauthor=V.+Stroobantauthor=D.+Colauauthor=N.+Parmentierauthor=T.+Boonauthor=B.+J.+Van+Den+Eynde&title=Evidence+for+a+tumoral+immune+resistance+mechanism+based+on+typrotophan+degradation+by+indoleamine-2%2C3-dioxygenase&doi=10.1038%2Fnm934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm934%26sid%3Dliteratum%253Aachs%26aulast%3DUyttenhove%26aufirst%3DC.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ate%26aufirst%3DI.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DParmentier%26aufirst%3DN.%26aulast%3DBoon%26aufirst%3DT.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520tumoral%2520immune%2520resistance%2520mechanism%2520based%2520on%2520typrotophan%2520degradation%2520by%2520indoleamine-2%252C3-dioxygenase%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D10%26spage%3D1269%26epage%3D1274%26doi%3D10.1038%2Fnm934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikaido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaihara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isonishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">6030</span><span class="NLM_x">–</span> <span class="NLM_lpage">6039</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-04-2671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=16115948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6030-6039&author=A.+Okamotoauthor=T.+Nikaidoauthor=K.+Ochiaiauthor=S.+Takakuraauthor=M.+Saitoauthor=Y.+Aokiauthor=N.+Ishiiauthor=N.+Yanaiharaauthor=K.+Yamadaauthor=O.+Takikawaauthor=R.+Kawaguchiauthor=S.+Isonishiauthor=T.+Tanakaauthor=M.+Urashima&title=Indoleamine+2%2C3-dioxygenase+serves+as+a+marker+of+poor+prognosis+in+gene+expression+profiles+of+serous+ovarian+cancer+cells&doi=10.1158%2F1078-0432.CCR-04-2671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells</span></div><div class="casAuthors">Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu; Yamada, Kyosuke; Takikawa, Osamu; Kawaguchi, Rie; Isonishi, Seiji; Tanaka, Tadao; Urashima, Mitsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6030-6039</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We aimed to find key mols. assocd. with chemoresistance in ovarian cancer using gene expression profiling as a screening tool.  Exptl. Design: Using two newly established paclitaxel-resistant ovarian cancer cell lines from an original paclitaxel-sensitive cell line and four supersensitive and four refractory surgical ovarian cancer specimens from paclitaxel-based chemotherapy, mols. assocd. with chemoresistance were screened with gene expression profiling arrays contg. 39,000 genes.  We further analyzed 44 genes that showed significantly different expressions between paclitaxel-sensitive samples and paclitaxel-resistant samples with permutation tests, which were common in cell lines and patients' tumors.  Results: Eight of these genes showed reproducible results with real-time reverse transcription-PCR, of which indoleamine 2,3-dioxygenase gene expression was the most prominent and consistent.  Moreover, by immunohistochem. anal. using a total of 24 serous-type ovarian cancer surgical specimens (stage III, n = 21; stage IV, n = 7), excluding samples used for GeneChip anal., the Kaplan-Meier survival curve showed a clear relationship between indoleamine 2,3-dioxygenase staining patterns and overall survival (log-rank test, P = 0.0001).  All patients classified as neg. survived without relapse.  The 50% survival of patients classified as sporadic, focal, and diffuse was 41, 17, and 11 mo, resp.  Conclusion: The indoleamine 2,3-dioxygenase screened with the GeneChip was pos. assocd. with paclitaxel resistance and with impaired survival in patients with serous-type ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKy6bi9608B7Vg90H21EOLACvtfcHk0ljIFNyzGUEWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cisb0%253D&md5=b8b8784e723cd5c337cec2c4e159d865</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2671%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DNikaido%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DTakakura%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DYanaihara%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DKawaguchi%26aufirst%3DR.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUrashima%26aufirst%3DM.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520serves%2520as%2520a%2520marker%2520of%2520poor%2520prognosis%2520in%2520gene%2520expression%2520profiles%2520of%2520serous%2520ovarian%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6030%26epage%3D6039%26doi%3D10.1158%2F1078-0432.CCR-04-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brandacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perathoner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladurner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneeberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obrist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner-Felmayer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margreiter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konigsrainer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amberger, A.</span><span> </span><span class="NLM_article-title">PrognosticValue of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-1966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-05-1966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=16489067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1144-1151&author=G.+Brandacherauthor=A.+Perathonerauthor=R.+Ladurnerauthor=S.+Schneebergerauthor=P.+Obristauthor=C.+Winklerauthor=E.+R.+Wernerauthor=G.+Werner-Felmayerauthor=H.+G.+Weissauthor=G.+Gobelauthor=R.+Margreiterauthor=A.+Konigsrainerauthor=D.+Fuchsauthor=A.+Amberger&title=PrognosticValue+of+Indoleamine+2%2C3-Dioxygenase+Expression+in+Colorectal+Cancer%3A+Effect+on+Tumor-Infiltrating+T+Cells&doi=10.1158%2F1078-0432.CCR-05-1966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</span></div><div class="casAuthors">Brandacher, Gerald; Perathoner, Alexander; Ladurner, Ruth; Schneeberger, Stefan; Obrist, Peter; Winkler, Christiana; Werner, Ernst R.; Werner-Felmayer, Gabriele; Weiss, Helmut G.; Goebel, Georg; Margreiter, Raimund; Koenigsrainer, Alfred; Fuchs, Dietmar; Amberger, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1144-1151</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pathol. interactions between tumor and host immune cells within the tumor microenvironment create an immunosuppressive network that promotes tumor growth and protects the tumor from immune attack.  In this study, we examd. the contribution of the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) on this phenomenon.  Exptl. Design: Expression of IDO was analyzed in colorectal cancer cell lines by reverse transcription-PCR and functional enzyme activity was assessed by high-pressure liq. chromatog.  Semiquant. immunohistochem. was used to evaluate IDO expression in the tissue samples of 143 patients with colorectal carcinoma, and was then correlated with the no. of tumor-infiltrating T cells and clin. variables.  RESULTS: In vitro IDO expression and functional enzyme activity in colorectal cancer cells was found to be strictly dependent on IFN-γ stimulation.  Immunohistochem. scores revealed IDO-high expression in 56 of 143 (39.2%) tumor specimens, whereas 87 of 143 (60.8%) cases showed low IDO expression levels.  IDO-high expression was assocd. with a significant redn. of CD3+ infiltrating T cells (46.02 ± 7.25) as compared with tissue samples expressing low IDO (19.42 ± 2.50; P = 0.0003).  Furthermore, IDO-high immunoreactivity significantly correlated with the frequency of liver metastases (P = 0.003).  Kaplan-Meier anal. showed the crossing of survival curves at 45 mo.  By multivariate Cox's anal., IDO-high expression emerged as an independent prognostic variable (<45 mo, P = 0.006; >45 mo, P = 0.04).  CONCLUSION: IDO-high expression by colorectal tumor cells enables certain cancer subsets to initially avoid immune attack and defeat the invasion of T cells via local tryptophan depletion and the prodn. of proapoptotic tryptophan catabolites.  Thus, IDO significantly contributes to disease progression and overall survival in patients with colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuBdys9PLf7Vg90H21EOLACvtfcHk0lifIdmsVP0nVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFalt7g%253D&md5=623837bb245e71dd4fe137e790ddbfe9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1966%26sid%3Dliteratum%253Aachs%26aulast%3DBrandacher%26aufirst%3DG.%26aulast%3DPerathoner%26aufirst%3DA.%26aulast%3DLadurner%26aufirst%3DR.%26aulast%3DSchneeberger%26aufirst%3DS.%26aulast%3DObrist%26aufirst%3DP.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DWerner%26aufirst%3DE.%2BR.%26aulast%3DWerner-Felmayer%26aufirst%3DG.%26aulast%3DWeiss%26aufirst%3DH.%2BG.%26aulast%3DGobel%26aufirst%3DG.%26aulast%3DMargreiter%26aufirst%3DR.%26aulast%3DKonigsrainer%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DD.%26aulast%3DAmberger%26aufirst%3DA.%26atitle%3DPrognosticValue%2520of%2520Indoleamine%25202%252C3-Dioxygenase%2520Expression%2520in%2520Colorectal%2520Cancer%253A%2520Effect%2520on%2520Tumor-Infiltrating%2520T%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1144%26epage%3D1151%26doi%3D10.1158%2F1078-0432.CCR-05-1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Holmgaard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamarin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munn, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, J. P.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1084/jem.20130066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1084%2Fjem.20130066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23752227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=1389-402&author=R.+B.+Holmgaardauthor=D.+Zamarinauthor=D.+H.+Munnauthor=J.+D.+Wolchokauthor=J.+P.+Allison&title=Indoleamine+2%2C3-dioxygenase+is+a+critical+resistance+mechanism+in+antitumor+T+cell+immunotherapy+targeting+CTLA-4&doi=10.1084%2Fjem.20130066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4</span></div><div class="casAuthors">Holmgaard, Rikke B.; Zamarin, Dmitriy; Munn, David H.; Wolchok, Jedd D.; Allison, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1389-1402</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The cytotoxic T lymphocyte antigen-4 (CTLA-4)-blocking antibody ipilimumab results in durable responses in metastatic melanoma, though therapeutic benefit has been limited to a fraction of patients.  This calls for identification of resistance mechanisms and development of combinatorial strategies.  Here, we examine the inhibitory role of indoleamine 2,3-dioxygenase (IDO) on the antitumor efficacy of CTLA-4 blockade.  In IDO knockout mice treated with anti-CTLA-4 antibody, we demonstrate a striking delay in B16 melanoma tumor growth and increased overall survival when compared with wild-type mice.  This was also obsd. with antibodies targeting PD-1-PD-L1 and GITR.  To highlight the therapeutic relevance of these findings, we show that CTLA-4 blockade strongly synergizes with IDO inhibitors to mediate rejection of both IDO-expressing and nonexpressing poorly immunogenic tumors, emphasizing the importance of the inhibitory role of both tumor- and host-derived IDO.  This effect was T cell dependent, leading to enhanced infiltration of tumor-specific effector T cells and a marked increase in the effector-to-regulatory T cell ratios in the tumors.  Overall, these data demonstrate the immunosuppressive role of IDO in the context of immunotherapies targeting immune checkpoints and provide a strong incentive to clin. explore combination therapies using IDO inhibitors irresp. of IDO expression by the tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn2vZr-icci7Vg90H21EOLACvtfcHk0lifIdmsVP0nVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGiurnP&md5=ed5a4e2074d7f0448eb503d7e11c2e91</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130066%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgaard%26aufirst%3DR.%2BB.%26aulast%3DZamarin%26aufirst%3DD.%26aulast%3DMunn%26aufirst%3DD.%2BH.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520is%2520a%2520critical%2520resistance%2520mechanism%2520in%2520antitumor%2520T%2520cell%2520immunotherapy%2520targeting%2520CTLA-4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D1389%26epage%3D402%26doi%3D10.1084%2Fjem.20130066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Platten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Knebel Doeberitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oezen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, K.</span><span> </span><span class="NLM_article-title">Cancer immunotherapy by targeting IDO-1/TDO and their downstream effectors</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="refDoi"> DOI: 10.3389/fimmu.2014.00673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.3389%2Ffimmu.2014.00673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=25628622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=673&author=M.+Plattenauthor=N.+von+Knebel+Doeberitzauthor=I.+Oezenauthor=W.+Wickauthor=K.+Ochs&title=Cancer+immunotherapy+by+targeting+IDO-1%2FTDO+and+their+downstream+effectors&doi=10.3389%2Ffimmu.2014.00673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2014.00673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2014.00673%26sid%3Dliteratum%253Aachs%26aulast%3DPlatten%26aufirst%3DM.%26aulast%3Dvon%2BKnebel%2BDoeberitz%26aufirst%3DN.%26aulast%3DOezen%26aufirst%3DI.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DOchs%26aufirst%3DK.%26atitle%3DCancer%2520immunotherapy%2520by%2520targeting%2520IDO-1%252FTDO%2520and%2520their%2520downstream%2520effectors%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D5%26spage%3D673%26doi%3D10.3389%2Ffimmu.2014.00673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Röhrig, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majjigapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoete, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michielin, O.</span><span> </span><span class="NLM_article-title">Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9421</span><span class="NLM_x">–</span> <span class="NLM_lpage">9437</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlChsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9421-9437&author=U.+F.+R%C3%B6hrigauthor=S.+R.+Majjigapuauthor=P.+Vogelauthor=V.+Zoeteauthor=O.+Michielin&title=Challenges+in+the+discovery+of+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors</span></div><div class="casAuthors">Rohrig, Ute F.; Majjigapu, Somi Reddy; Vogel, Pierre; Zoete, Vincent; Michielin, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9421-9437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) as an attractive target for anticancer therapy in 2003, the search for inhibitors has been intensely pursued both in academia and in pharmaceutical companies.  Many novel IDO1 inhibitor scaffolds have been described, and a few potent compds. have entered clin. trials.  However, a significant no. of the reported compds. contain problematic functional groups, suggesting that enzyme inhibition could be the result of undesirable side reactions instead of selective binding to IDO1.  Here, we describe issues in the employed exptl. protocols, review and classify reported IDO1 inhibitors, and suggest different approaches for confirming viable inhibitor scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR3nr-l4vgNLVg90H21EOLACvtfcHk0lifIdmsVP0nVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlChsrw%253D&md5=1b44178d33badc00215915c28d027b5d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00326%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6hrig%26aufirst%3DU.%2BF.%26aulast%3DMajjigapu%26aufirst%3DS.%2BR.%26aulast%3DVogel%26aufirst%3DP.%26aulast%3DZoete%26aufirst%3DV.%26aulast%3DMichielin%26aufirst%3DO.%26atitle%3DChallenges%2520in%2520the%2520discovery%2520of%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9421%26epage%3D9437%26doi%3D10.1021%2Facs.jmedchem.5b00326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Beatty, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dwyer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajewski, T. F.</span><span> </span><span class="NLM_article-title">First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 Epacadostat (INCB024360) in patients with advanced solid malignancies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3269</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1158%2F1078-0432.CCR-16-2272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=28053021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3269-3276&author=G.+L.+Beattyauthor=P.+J.+O%E2%80%99Dwyerauthor=J.+Clarkauthor=J.+G.+Shiauthor=K.+J.+Bowmanauthor=P.+A.+Scherleauthor=R.+C.+Newtonauthor=R.+Schaubauthor=J.+Maleskiauthor=L.+Leopoldauthor=T.+F.+Gajewski&title=First-in-human+phase+I+study+of+the+oral+inhibitor+of+indoleamine+2%2C3-dioxygenase-1+Epacadostat+%28INCB024360%29+in+patients+with+advanced+solid+malignancies&doi=10.1158%2F1078-0432.CCR-16-2272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies</span></div><div class="casAuthors">Beatty, Gregory L.; O'Dwyer, Peter J.; Clark, Jason; Shi, Jack G.; Bowman, Kevin J.; Scherle, Peggy A.; Newton, Robert C.; Schaub, Richard; Maleski, Janet; Leopold, Lance; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3269-3276</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase-1 (IDO1) catalyzes the degrdn. of tryptophan to N-formyl-kynurenine.  Overexpressed in many solid malignancies, IDO1 can promote tumor escape from host immunosurveillance.  This first-in-human phase I study investigated the max. tolerated dose, safety, pharmacokinetics, pharmacodynamics, and antitumor activity of epacadostat (INCB024360), a potent and selective inhibitor of IDO1.  Fifty-two patients with advanced solid malignancies were treated with epacadostat [50 mg once daily or 50, 100, 300, 400, 500, 600, or 700 mg twice daily (BID)] in a dose-escalation 3 + 3 design and evaluated in 28-day cycles.  Treatment was continued until disease progression or unacceptable toxicity.  One dose-limiting toxicity (DLT) occurred at the dose of 300 mg BID (grade 3, radiation pneumonitis); another DLT occurred at 400 mg BID (grade 3, fatigue).  The most common adverse events in >20% of patients overall were fatigue, nausea, decreased appetite, vomiting, constipation, abdominal pain, diarrhea, dyspnea, back pain, and cough.  Treatment produced significant dose-dependent redns. in plasma kynurenine levels and in the plasma kynurenine/tryptophan ratio at all doses and in all patients.  Near maximal changes were obsd. at doses of ≥100 mg BID with >80% to 90% inhibition of IDO1 achieved throughout the dosing period.  Although no objective responses were detected, stable disease lasting ≥16 wk was obsd. in 7 of 52 patients.  Epacadostat was generally well tolerated, effectively normalized kynurenine levels, and produced maximal inhibition of IDO1 activity at doses of ≥100 mg BID.  Studies investigating epacadostat in combination with other immunomodulatory drugs are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdL__p3Q7B7Vg90H21EOLACvtfcHk0liCIFo-3wL6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurfP&md5=dee4464e680b476ebe0dbad7f5ec8d46</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2272%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DG.%2BL.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%2BG.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DSchaub%26aufirst%3DR.%26aulast%3DMaleski%26aufirst%3DJ.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DFirst-in-human%2520phase%2520I%2520study%2520of%2520the%2520oral%2520inhibitor%2520of%2520indoleamine%25202%252C3-dioxygenase-1%2520Epacadostat%2520%2528INCB024360%2529%2520in%2520patients%2520with%2520advanced%2520solid%2520malignancies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3269%26epage%3D3276%26doi%3D10.1158%2F1078-0432.CCR-16-2272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leffet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansbury, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span> </span><span class="NLM_article-title">Discovery of potent competitive inhibitors of Indoleamine 2,3-Dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7364</span><span class="NLM_x">–</span> <span class="NLM_lpage">7367</span><span class="refDoi"> DOI: 10.1021/jm900518f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900518f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7364-7367&author=E.+W.+Yueauthor=B.+Doutyauthor=B.+Waylandauthor=M.+Bowerauthor=X.+Liuauthor=L.+Leffetauthor=Q.+Wangauthor=K.+J.+Bowmanauthor=M.+J.+Hansburyauthor=C.+Liuauthor=M.+Weiauthor=Y.+Liauthor=R.+Wynnauthor=T.+C.+Burnauthor=H.+K.+Koblishauthor=J.+S.+Fridmanauthor=B.+Metcalfauthor=P.+A.+Scherleauthor=A.+P.+Combs&title=Discovery+of+potent+competitive+inhibitors+of+Indoleamine+2%2C3-Dioxygenase+with+in+vivo+pharmacodynamic+activity+and+efficacy+in+a+mouse+melanoma+model&doi=10.1021%2Fjm900518f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model</span></div><div class="casAuthors">Yue, Eddy W.; Douty, Brent; Wayland, Brian; Bower, Michael; Liu, Xiangdong; Leffet, Lynn; Wang, Qian; Bowman, Kevin J.; Hansbury, Michael J.; Liu, Changnian; Wei, Min; Li, Yanlong; Wynn, Richard; Burn, Timothy C.; Koblish, Holly K.; Fridman, Jordan S.; Metcalf, Brian; Scherle, Peggy A.; Combs, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7364-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydroxyamidine chemotype has been discovered as a key pharmacophore in novel inhibitors of indoleamine 2,3-dioxygenase (IDO).  Optimization led to the identification of (I), which is a potent (HeLa IC50 = 19 nM) competitive inhibitor of IDO.  Testing of I in mice demonstrated pharmacodynamic inhibition of IDO, as measured by decreased kynurenine levels (>50%) in plasma and dose dependent efficacy in mice bearing GM-CSF-secreting B16 melanoma tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsq88hx0J77Vg90H21EOLACvtfcHk0liCIFo-3wL6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSksb8%253D&md5=328d92bffb88a86da030c31eff707dc6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm900518f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900518f%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DWayland%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBowman%26aufirst%3DK.%2BJ.%26aulast%3DHansbury%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520competitive%2520inhibitors%2520of%2520Indoleamine%25202%252C3-Dioxygenase%2520with%2520in%2520vivo%2520pharmacodynamic%2520activity%2520and%2520efficacy%2520in%2520a%2520mouse%2520melanoma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7364%26epage%3D7367%26doi%3D10.1021%2Fjm900518f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLonde, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuHadaway, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malachowski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. J.</span><span> </span><span class="NLM_article-title">Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4977</span><span class="refDoi"> DOI: 10.1021/jm800512z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800512z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4968-4977&author=S.+Kumarauthor=D.+Jallerauthor=B.+Patelauthor=J.+M.+LaLondeauthor=J.+B.+DuHadawayauthor=W.+P.+Malachowskiauthor=G.+C.+Prendergastauthor=A.+J.+Muller&title=Structure+based+development+of+phenylimidazole-derived+inhibitors+of+indoleamine+2%2C3-dioxygenase&doi=10.1021%2Fjm800512z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase</span></div><div class="casAuthors">Kumar, Sanjeev; Jaller, Daniel; Patel, Bhumika; LaLonde, Judith M.; DuHadaway, James B.; Malachowski, William P.; Prendergast, George C.; Muller, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4968-4977</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterized by pathol. immune suppression.  With the goal of developing more potent IDO inhibitors, a systematic study of 4-phenylimidazole (4-PI) derivs. was undertaken.  Computational docking expts. guided design and synthesis efforts with analogs of 4-PI.  In particular, three interactions of 4-PI analogs with IDO were studied: the active site entrance, the interior of the active site, and the heme iron binding.  The three most potent inhibitors I (R = 4-HOC6H4, 3-HSC6H4, 4-HSC6H4) appear to exploit interactions with C129 and S167 in the interior of the active site.  All three inhibitors are approx. 10-fold more potent than 4-PI.  The study represents the first example of enzyme inhibitor development with the recently reported crystal structure of IDO and offers important lessons in the search for more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHTIIEf7DjmLVg90H21EOLACvtfcHk0liCIFo-3wL6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVyrtrY%253D&md5=6e232cb983d0ba2396bea16060a5b7a1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800512z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800512z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DJaller%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%2BM.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26atitle%3DStructure%2520based%2520development%2520of%2520phenylimidazole-derived%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4968%26epage%3D4977%26doi%3D10.1021%2Fjm800512z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cady, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sono, M.</span><span> </span><span class="NLM_article-title">1-Methyl-DL-tryptophan, beta-(3- benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/0003-9861(91)90142-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2F0003-9861%2891%2990142-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1991&pages=326-333&author=S.+G.+Cadyauthor=M.+Sono&title=1-Methyl-DL-tryptophan%2C+beta-%283-+benzofuranyl%29-DL-alanine+%28the+oxygen+analog+of+tryptophan%29%2C+and+beta-%5B3-benzo%28b%29thienyl%5D-DL-alanine+%28the+sulfur+analog+of+tryptophan%29+are+competitive+inhibitors+for+indoleamine+2%2C3-dioxygenase&doi=10.1016%2F0003-9861%2891%2990142-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2891%2990142-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252891%252990142-6%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BG.%26aulast%3DSono%26aufirst%3DM.%26atitle%3D1-Methyl-DL-tryptophan%252C%2520beta-%25283-%2520benzofuranyl%2529-DL-alanine%2520%2528the%2520oxygen%2520analog%2520of%2520tryptophan%2529%252C%2520and%2520beta-%255B3-benzo%2528b%2529thienyl%255D-DL-alanine%2520%2528the%2520sulfur%2520analog%2520of%2520tryptophan%2529%2520are%2520competitive%2520inhibitors%2520for%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1991%26volume%3D291%26spage%3D326%26epage%3D333%26doi%3D10.1016%2F0003-9861%2891%2990142-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Peterson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migawa, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaker, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arend, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of functionalized tryptophan derivatives and related compounds as competitive inhibitors of indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFCqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=531-544&author=A.+C.+Petersonauthor=M.+T.+Migawaauthor=M.+J.+Martinauthor=L.+K.+Hamakerauthor=K.+M.+Czerwinskiauthor=W.+Zhangauthor=R.+A.+Arendauthor=P.+L.+Fisetteauthor=Y.+Okaziauthor=J.+A.+Willauthor=R.+R.+Brownauthor=J.+M.+Cook&title=Evaluation+of+functionalized+tryptophan+derivatives+and+related+compounds+as+competitive+inhibitors+of+indoleamine+2%2C3-dioxygenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">evaluation of functionalized tryptophan derivatives and related compounds as competitive inhibitors of indoleamine 2,3-dioxygenase</span></div><div class="casAuthors">Peterson, Andrew C.; Migawa, Michael T.; Martin, Michael J.; Hamaker, Linda K.; Czerwinski, Kevin M.; Zhang, Weijiang; Arend, Richard A.; Fisette, Philip L.; Ozaki, Yoshisuke; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">531-44</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    </div><div class="casAbstract">The stereochem. requirements of the active site of human monocyte/macrophage indoleamine 2,3-dioxygenase (IDO) were probed by assays of both antipodes of 1-methyltryptophan.  The L-isomer of 1-methyltryptophan (62.9% inhibition, Ki=34 μM) was significantly more active than its antipode (11.6% inhibition).  These results indicate stereoselectivity of binding at the tryptophan binding site of IDO.  The 1-ethyltryptophan antipodes, however, were not potent inhibitors of this enzyme.  In addn., both D- and L-dihydrotryptophan diastereomers were inactive.  In contrast, both DL-oxindolylalanine and 5-methoxytryptamine were relatively potent effectors, activating IDO at 43.3% and 43.9% activation, resp.  Quinolinic acid, kynurenic acid, L-kynurenine, 3-hydroxykynurenine, xanthurenic acid and picolinic acid were all inactive.  However, L-5-hydroxytryptophan showed modest inhibition (14% inhibition).  The D-and L-isomers of quinoline-3-alanine, resp., were inactive as were tryptazan and DL-7-azatryptophan.  These results suggest that the tryptophan binding site of IDO is composed of a largely lipophilic cleft, except in the region where the amino acid function binds.  The nonindolic compd., 3-amino-2-naphthoic acid, was the most potent inhibitor in this investigation (75.2% inhibition) and demonstrates that the indole nitrogen moiety is not necessary for activity at this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrSynMTA04LVg90H21EOLACvtfcHk0lgzWCc7F_kGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFCqsbc%253D&md5=228fb816606e3519fe96bb54aa7ca158</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DA.%2BC.%26aulast%3DMigawa%26aufirst%3DM.%2BT.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DHamaker%26aufirst%3DL.%2BK.%26aulast%3DCzerwinski%26aufirst%3DK.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArend%26aufirst%3DR.%2BA.%26aulast%3DFisette%26aufirst%3DP.%2BL.%26aulast%3DOkazi%26aufirst%3DY.%26aulast%3DWill%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DR.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520functionalized%2520tryptophan%2520derivatives%2520and%2520related%2520compounds%2520as%2520competitive%2520inhibitors%2520of%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D1994%26volume%3D3%26spage%3D531%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, M. P.</span><span> </span><span class="NLM_article-title">4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferongamma-stimulated monocytes (THP-1 cells)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1042/bj2910011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1042%2Fbj2910011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1993&pages=11-14&author=K.+Saitoauthor=C.+Y.+Chenauthor=M.+Masanaauthor=J.+S.+Crowleyauthor=S.+P.+Markeyauthor=M.+P.+Heyes&title=4-Chloro-3-hydroxyanthranilate%2C+6-chlorotryptophan+and+norharmane+attenuate+quinolinic+acid+formation+by+interferongamma-stimulated+monocytes+%28THP-1+cells%29&doi=10.1042%2Fbj2910011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj2910011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2910011%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DMasana%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DJ.%2BS.%26aulast%3DMarkey%26aufirst%3DS.%2BP.%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26atitle%3D4-Chloro-3-hydroxyanthranilate%252C%25206-chlorotryptophan%2520and%2520norharmane%2520attenuate%2520quinolinic%2520acid%2520formation%2520by%2520interferongamma-stimulated%2520monocytes%2520%2528THP-1%2520cells%2529%26jtitle%3DBiochem.%2520J.%26date%3D1993%26volume%3D291%26spage%3D11%26epage%3D14%26doi%3D10.1042%2Fbj2910011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gaspari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malachowski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuHadaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, A. M.</span><span> </span><span class="NLM_article-title">Structure-activity study of brassinin derivatives as indoleamine 2,3- dioxygenase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1021/jm0508888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=684-692&author=P.+Gaspariauthor=T.+Banerjeeauthor=W.+P.+Malachowskiauthor=A.+J.+Mullerauthor=G.+C.+Prendergastauthor=J.+DuHadawayauthor=S.+Bennettauthor=A.+M.+Donovan&title=Structure-activity+study+of+brassinin+derivatives+as+indoleamine+2%2C3-+dioxygenase+inhibitors&doi=10.1021%2Fjm0508888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0508888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508888%26sid%3Dliteratum%253Aachs%26aulast%3DGaspari%26aufirst%3DP.%26aulast%3DBanerjee%26aufirst%3DT.%26aulast%3DMalachowski%26aufirst%3DW.%2BP.%26aulast%3DMuller%26aufirst%3DA.%2BJ.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDuHadaway%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DA.%2BM.%26atitle%3DStructure-activity%2520study%2520of%2520brassinin%2520derivatives%2520as%2520indoleamine%25202%252C3-%2520dioxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D684%26epage%3D692%26doi%3D10.1021%2Fjm0508888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikkyu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8661</span><span class="NLM_x">–</span> <span class="NLM_lpage">8669</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2008.07.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8661-8669&author=H.+Nakashimaauthor=Y.+Utoauthor=E.+Nakataauthor=H.+Nagasawaauthor=K.+Ikkyuauthor=N.+Hiraokaauthor=K.+Nakashimaauthor=Y.+Sasakiauthor=H.+Sugimotoauthor=Y.+Shiroauthor=T.+Hashimotoauthor=Y.+Okamotoauthor=Y.+Asakawaauthor=H.+Hori&title=Synthesis+and+biological+activity+of+1-methyl-tryptophan-tirapazamine+hybrids+as+hypoxia-targeting+indoleamine+2%2C3-dioxygenase+inhibitors&doi=10.1016%2Fj.bmc.2008.07.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.087%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DUto%26aufirst%3DY.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DNagasawa%26aufirst%3DH.%26aulast%3DIkkyu%26aufirst%3DK.%26aulast%3DHiraoka%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DShiro%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25201-methyl-tryptophan-tirapazamine%2520hybrids%2520as%2520hypoxia-targeting%2520indoleamine%25202%252C3-dioxygenase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8661%26epage%3D8669%26doi%3D10.1016%2Fj.bmc.2008.07.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dolusič, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapunaric, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredérick, R.</span><span> </span><span class="NLM_article-title">Discovery and preliminary SARs of keto- indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3058</span><span class="NLM_x">–</span> <span class="NLM_lpage">3065</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.02.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.ejmech.2011.02.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3058-3065&author=E.+Dolusi%C4%8Dauthor=P.+Larrieuauthor=S.+Blancauthor=F.+Sapunaricauthor=J.+Pouyezauthor=L.+Moineauxauthor=D.+Coletteauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=T.+Ferainauthor=G.+Fraserauthor=M.+Galleniauthor=J.-M.+Frereauthor=B.+Masereelauthor=B.+Van+den+Eyndeauthor=J.+Woutersauthor=R.+Fred%C3%A9rick&title=Discovery+and+preliminary+SARs+of+keto-+indoles+as+novel+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.ejmech.2011.02.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.02.049%26sid%3Dliteratum%253Aachs%26aulast%3DDolusi%25C4%258D%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DS.%26aulast%3DSapunaric%26aufirst%3DF.%26aulast%3DPouyez%26aufirst%3DJ.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DColette%26aufirst%3DD.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DFerain%26aufirst%3DT.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.-M.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFred%25C3%25A9rick%26aufirst%3DR.%26atitle%3DDiscovery%2520and%2520preliminary%2520SARs%2520of%2520keto-%2520indoles%2520as%2520novel%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3058%26epage%3D3065%26doi%3D10.1016%2Fj.ejmech.2011.02.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dolusič, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapunaric, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredérick, R.</span><span> </span><span class="NLM_article-title">Indol-2-yl ethanones as noveĺ indoleamine 2,3-dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2010.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1550-1561&author=E.+Dolusi%C4%8Dauthor=P.+Larrieuauthor=S.+Blancauthor=F.+Sapunaricauthor=B.+Norbergauthor=L.+Moineauxauthor=D.+Coletteauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=T.+Ferainauthor=G.+Fraserauthor=M.+Galleniauthor=M.+Galeniauthor=J.-M.+Frereauthor=B.+Masereelauthor=B.+Van+den+Eyndeauthor=J.+Woutersauthor=R.+Fred%C3%A9rick&title=Indol-2-yl+ethanones+as+nove%C4%BA+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.bmc.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DDolusi%25C4%258D%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DS.%26aulast%3DSapunaric%26aufirst%3DF.%26aulast%3DNorberg%26aufirst%3DB.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DColette%26aufirst%3DD.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DFerain%26aufirst%3DT.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DGaleni%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.-M.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFred%25C3%25A9rick%26aufirst%3DR.%26atitle%3DIndol-2-yl%2520ethanones%2520as%2520nove%25C4%25BA%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1550%26epage%3D1561%26doi%3D10.1016%2Fj.bmc.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, Y.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3- dioxygenase (IDO) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1016%2Fj.bmc.2012.12.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1159-1165&author=M.+Tanakaauthor=X.+Liauthor=H.+Hikawaauthor=T.+Suzukiauthor=K.+Tsutsumiauthor=M.+Satoauthor=O.+Takikawaauthor=H.+Suzukiauthor=Y.+Yokoyama&title=Synthesis+and+biological+evaluation+of+novel+tryptoline+derivatives+as+indoleamine+2%2C3-+dioxygenase+%28IDO%29+inhibitors&doi=10.1016%2Fj.bmc.2012.12.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHikawa%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsutsumi%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520tryptoline%2520derivatives%2520as%2520indoleamine%25202%252C3-%2520dioxygenase%2520%2528IDO%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1159%26epage%3D1165%26doi%3D10.1016%2Fj.bmc.2012.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cavalheiro Tourino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belle, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dörr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campa, A.</span><span> </span><span class="NLM_article-title">Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells</span> <span class="citation_source-journal">Cell Biochem. Funct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1002/cbf.2980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=10.1002%2Fcbf.2980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=23754498" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=361-364&author=M.+Cavalheiro+Tourinoauthor=E.+M.+de+Oliveiraauthor=L.+P.+Belleauthor=F.+H.+Knebelauthor=R.+C.+Albuquerqueauthor=F.+A.+D%C3%B6rrauthor=S.+S.+Okadaauthor=S.+Miglioriniauthor=I.+S.+Soaresauthor=A.+Campa&title=Tryptamine+and+dimethyltryptamine+inhibit+indoleamine+2%2C3+dioxygenase+and+increase+the+tumor-reactive+effect+of+peripheral+blood+mononuclear+cells&doi=10.1002%2Fcbf.2980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcbf.2980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.2980%26sid%3Dliteratum%253Aachs%26aulast%3DCavalheiro%2BTourino%26aufirst%3DM.%26aulast%3Dde%2BOliveira%26aufirst%3DE.%2BM.%26aulast%3DBelle%26aufirst%3DL.%2BP.%26aulast%3DKnebel%26aufirst%3DF.%2BH.%26aulast%3DAlbuquerque%26aufirst%3DR.%2BC.%26aulast%3DD%25C3%25B6rr%26aufirst%3DF.%2BA.%26aulast%3DOkada%26aufirst%3DS.%2BS.%26aulast%3DMigliorini%26aufirst%3DS.%26aulast%3DSoares%26aufirst%3DI.%2BS.%26aulast%3DCampa%26aufirst%3DA.%26atitle%3DTryptamine%2520and%2520dimethyltryptamine%2520inhibit%2520indoleamine%25202%252C3%2520dioxygenase%2520and%2520increase%2520the%2520tumor-reactive%2520effect%2520of%2520peripheral%2520blood%2520mononuclear%2520cells%26jtitle%3DCell%2520Biochem.%2520Funct.%26date%3D2013%26volume%3D31%26spage%3D361%26epage%3D364%26doi%3D10.1002%2Fcbf.2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Soret, J.-L.</span><span> </span><span class="NLM_article-title">Analyse Spectrale – Sur le spectre d’absorption du sang dans la partie violette et ultra-violette</span> <span class="citation_source-journal">C. R. Hebd. Séances Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1883</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1883&pages=1269-70&author=J.-L.+Soret&title=Analyse+Spectrale+%E2%80%93+Sur+le+spectre+d%E2%80%99absorption+du+sang+dans+la+partie+violette+et+ultra-violette"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoret%26aufirst%3DJ.-L.%26atitle%3DAnalyse%2520Spectrale%2520%25E2%2580%2593%2520Sur%2520le%2520spectre%2520d%25E2%2580%2599absorption%2520du%2520sang%2520dans%2520la%2520partie%2520violette%2520et%2520ultra-violette%26jtitle%3DC.%2520R.%2520Hebd.%2520S%25C3%25A9ances%2520Acad.%2520Sci.%26date%3D1883%26volume%3D97%26spage%3D1269%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cady, S. G.</span><span> </span><span class="NLM_article-title">Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">5392</span><span class="NLM_x">–</span> <span class="NLM_lpage">5399</span><span class="refDoi"> DOI: 10.1021/bi00439a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00439a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;key=1%3ACAS%3A528%3ADyaL1MXktF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=5392-5399&author=M.+Sonoauthor=S.+G.+Cady&title=Enzyme+kinetic+and+spectroscopic+studies+of+inhibitor+and+effector+interactions+with+indoleamine+2%2C3-dioxygenase.+1.+Norharman+and+4-phenylimidazole+binding+to+the+enzyme+as+inhibitors+and+heme+ligands&doi=10.1021%2Fbi00439a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands</span></div><div class="casAuthors">Sono, Masanori; Cady, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5392-9</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The effects of norharman, one of the few known inhibitors of the heme protein indoleamine 2,3-dioxygenase, and of 4-phenylimidazole (4-PheImid), a heme ligand, on the catalytic (Vmax, Km) and spectroscopic properties (optical absorption, CD, and MCD) of rabbit small intestine dioxygenase were investigated.  Assays were performed with the substrate L- or D-tryptophan (Trp) and an ascorbic acid-methylene blue cofactor system at 25°.  Both norharman and 4-PheImid exhibit noncompetitive inhibition with respect to L-Trp and D-Trp.  The binding of norharman to the enzyme results in the formation of a low-spin complex in both the ferric and ferrous enzyme with comparable dissocn. consts. (Kd = ∼10 μM at pH 7.0) that are ∼10-fold smaller than the obsd. Ki.  L-Trp exerts no effect for the ferric enzyme and slight neg. cooperative effects for the ferrous enzyme on norharman binding.  Close spectral similarities are obsd. between the adducts of the enzyme with norharman and 4-PheImid in the resp. oxidn. states.  This, together with competition expts. using CN-, demonstrates that norharman binds directly to the heme Fe of the enzyme as a N donor ligand.  Thus, norharman competes with O2 for the heme Fe of the ferrous (active) enzyme, resulting in the obsd. inhibition.  L-Trp and 4-PheImid appear to compete for the heme-binding site in the ferric enzyme and display slight neg. cooperativity on binding to the ferrous enzyme.  The obsd. Ki for 4-PheImid is comparable with the Kd (∼10 μM at pH 7.0) of its adduct with the ferric enzyme, but is ∼40-fold smaller than the Kd for the corresponding ferrous complex.  Apparently, the inhibition of the dioxygenase activity by 4-PheImid is due to its binding to the heme Fe of the ferric enzyme, preventing the reductive activation of the dioxygenase by the ascorbic acid-methylene blue cofactor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFgFeeIW5--LVg90H21EOLACvtfcHk0liY6UCn_fsuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktF2qtLg%253D&md5=87f3a4be44f5626760b567185013050a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00439a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00439a012%26sid%3Dliteratum%253Aachs%26aulast%3DSono%26aufirst%3DM.%26aulast%3DCady%26aufirst%3DS.%2BG.%26atitle%3DEnzyme%2520kinetic%2520and%2520spectroscopic%2520studies%2520of%2520inhibitor%2520and%2520effector%2520interactions%2520with%2520indoleamine%25202%252C3-dioxygenase.%25201.%2520Norharman%2520and%25204-phenylimidazole%2520binding%2520to%2520the%2520enzyme%2520as%2520inhibitors%2520and%2520heme%2520ligands%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D5392%26epage%3D5399%26doi%3D10.1021%2Fbi00439a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, S. R.</span><span> </span><span class="NLM_article-title">Biochem. Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5028</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1021/bi1005078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1005078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=5028-34&author=C.+Luauthor=Y.+Linauthor=S.+R.+Yeh&title=Biochem.+Spectroscopic+studies+of+ligand+and+substrate+binding+to+human+indoleamine+2%2C3-dioxygenase&doi=10.1021%2Fbi1005078"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi1005078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005078%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DS.%2BR.%26atitle%3DBiochem.%2520Spectroscopic%2520studies%2520of%2520ligand%2520and%2520substrate%2520binding%2520to%2520human%2520indoleamine%25202%252C3-dioxygenase%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D5028%26epage%3D34%26doi%3D10.1021%2Fbi1005078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gomes, B.; Driessens, G.; Bartlett, D.; Cauwenberghs, S.; Crosignani, S.; Dalvie, D.; Denies, S.; Fantin, V. R.; Guo, J.; Letellier, M.-C.; Li, W.; Maegley, K.; Marillier, R.; Miller, N.; Pirson, R.; Rabolli, V.; Ray, C.; Streiner, N.; Torti, V. R.; Tsaparikos, K.; van den Eynde, B.; Wythes, M.; Zheng, X.; Tumang, J.; Kraus, M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gomes%2C+B.%3B+Driessens%2C+G.%3B+Bartlett%2C+D.%3B+Cauwenberghs%2C+S.%3B+Crosignani%2C+S.%3B+Dalvie%2C+D.%3B+Denies%2C+S.%3B+Fantin%2C+V.+R.%3B+Guo%2C+J.%3B+Letellier%2C+M.-C.%3B+Li%2C+W.%3B+Maegley%2C+K.%3B+Marillier%2C+R.%3B+Miller%2C+N.%3B+Pirson%2C+R.%3B+Rabolli%2C+V.%3B+Ray%2C+C.%3B+Streiner%2C+N.%3B+Torti%2C+V.+R.%3B+Tsaparikos%2C+K.%3B+van+den+Eynde%2C+B.%3B+Wythes%2C+M.%3B+Zheng%2C+X.%3B+Tumang%2C+J.%3B+Kraus%2C+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DB." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Crosignani, S.; Cauwenberghs, S.; Driessens, G.; Deroose, F.</span> Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as indoleamine 2,3-dioxygenase-1 inhibitors. PCT Patent WO 2015173764, Nov 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Crosignani%2C+S.%3B+Cauwenberghs%2C+S.%3B+Driessens%2C+G.%3B+Deroose%2C+F.+Pyrrolidine-2%2C5-dione+derivatives%2C+pharmaceutical+compositions+and+methods+for+use+as+indoleamine+2%2C3-dioxygenase-1+inhibitors.+PCT+Patent+WO+2015173764%2C+Nov+19%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WHR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WHR','PDB','5WHR'); return false;">PDB: 5WHR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK3','PDB','5EK3'); return false;">PDB: 5EK3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2D0T','PDB','2D0T'); return false;">PDB: 2D0T</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00974">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_74582"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00974">10.1021/acs.jmedchem.7b00974</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full list of compounds not showing significant activity on hIDO-1 and statistics for the crystallographic analysis (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_001.pdf">jm7b00974_si_001.pdf (177.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00974/suppl_file/jm7b00974_si_002.csv">jm7b00974_si_002.csv (1.51 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Compound <b>6a</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WHR">5WHR</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00974%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00974" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996667b793d36","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
